Home Blog Page 216

Smartphone use in nursing practice: evolution or revolution?

0

AA female nurse using smartphone

(By Cheryl D. Parker, PhD, MSN, RNBC, FHIMSS)

Since smartphones were introduced in 2002, a communications revolution has taken place. We talk on our smart phones, we text on them, we take pictures and post them to social networks, we communicate in 140-character “tweets,” and share our thoughts and events on our personal networks. We use Smartphone applications to monitor our exercise, manage our calendars, and practice our deep breathing. For many people, forgetting their smartphone causes instant panic.

In health care, physicians’ smartphone use has grown exponentially. Just 6 years ago, I listened as chief information officers (CIOs) at the largest health care organisations in Texas insisted emphatically that a bring-your-own-device (BYOD) policy would never happen in their facilities. Of course, things don’t always go as planned. According to the Wolters Kluwer Health 2013 Physician Outlook Survey, approximately 80 per cent of physicians now use smart phones in their work.

But in the context of nursing practice, the communications revolution is only now starting to make a direct impact. Most nurses continue to use voice-only phones, multiple pagers, or wearable voice-activated two-way communication devices provided by their employers. While we may use smartphones in our private lives, many of us still use outdated communication devices at work. Or do we?

After visiting health care facilities across the country, I’m convinced nurses are in on the communications revolution. I’ve seen them use their own devices—not those provided by their employers—to text other healthcare team members (including physicians) outside the facility, access reference materials, and perform many other functions on their smartphones that aren’t supported by employer-provided technology.

Is this a problem? For several reasons, increasing use of personal smartphones should raise concern for healthcare facilities. (See Infection prevention for smartphones.)

Legal and regulatory compliance

The foremost concern is legal regulatory compliance. Despite hospital policies forbidding use of personal phones by employees during work hours, 67 per cent of hospitals reported in 2013 that their nurses used personal devices to communicate and support their workflow. This means, in effect, that nurses could be violating federal laws (specifically, the Healthcare Insurance Portability and Accountability Act), hospital security policies, and the American Nurses Association’s Code of Ethics. If they’re sending protected health information (PHI) on their smartphones in a way that can be linked to a specific patient, they’re also violating state nurse practice acts. Sending PHI could lead to loss of employment, financial fines, jail sentences, and loss of one’s nursing license.

To make sure they’re not jeopardizing their jobs, nurses must determine if their communication and workflow habits comply with applicable laws, policies, and procedures.

 Cell phone security

What about security? Don’t most people secure their smart phones? In a word, no. Two of five people surveyed don’t take the most basic smart phone security precautions. Criminal hackers are focusing more attention on smart phones than on other electronic devices, according to cyber security experts.

A 2013 survey asked 1,000 full-time American workers to describe their personal smart phone use in the workplace. Among respondents who chose health care as their employment sector, 88.6 per cent said they used their personal phones for work purposes. Among all respondents, 39 per cent said they don’t password-protect their phones. Potentially more dangerous, 52 per cent used their smart phones on unsecured Wi-Fi networks, such as those at coffee shops. Use of unsecured Wi-Fi is a well-known security vulnerability because it can allow for easy phone data theft.

Do you know if your smartphone’s Bluetooth is set to “discoverable” by other devices, such as your hands-free headset? This is another security layer most people don’t think about. Data on an employer-owned phone usually can be deleted remotely if the phone is lost or stolen. This is sometimes called “wiping” or “bricking,” meaning the device is no longer functional because the operating system, programmes, and data have been rendered inoperable. But it’s rare that data on individually owned devices can be deleted remotely. So even if you never use your smartphone for work, ask yourself if you could delete all those pictures, texts, and emails if you lost your phone. Do you have a backup of your phone’s data just in case you have to delete everything?

 Who owns the phone?

Employers have the greatest control over devices they own and distribute. But even in a BYOD environment, employers can require installation and use of applications that provide the necessary security. Policies and procedures help outline what devices are permitted and specify security requirements to ensure password protection. In many cases, the standard four- to six-digit password is not secure enough; a hacker could crack a password such as 654256 in less than one second.

Policies need to spell out clearly who’s responsible for smartphone-related services, including dealing with problems accessing the facility’s secure network. Employers need to decide which applications are allowed, when updates must be performed to maintain application security, and what happens if the employee leaves the organisation.

In a BYOD environment, wiping the device in case of theft or loss becomes an interesting question. If the device is storing both organisational and personal data, both types will be lost in the wipe. What are the rights of the individual and the organisation in this situation? This is another area where policies and procedures must be made clear to all. If you’re using your personal device at work, find out if your organisation has a BYOD policy and ensure that you’re in compliance.

In the future, certain communication exchanges may become part of the electronic health record (EHR). Such data, including pictures, shouldn’t reside on smartphones no matter who owns them, but instead should be stored on a secure server with audit tracking.

 Future of smartphones in nursing

Facilities considering use of smartphones for clinical staff need to think about clinical communication as part of the patient-care process instead of just replacing current phones and functionality. Nurses need choices in communication methods, including secure, encrypted texting and email. Communication must be put in a clinical context to properly identify the patient, who should be at the heart of the communication exchange. Use of pictures, such as of a patient’s wound, should be part of the available communication methods even if the photos can’t be uploaded to the EHR.

Even more important, just as smartphones give us cognitive support in our personal lives, we need to look for solutions that do the same in the complex work of nursing. Just as personal smartphones remind us that our best friend’s birthday is next Saturday, nurses could use employer-provided smartphones and technology to help them in clinical practice.

If you’re asked for input on your organisation’s next communication solution, consider the issues discussed in this article. It’s not enough that your phone can send texts. Is your phone data secure? Can the phone be disinfected? Will it survive the rough-and-tumble health care environment? What’s the vendor’s vision for the future of its platform, and how will it support nursing practice?

Envision the future of smartphones that can assist us both as nurses and in our private lives. And envision yourself using a smartphone in compliance with laws, policies, and procedures in a way that’s safe and secure.

 

References

Baril AF. Electronic medical record & HIPAA violations. Advance Health Network for Nurses. August 30, 2010. http://nursing.advanceweb.com/continuing-education/ce-articles/electronic-medical-record-hipaa-violations.aspx?CP=2. Accessed June 30, 2014.

Cisco partner firms. BYOD insights 2013: A Cisco partner network study. March 2013. www.structuredweb.com/sw/swchannel/CustomerCenter/documents/8523/22089/Cisco_mCon_BYOD_Insights_2013.pdf. Accessed June 30, 2014.

Mayer A. Smartphones becoming prime target for criminal hackers. CBS News. March 6, 2014. www.cbc.ca/news/technology/smartphones-becoming-prime-target-for-criminal-hackers-1.2561126. Accessed June 30, 2014.

Porter C. Calling all germs. The Wall Street Journal. October 23, 2012. http://online.wsj.com/news/articles/Accessed June 30, 2014.

Spyglass Consulting Group. Healthcare without bounds: Point of care communications for nursing 2014. March 2014. www.spyglass-consulting.com/wp_PCOMM_Nursing_2014.html. Accessed June 30, 2014.

Wolters Kluwer Health 2013 physician outlook survey. Wolters Kluwer Health. (n.d.). www.wolterskluwerhealth.com/News/Documents/White%20Papers/%20Study%20Executive%20Summary.pdf. Accessed June 30, 2014.

Cheryl D. Parker teaches nursing informatics at the Walden University School of Nursing in Minneapolis, Minnesota. She is chief nursing informatics officer for PatientSafe Solutions, based in San Diego, California.

 

Experts lament failings in health sector

0
Dr femi olaleye
Dr Femi Olaleye

A seasoned health care management consultant, Dr Femi Olaleye, has bemoaned the seeming incompetence of the current crop of leaders in the health care industry, citing several unresolved challenges in the sector as a proof.

Olaleye, who was speaking on the topic, “Essentials of Clinical Leadership”, at a workshop organised by Pharmanews Limited in Lagos, recently, critically examined leadership qualities as it affects the Nigerian health care delivery system.

In his words: “The issue of leadership, if it comes to health care in Nigeria is bad, and there is no other way to put it better”.

Acknowledging the possibility of health workers attaining leadership position through professionalism, he said it was imperative for such practitioners to learn and acquire leadership skills in order to be successful.

Citing some failures of the health sector leaders, Olaleye noted that Nigeria, at 54, still has huge deficits of health human resources, professionalism, best practices, job description, job roles and team play under universal leadership and co-ordination of medical doctors.

“Clinical team leadership seems to have taken its flight from Nigeria’s public hospitals, with attendant negative consequences on inter-professional relationship and effective service delivery”, he said.

Olaleye opined that crises in the health sector may never be resolved if the leaders fail to improve their orientation and managerial skills. In order to achieve this, he said, they must learn what clinical leadership is all about and how best to achieve result.

He defined clinical leadership as “a set of tasks to lead improvement in the safety and quality of health care delivery, and the attributes required to successfully carry them out”, adding that while good clinical leadership results in excellent patient experience and outcomes, incompetent leadership leads to low staff morale, higher rates of incidents and poor patients experience.

Olaleye also differentiated between leadership and management, describing leadership as setting direction, influencing others and managing change, while management deals with marshalling and organising resources, as well as maintaining stability and growth of the organisation.

He therefore urged leaders of the health sector to aspire to acquire new tools in solving the multifaceted problems.

In his own contribution, Consultant Psychiatrist, Dr Rotimi Coker, harped on the need for health practitioners to effectively manage their stressful environment, as 75 per cent of management staff consider their jobs highly stressful.

The expert, who noted that most health care professionals cannot change their stressors, however pointed out that while stress can add spice to life, it could also be devastating and deadly. He defined stress as “issues that disturb your mental, emotional, social, financial, spiritual or physical status”, describing it as when pressure is higher than coping resources.

The psychiatrist identified sources of stress to include: environmental, social, organisational, life events and daily hassles to mention but a few. He however counselled the participants to note their key stressors and apply suitable techniques such as physical exercise; slow, deep breathing and relaxation among others.

How government aided proliferation of patent medicine dealers – Sir Chukwumerije

0

Sir Chukwumerije

In this interview with Adebayo Folorunsho-Francis, Sir Anthony Azubuike Chukwumerije, a Fellow of the Pharmaceutical Society of Nigeria (FPSN) and first president of the Pharmaceutical Association of Nigeria Students (PANS), revealed how government encouraged proliferation of patent medicine dealers. He also disclosed the reason pharmacy students went on hunger strike in the 1960s and why he thinks pharmacists are the most suited for public offices. Excerpts:

Tell us a little about your educational background

I gained admission into Government Secondary School, Afikpo (now in Ebonyi State) in 1953 and I went to the Nigerian College of Arts, Science and Technology, Enugu,for my G.C.E. Advanced Level studies in Physics, Chemistry and Biology In 1958. I also attended the Nigerian College of Arts, Science and Technology, Ibadan (Oyo State), for my diploma studies in Pharmacy, and the University of Ife, Ile-Ife (now Obafemi Awolowo University) in Osun State, for a degree in Pharmacy.

 Would you say studying Pharmacy was a good decision for you?

Pharmacy was a wise choice,   even   though   there were occasions when   one   had   one’s   doubts. For example, while at school,   we learnt that despite the   fact   that we entered pharmacy school   with   G.C.E.   A   Level papers in   three   core science subjects, we were,on graduation,to be placed at a grade level in the civil service that was lower than that of other graduates. At that time, we went on hunger strike and the school authorities had to beg us to call off the strike after nearly four days. This, notwithstanding, pharmacy students were still the busiest, the happiest and the most sought after in the campus.

How does the pharmacy profession in your day compare to today’s practice?

Pharmacy practice was characterised by fighting within and fighting without (in the civil service). We contended with low salary grading and unfavourable practice environment. There was no job satisfaction, and all the years spent at school seemed wasted. Many left for Medicine and others for Law. Community pharmacy practice was fully rewarding and the few who were in it prospered financially and in health. Quackery was minimal and proliferation of adulterated and fake drugs was not common.

What about the problem of drug counterfeiting?

Dealers incounterfeit drugs could easily be traced and dealt with;while multinational drug companies who   dared sell prohibited drugs to the open market were easily identified and their parent companies in Europe queried and admonished. There was strict adherence to discounts to pharmacies, hospitals and doctors. Indigenous drug manufacturing was at its incipient stages and only multinational companies imported drugs and medicinal products.

Soon after, drug detailing started and the early pharmacists who were in it had chauffeur-driven flashy cars and enjoyed bountiful allowances. Then the civil war set in and, after it, every person became a drug seller and governments introduced import licences for importation of drugs, even   to moneybags   who   never went   to school. Abuse inevitably set in and remains uncontrollable.

Did you also contend with the issue of multiple registration of premises?

The Supreme Court’s interpretation of “in continuous supervision” of a premises has finally settled that (the   issue of multiple premises for practitioners) and   considerably reduced the take­home income of our   members, while medical practitioners got away with multiple clinics.

As I earlier mentioned, counterfeit, sub-standard and adulterated drugs are still everywhere. When   Chief Akuneme (now late) was the Chief Inspector in Eastern Nigeria, he would trace any drug classified as poison found in any marketplace to its original manufacturer in Europe or anywhere and inquire why such a drug should be found in the shop of a person not licensed to practise as a pharmacist. Any dealer in counterfeit, sub-standard or adulterated drug was promptly prosecuted.

Some state governments themselves encouraged sale of drugs in open markets by issuing drug importation licences to unqualified persons. Pharmaceutical inspectors were few and could not cope with the problem. Schools of pharmacy were few and only a few pharmacists could be produced. Consequently, community pharmacists already restricted by law to one premises each,could not cope with the expanding population, and colluding governments seized the opportunity to proliferate patent and proprietary medicine stores.

Predictably, in a very short time, the patent medicine dealers outnumbered qualified pharmacists and having saturated the towns, they invaded the open markets, formed very strong unions, and overwhelmed the few fearless pharmacists who wanted to do honest business. The situation has persisted even though the late Director-General of NAFDAC, Dora Akunyili,   dealt severe blows on counterfeiters, open market drug dealers and importers of fake and sub-standard drugs.

What is your view about pharmacists in politics?

I have always advocated that pharmacists should be in politics. We are the only health professionals properly trained to handle men, money and materials. Remember that pharmacy is a profession, a science and a business. Tell me of any business that is more complex than politics and government? If pharmacists are in government, they will correctly interpret the pharmaceutical component of any health bill to their colleagues and be in a position to challenge assaults on pharmacists in any area of practice.

How best do you think the issue of fake drugs and counterfeit medicines can be curbed?

I have earlier suggested that to curb fake drugs and counterfeit medicines, a competent and incorrupt pharmacist should head NAFDAC. Some state directors of pharmacy are also corrupt and issue patent and proprietary medicine licences recklessly; andthey hardly go oninspection nor have a strong inspectorate division.

In our time, part-time inspectors were appointed from practitioners to complement the scarcity in government. Even though governments in Nigeria pay lip service to local manufacturing, I have   not   seen any incentive to local manufacturers of anything. All sorts of things are imported freely into this country; and these include drugs.

To what extent did you participate in pharmaceutical activities?

I was the first president of the Pharmaceutical Association of Nigeria Students (PANS). We started fighting for pharmacy while at the university and I remember being called to the office of the then Vice Chancellor, the Late Prof. Oluwasanmi, to be persuaded to ask pharmacy students to call off their strike and go back to the classroom.

At the end of the Nigerian civil war, I found myself in Enugu.   I enrolled with   the   Enugu   State branch of the PSN, became its Assistant Secretary, then   Secretary, then Assistant Chairman and finally, Chairman. I was member of council for several years and served in various committees both at the state and national levels. This culminated in my award of the Fellowship (FPSN) in 1985.

What is your impression about the annual PSN national conferences?

The annual PSN conference was instituted in our time and pharmacists generally loved it. I remember that as a younger man, I never   missed any PSN or FIP conferences but age has many limitations including less travelling and limited resources. These conferences afford opportunities for   interaction, fellowship, updates in scientific advances, getting to know places and asking questions on confusing issues. Branches and more affluent members should occasionally sponsor older colleagues to some of these conferences.

 Should an active pharmacist be made to retire?

My answer is yes ­ when he can   no longer   understand advances in the profession and would therefore not counsel properly on the correct and safe use of drugs. In my opinion, all professionals should retire at the age of 80 and like the psalmist, number their days to apply their hearts unto wisdom.

What is your advice to young pharmacists?

Young pharmacists should learn to appreciate their profession and do whatever they can in their practice area to adhere to good and ethical practice. The present acquisitive proclivity of the youth is condemnable. Wealth comes through hard work and faith in God whose wish is that we should prosper and be in health, even as our souls prosper. If we all practise ethically and not abet quacks and counterfeiters, no pharmacist has business with poverty.

Why Seagreen launched Gvither Plus and Klovinal – Product manager

0

In this exclusive chat with Temitope Obayendo, a product manager with Seagreen Pharmaceuticals Limited, Pharm. Abiola Akinwunmi, explains the company’s vision for the health care needs of Nigerians and why it recently launched two key products into the Nigerian market. Excerpts:

Could you tell us a bit about Seagreen Pharmaceuticals Ltd?                

Seagreen is a fully indigenous pharmaceutical company incorporated in Nigeria. The company commenced operations in 2010. We are a company wholly committed to enhancing the health and wellness status of the Nigerian society. We see a Nigeria where every individual has access to basic essential medicines regardless of their socio-economic status.

Seagreen Pharmaceuticals Limited specialises in manufacturer’s representation, maintenance of scientific offices, importation, distribution, sales and marketing of pharmaceutical products. Our product portfolio includes drugs for management of tropical diseases, anti-infectives, drugs for management of chronic diseases, paediatric health, obstetrics and gynaecology and daily healthy living products.

We continuously scan the health care landscape to come up with products that can deliver exceptional value to health professionals and patients alike, in terms of quality, efficacy and relevance to the health care burden of the society. We specially focus on key challenges in the management of common tropical diseases and essential medicines for women and children’s health needs. Recently, we launched two products to tackle highly prevalent conditions in Nigeria – Gvither Plus, for malaria and Klovinal, for female genital tract infections.

 Could you further explain why you decided to produce Gvither Plus?

The endemicity of malaria in Nigeria, coupled with the high incidence of treatment failures, prompted our search for a solution. Seagreen consequently collaborated with a leading company in the antimalarial therapy field in Africa, Bliss GVS, to avail the society of an efficacious antimalarial product. Bliss GVS has evolved substantial expertise in the antimalarial market in Africa, being the company to pioneer the 80/480 Artemether-Lumefantrine formulation and also Dihydroartemisinin-Piperaquine combination. The company’s antimalararial brands are well known and trusted in over 40 African countries. Gvither Plus is a uniquely cost-effective combination of Artemether and Lumefantrine. Currently, Artemisinin-based combination therapies are the mainstay of malaria treatment and Artemether-Lumefantrine is a well-tolerated and effective ACT.

 It is commonplace for an individual that is down with malaria to use three to four brands before getting well. What is responsible for this?

The need to repeat courses of antimalarial drugs could result from recurrence following treatment. Recurrence of malaria has been attributed to repeat infections, relapsing malaria and recrudescence. Recrudescence is caused by failure of a course of antimalarial treatment and it accounts for majority of cases of recurrence.

The WHO guidelines for malaria treatment notes that treatment failures could result from drug resistance, poor adherence and inadequate exposure to the administered agent. Here, we talk about low quality substitute drugs that, in themselves, promote drug resistance, sub-optimal dosing, and lack of dosing consistency and even outright use of the wrong drugs.

Treatment failures can be minimised by careful selection of antimalarial brands to guarantee quality and efficacy. Brand selection must take bioequivalence into cognisance. Not all substitute brands will achieve the same drug target concentrations as brands that have been tested and proven over the years.

Repeat infections can be reduced by eliminating or minimising exposures to the disease vector, mosquito bites. Proper hygiene and environmental sanitation go a long way to reducing breeding of mosquitoes. Use of insecticides and insecticide treated bed-nets is also a viable means of controlling malaria spread.

Self-diagnosis of malaria by patients is also rampant. Misdiagnosis is as such common, since symptoms of malaria may mimic symptoms of other common ailments such as influenza and typhoid fever. Rapid malaria diagnostic kits are now available to reduce misdiagnosis.

 What are the properties inherent in Gvither Plus which make it unique compared to other antimalarial drugs?

Gvither Plus represents a solution to antimalarial treatment failure. The brands positive attributes include the manufacturer’s track record and competence, assured quality and convenience of administration.

The brand is manufactured by Bliss GVS, a company that has a track record as a leader in antimalarial therapy across Africa. The company manufactures the constituent drug molecules of Artemether and Lumefantrine; this eliminates inter-batch variability so the issues of bioequivalence and quality assurance are addressed.

Gvither plus also promotes dosing compliance. It is formulated as 80/480 tablets for adults. That means just a single tablet is required for each dose. This reduces the pill burden on the patient, provides convenience and promotes compliance.

Treatment failure in children is also common. Here lack of dosing accuracy and consistency plays a major role. The paediatric formulation of Gvither Plus is presented as pleasantly flavoured dispersible tablets. Children find this more palatable and so adherence is improved. Dosing variation and inaccuracy is usually due to human factors introduced by carers that administer the drug, Gvither plus dispersible eliminates this risk because each dose has been carefully measured into a tablet. No measurement is therefore needed on the part of the patient’s carer.

 WHO’s prequalification is gaining credence in the country, and the continuity of this trend may spell doom for pharma manufacturers without the qualification. Is there any plan to get the qualification for your brands?         

Our mission at Seagreen is closely aligned with the WHO’s purpose for prequalification – provision of quality-assured priority medicines. With Seagreen, the goal is to make available good quality pharmacotherapy options for the management of prevalent healthcare challenges in the country. Hence the company adopted a proactive approach to quality right from inception. This has ensured that Seagreen’s activities would not be significantly affected by the prequalification requirements.

We maintain a stringent prequalification and selection process for our manufacturers. Our main manufacturer, Bliss GVS, operates a Total Quality Management (TQM) system that has been validated and accredited by WHO GMP, EU GMP, PIC/S, ISO and NAFDAC.

 In this age of counterfeiting, how do you ensure quality for your customers?

At Seagreen, we hold quality close to our hearts. Apart from this, we have invested in the MAS. Gvither Plus comes with the scratch cards that enable verification of the authenticity of each product pack by the end user. We also invest in other quality monitoring and enhancement activities, including distribution channel and market surveillance.

 Klovinal is another new product from Seagreen Pharma. Could you tell us more about it?

Research has it that, annually, up to 40 per cent of women would suffer episodes of non-sexually transmitted urogenital infections, leading to vaginitis; and over a million and half Nigerian women have recurrent fungal forms of vaginitis annually. These require at least four treatment courses annually.

Infective vaginitis is characterised by abnormal malodorous discharge, itch, burning sensation and dyspareunia. Mixed infections are common. Recurrence is a major challenge to the pharmacotherapy of vaginitis and recurrent vaginitis is a risk factor for sexually transmitted infections including HIV.

Seagreen, being a customer responsive company decided to respond to the yearnings of the health care industry for a solution that can provide sustained cure against vaginitis. This heralded the launch of Klovinal.

Klovinal is a brand of polyactive pessaries introduced by Seagreen in the course of the company’s last business year. It is specially designed and formulated for the management of vaginitis due to bacterial, fungal, protozoal organisms. Klovinal has a spectrum of antimicrobial activity that covers the three most prevalent forms of vaginitis, which are bacteria vaginosis, vaginal candidiasis and trichomoniasis. It is therefore suitable for empirical or syndromic management of vaginitis including mixed infections.

 What elements distinguish Klovinal from competitive brands?

Klovinal is, indeed, a veritably unique product in its category. It represents a whole paradigm shift in the management of vaginitis. Moving from merely eradicating pathogenic species to a system where microbiological cure is augmented by re-establishing the dominance of the healthy normal flora.

Klovinal is different from other agents useful in the management of vaginitis by the following factors: Firstly is its unique composition. Klovinal consists of three active agents – Metronidazole, Clotrimazole and Lactobacillus spores co-formulated as pessaries. The first two actives confer efficacy against the common forms of vaginitis, while Lactobacillus is included as a probiotic. Probiotics, according to the WHO, are live microorganisms which are administered in adequate amounts for health benefits in the human host system. So we purposefully use a species of microorganism to inhibit other pathogenic species.

The essence of the combination is to achieve the dual purpose of achieving microbiological cure and restoring the dominance of the normal healthy vaginal flora with the same agent. The outcome is efficacy against mixed infection and minimisation of the risk of recurrence. This is the first agent available in Nigeria to achieve this.

Secondly, Klovinal is manufactured with outstanding attention to quality in the pessary laboratories of Bliss GVS. That manufacturing facility is WHO GMP compliant, EU GMP compliant, ISO14001 and PIC/S.

Thirdly, Klovinal is produced using a new and innovative formulation technique, termed, SMEDDS – Self Micro Emulsifying Drug Delivery System. SMEDDS guarantees that the pessary will melt rapidly at body temperature and uniformly coat the affected surface. So, with Klovinal, you are sure that the pessary releases the active drug to the site where it is required. Women will not wake up to find administered pessaries falling off wholly or partially without having elicited any effects.

 What is your vision for these products in the next five years?

I sum that up as “sustained relevance”. Health care science and practice are dynamic. In five years, it is our desire that Seagreen attains greater relevance in the health care system; and we are vigorously pursuing this. We are also positive that the products would have attained full acceptance as veritable health care solutions and, barring any major evolutions in science and knowledge, that the health care community would find them dependable allies in the management of the disease conditions.

 

The National Health Act and the road ahead

0

 The year 2014 ended with the signing of the harmonised National Health Bill by President Goodluck Jonathan. The Bill, which is now an Act of Parliament, is designed to provide a framework for the regulation, development and management of a National Health System and set standards for rendering health service in the country. Among other things, it provides a comprehensive integration of the functions of the different sectors of health care in Nigeria and provides a description of “The National Health System”.

The Act, which was long in coming, and the processes heralding the emergence of the harmonised version, which is believed to have been signed by the president, reflect the nature of the peculiar challenges facing the Nigerian health care industry. The sheer magnitude of the inter-professional rivalry that exists in the Nigerian health care sector was unveiled in the events leading to the presidential assent.

It is particularly notable that, at the news of the signing, President of the Pharmaceutical Society of Nigeria, Pharm. Olumide Akintayo, in his congratulatory remarks, expressed some reservations, particularly of his hope that the landmark document was not doctored after the harmonised version had been passed at the National Assembly. Prior to the harmonisation, the PSN and other associations had fought hard to ensure that specific clauses that favoured only medical doctors in the operation of the health care system be removed. Though the harmonised copy passed by the National Assembly reflects the success of their efforts, we are yet to confirm if it was the same one endorsed by the President.

In a statement signed by its President, the PSN said: “the harmonised version of the National Health Bill signifies the first time the borders of restriction in health care were opened as major Health professional associations and trade unions are represented in key structures of the new Health Act”. The Act, among other things, makes it a legal statute that 1 per cent of the consolidated revenue of the Federal Republic of Nigeria be dedicated to the funding of Primary Health Care. Though this represents a progressive effort in the right direction, it still does not reflect the realities of the Nigerian challenge. Considering that diseases like malaria account for 60 per cent of outpatient hospital visits in Nigeria, Primary Health Care in Nigeria needs greater attention – one that is embedded in a health insurance system that is adequately funded and managed.

At present, going by the 2013 and 2014 budgets, less than 6 per cent budgetary allocations were made to the health care sector, as against the agreed on 15 per cent in the Abuja declaration by African Heads of States in 2001.It is expected that the funding in 2015 would be even far less, considering the dramatically reduced government earnings, as a result of the global fall in oil prices. Our concern is that, given the level of bickering among health care professionals, the shrinking oil revenues and the present low level of health care funding, there are very tough times ahead. Hence, in as much as we must congratulate ourselves that we now have the Health Care Act, it must be emphasised that the journey is just beginning.

The next vital step is to design a pragmatic implementation system that is focused on the national health insurance structure – one that seeks to protect the lives of Nigerians in the days ahead, guaranteeing access to basic care, making the most of the 1 per cent of consolidated revenue commitment enshrined in the Health Act, while we ask for more.To achieve this, the Federal Government must, once and for all, take up the serious challenge of resolving the inter-professional bickering in the Nigerian health care sector, as this management challenge alone contributes a major bulwark hindering efficiency in the sector.

 

Commercial transactions 1: When is there a contract?

2

Legal Angle

While reading the daily newspaper, Mrs Uche comes across an advert for Multivitamin Blood Tonic. She is informed that the product is available at Allen Pharmacy and immediately decides to purchase one when she goes shopping later in the day. On getting to the pharmacy, she sees the sales girl, Stella, who is busy attending to other customers. Mrs Uche picks up a shopping basket and proceeds to select the only bottle of Multivitamin Blood Tonic on the shelf, along with some baby food and household products.

Meanwhile, Stella receives a phone call. It is Madam Tinubu, her regular customer. Tinubu calls to enquire about the blood tonic. Stella confirms that there is one bottle left and promises to keep it for her. Fortunately, the price of the blood tonic can be deducted from a refund that Madam Tinubu was meant to have collected from the pharmacy earlier. Tinubu is happy about this and promises to pass by in the morning to pick up the blood tonic and the balance of her refund.

By the end of the call, Mrs Uche gets to the counter and offloads the contents of the shopping basket with the intention to pay. A serious argument erupts between the two ladies. Stella tries to explain that she has already sold the blood tonic to her regular customer. Mrs Uche, on the other hand, refuses to give up the product, having responded to an advert, driven all the way to the pharmacy and picked up the blood tonic from the shelf.

The question is, who has the legal right to this product?

In law, every business transaction is premised on a contract. A contract is defined as an agreement between two parties which is enforceable. For a contract to be valid there must have been an offer by one party and then an acceptance by the other. Commercial transactions would be problematic if there were no principles governing the conduct of business. The law of contract covers every field of human endeavour.

The scenario above raises some legal questions:

  1. Are the elements of a contract present to make the transaction valid?
  2. What constitutes an offer?
  3. What distinguishes an offer from an invitation to treat?
  4. At what point is the agreement for sale reached?

The foremost authority on Nigerian Law of Contract, Professor Sagay, defines an offer as “a promise made by one party with the intention that it shall become binding on the party making it, as it is accepted by the party to whom it is addressed.” An offer must be precise, leaving no room for speculation.

The offer may be expressly communicated or implied by action. Everyday in life, we engage in activities that constitute the making of offers: When we call for a newspaper from a vendor; when we get into a bus or taxi; when we drive into a petrol station to refuel or when we place an order for food at a restaurant. Each of these actions constitutes an offer to do business with another party.

However, for an offer to be capable of binding the person making it, the offer must be clear and final. If the act is a preliminary step taken towards making the actual offer, it is termed in law, an invitation to treat. In the classic case, Carlill v. Carbolic Smoke Ball Co., the judgement held that when someone offers to negotiate, or issues advertisements that they have got a stock of books to sell (for instance), “there is no offer to be bound by any contract. Such advertisements are offers to negotiate – offers to receive offers.”

In the case at Allen Pharmacy, it is necessary to pinpoint exactly when a valid offer was made in the transaction. We have seen that a newspaper advertisement was published. It may be the view of some that such an advert constitutes an offer for sale of the specific product. Nevertheless, the law is very clear on this issue. The publication of the advert is merely an invitation to potential buyers to come and make offers for purchase. The advertiser reserves the right to reject offers from members of the public who respond to the advertisement.

In this case also, goods were displayed in the shop for the purpose of sale to buyers. It could be argued that the display of goods, in this manner, is an offer for sale which could be accepted, culminating in a valid transaction. On the contrary, in the case of Pharmaceutical Society of Great Britain v. Boots Cash Chemists, it was held that “goods are merely displayed to enable customers to choose what they want and that the contract is not completed until the shopkeeper or someone on his behalf accepts the offer after the customer has indicated the articles he needs.”

It therefore means that the act of selecting a product from the shelf and presenting at the counter is itself the offer that is made. In a shop situation, it is the buyer that makes the offer and the seller that decides whether or not to accept.

In view of this, it was the act of the phone call from Madam Tinubu that constituted a valid offer for purchase. This offer was accepted, resulting in a contract. In conclusion, even though Mrs Uche had received an advertisement; gone to great lengths to make the purchase and actually picked up the product from the shelf, she had not made an offer at the time the phone call came through, leading to the sale. In essence, the blood tonic now belongs to Madam Tinubu who had made a valid purchase over the phone.

 

Principles and cases are drawn from Sagay: Nigerian Law of Contract

Now that ACTs appear to be failing

1
Nelson Okwonna
Pharm. Nelson Okwonna

 

It is no longer news, at least to general practice doctors and community pharmacists that our cherished Artemisinin-based Combination Therapies (ACTs) appear to have begun to fail. Though no one has produced a clinical trial documenting the scale and nature of this development in Nigeria, products sourced from leading proprietary and generic brands have been reported by some health care providers to be ineffective in achieving total clearance of the malaria parasite from the bloodstream as they once did. These observations are in volumes too numerous to be completely discounted.

There are many possible reasons for these observations. The first culprit could be poor diagnosis by the clinician. Next are adulteration and the use of mono therapy; and then the one we fear the most – resistance by the protozoa.

Most of our antimalarial medications are sourced from India and China and if one should go by the recent USFDA’s concerns about the quality of medications from these two countries, we might have a lot to be worried about. A notable pharmaceutical company in India, for example, was fined $500 Million dollars by the US FDA in 2013 for seven felony counts related to data fabrication about the safety of the company’s products over the prior decade.

The question is, if the United States could experience such massive scale adulteration by a renowned company, what could be the case for Nigeria, where we are yet to publicly indict any foreign pharmaceutical company? However, we believe that NAFDAC is doing a lot to protect the interests of Nigerians by ensuring consistency in the quality of antimalarial medications in the market.

That said, let’s assume that this is not a case of adulteration but rather, of resistance, which could as well have been caused by adulteration. Let us now evaluate a scenario where the malaria parasite is developing resistance to our therapy.

 In the event of resistance to ACTs

At present, malaria accounts for more deaths and morbidity in Nigeria than in any other country in the world. At least, a whopping 300,000 individuals die annually from malaria in Nigeria. That is about 34 individuals per hour.

Each year, Nigeria experiences more than a 100 million malaria episodes. What this means is that if, for any reason, we fail to not have a cure for malaria, in one year alone, we would be facing an epidemic of monumental proportions. It is therefore right that we endeavour to evaluate scenarios like this so that we can, at least, prepare. It should be borne in mind that there are countries where ACTs have been proven to have failed.

One important thing to note is that, unlike Ebola, we could be facing this alone. Again, if our experience with Ebola and available therapies are anything to go by, the picture is definitely not an exciting one; hence my decision not to shy away from this article, regardless of how gloomy things may appear.

As health care practitioners, our job includes preparing for such public health emergencies and from our training, the following are obvious indicators we could use to evaluate our preparedness for such a day:

  1. The presence of a long term strategic commitment
  2. Institutional mandate
  3. Ongoing research and development projects
  4. Public–private ownership of the development challenge

Essentially, we need to ask ourselves if there is a long term strategic commitment by anyone, public or private, in preparing for a day like this. Is there an institution whose mandate includes harbouring and managing such a commitment? Are there sufficient will and resources deployed in the form of research and development projects to reflect such commitments? If there are, do we have sufficient local engagement of the stakeholders – both private and public – in ensuring the feasibility of such endeavours?

Presence of a long term strategic commitment

A study of the Ebola scenario offers some interesting highlights, one of which is that there was a long term strategy for the virus disease. Somebody was worrying about what could happen and was doing something about it. ZMapp, for example, represented a wonderful demonstration of the power of effective partnerships between public research organisations and the private industry. For such partnerships to occur, there must have been strategic commitment.

At present, malaria receives massive funding from a wide diversity of donors. In 2012 alone, funding for malaria control peaked at US$ 2.5billion, representing more than a fivefold increase since 2004, when funding was less than US$ 400 million. At the center of these interventions, specifically for drug treatments, are the Artemisinin-based Combination Therapies (ACTs). ACTs are recommended as the first-line treatment of malaria caused by P. falciparum, the most dangerous of the Plasmodium parasites that infect humans. By 2012, 79 countries and territories had adopted ACTs as first-line treatmentfor P. falciparum malaria.

According to the 2013 WHO World Malaria Report, parasite resistance to artemisinins has now been detected in four countries of the Greater Mekong sub region: Cambodia, Myanmar, Thailand and Viet Nam. In Cambodia’s Pailin province, resistance has been found to both of the components of multiple ACTs; therefore, special provisions for directly observed therapy using a non artemisinin-based combination (atovaquone+proguanil) have been introduced.

One could say with confidence that there is a commitment to research and development of new antimalarials, but if we are to judge by recent occurrences, such commitments have not yielded a product yet.

Institutional mandates

Still on the Ebola scenario. A study of the efforts made by the US government to prepare for an Ebola Virus Disease situation shows a strong degree of long–term cohesive thrust between different organisations that include the National Institute of Health (NIH), Centres for Disease Control and Prevention (CDC), the United States Army Medical Research Institute of Infectious Diseases (USMRIID), the Canadian government and a host of private pharmaceutical firms.Apparently, each member of the partnering group had been preparing for a time like this and the outbreak was simply an opportunity to evaluate their degree of preparedness.

One could point out that the United States, in particular, had reasons to take the Ebola Virus Disease seriously – considering that there are no known cures for EVD and that Ebola virus constitutes a potential biological weapon. That said, should malaria not be of more concern to Nigeria at least – considering that we bear the largest global burden of the disease?

Going by the volume of funding dedicated to malaria control and the plethora of organisations involved in its disbursement, one could say that “yes, there is a long term strategic commitment. Institutions like Global Fund, World Bank, WHO, National Malaria Control Programme and the Ministry of Health, are the ones leading such interventions in Nigeria.

Ongoing research and development projects

This is one area that I am bit bothered about – not necessarily about the volume of the interventions but in their ownership. Preliminary investigations suggest that there is no ownership, at least in Nigeria, of the much needed research and development endeavours required to prepare for this eventuality – the failure of ACTs, a scenario that is quite predictable.

We all know that, in no distant time, we are going to have increased resistance to ACTs and that Nigeria bears the world’s largest global burden; yet it appears there are insufficient coordinated efforts in preparation for this eventuality. Some of the events seen in the management of the Ebola outbreak suggest that in situations of national emergencies like the one seen with the Ebola Virus Disease, it is possible that seemingly available therapies can be withheld on various grounds.

Ownership is very important. Yes, there are ongoing research and development efforts in finding malaria therapies which, by the way, are not as many as the level of R and D investment in HIV although malaria kills more people than HIV in Nigeria. The issue is that I do not think Nigeria owns these efforts; if it does, it would show in the level of funding dedicated to it.

The National Institute for Pharmaceutical Research and Development (NIPRD), in my opinion, should be leading such an effort. I know they are working on some antimalarial projects, yet the level of funding dedicated to such ventures is abysmal by any standard. Considering the magnitude of the scenario, it should be a national emergency and a malaria research and development tax could be justified if our government believes the problem is insufficiency of resources.

Public-Private ownership of the development challenge

As mentioned earlier, the Nigerian government, through appropriate parastatals, should be engaging other public and private organisations to ensure effectiveness and efficiency. These organisations could be national or international. The private sector, because of their profit motive, bring a certain level of efficiency in their operations and their partnerships as shown also with the USA management of the Ebola scenario are critical in the timely delivery of intervention.

In the Nigeria scenario, government intervention could provide the impetus for private pharmaceutical firms to invest some resources to finding new antimalarial medication.

 Heading home for answers

One area I believe we should look closely at is combination therapies – that is, of combining our local indigenous herbs/extracts with known existing therapies. The ACTs were born in like fashion.

 

Neros CEO launches ‘Entrepreneurial Spirits’

1

Managing director/CEO, Neros Pharmaceuticals Limited, Chief Poly I. Emenike, has launched a new book, “Entrepreneurial Spirits”.

Neros Entreprenuer
L-R: Chief Poly I. Emenike, managing director/CEO, Neros Pharmaceuticals Limited and author of the book, ‘Enterpreneurial Spirits’; Mr Emeka Onwuka, former MD/CEO, Diamond Bank Plc and chairman of the occasion; and Prof. Pat Utomi, keynote speaker, during the book launch, held at the Nigerian Institute of International Affairs, Victoria Island, Lagos, recently

Published by Napoleon Hill Foundation, USA, the book is aimed at propagating the teachings of Dr Napoleon Hill, reputed to have inspired many people the world over to achieve financial success,

The memorable book launch, held at the Nigerian Institute of International Affairs, Victoria Island, Lagos, and chaired by Mr Emeka Onwuka, former MD/CEO, Diamond Bank Plc, was graced by distinguished Nigerians, among whom were: Prof. Pat Utomi, Prof. Ben Oghojafor, Chief Olubukunola Okunowo and Dr Helen Ekwueme, wife of former vice president, Dr Alex Ekwueme.

Speaking at the occasion, the author, Chief Emenike, said the book represented his humble contribution towards the expansion of the frontiers of knowledge through writing, adding that ‘Entrepreneurial Spirits’ is the story of how he climbed from the very bottom to the pinnacle of the success ladder. He added that, in the book, he directly acknowledges the far-reaching influence which the writings of Dr Napoleon Hill had had on him in his quest to achieve success in life.

The book, Chief Emenike further said, is “therefore a lucid exposition of the fact that Dr Hill’s success principles can work for people in Nigeria, nay, Africa – just in the same manner as it has continued to work for people in Europe, the Americas and, indeed, the world over.”

The Neros boss also explained that the book was written essentially to teach Nigerians how to employ the power of the mind to their greatest benefit, and to also show how to develop and maintain a positive mental attitude at all times in order to achieve the success they desire in life. He said the book also serves to localise the teachings of Dr Napoleon Hill, since they have universal applications.

Chief Emenike urged other eminent Nigerian leaders in various sectors to document their experiences in writing for posterity, noting that knowledge gained from reading the writings of present day leaders would be useful to the young ones when they assume leadership positions.

Professor Utomi, who was the keynote speaker at the occasion, said Chief Emenike represented a special breed to showcase to the next generation, adding that the author was an example of the saying that ‘if you can dream it, you can make it happen.’

Prof. Utomi, who bemoaned the current obsession with materialism in the country, noted that society is not built by the size of a man’s car or how much is in his bank account, but by people who think. He disclosed that Chief Emenike has continued to read as he builds businesses because he knows that to build is to know, adding that what the Neros boss has done by writing ‘Entrepreneurial Spirits’ is to tell the present and coming generations that it can be done. He stated further that, for the generations to learn about how to climb the ladder of success, they have to read, insisting that motivating them to read should be the concern of all.

Earlier in his opening remarks, chairman of the occasion, Mr Onwuka, urged Nigerians to read the book because it would help change their lives. He added that the book is a must read for anyone aspiring to be successful.

Also at the occasion were Pharm. (Sir) Ifeanyi Atueyi, MD, Pharmanews Limited; Pharm. (Sir) Nnamdi Obi, MD/CEO, Embassy Pharmaceuticals and Chemicals Limited; Dr Obiora Chukwuka, chairman, Greenlife Pharmaceuticals; and Mr Emma Umenwa, MD, Geneith Pharmaceuticals, amongst others.

 

Becoming successful through self-actualisation drive

2
 Dr Lolu Ojo
Dr Lolu Ojo

 

 

 

 

 

 

Self-actualisation is a term that was first used by Kurt Goldstein in 1939 to describe the ‘tendency to actualise, as much as possible, the (organism’s) individual capacities’ in the world. Abraham Maslow made the term more popular when he developed a hierarchical theory of human motivation in his book, Motivation and Personality (1954). Maslow defined self-actualisation as ‘the desire for self-fulfilment, namely, the tendency for him (the individual) to become actualised in what he is potentially…to become everything one is capable of becoming’. A simple textbook definition is ‘the full realisation of one’s potential’.

The purpose of this piece is not to discuss the theory and details of human motivation as expounded by Abraham Maslow and other renowned scholars but to briefly examine the route that pharmacists (and in fact, all young Nigerians) can take to self-actualisation. However, we will be relying on the writings of Abraham Maslow and other motivational personalities like Prof. Fola Tayo (Designed for Success, Engineered for Accomplishment, 2013) to chart the way forward.

 

Essence of education

According to Maslow, ‘What a man can be, he must be’. Simply put, if you are capable of scoring 90 per cent in an examination, you should not be satisfied with 70 per cent mark! Education is best defined as ‘the training of mind and character’. As a pharmacist, your mind and character have been trained and prepared to take on the world before you and be the best you can be. You are expected to make the full use (exploitation) of your talents, capacities and potentialities – your environment of operation notwithstanding.

Maslow also told us that ‘the story of the human race is the story of men and women selling themselves short’. With experience, we are almost giving credence to this assertion such that it can be said that the story of pharmacists in Nigeria is the story of men and women selling themselves short! We are challenged in all the areas of practice and we are desperately in need of self-actualisers to serve as role models.

A self-actualiser is a person living creatively and fully using his or her potentials. I will urge all to read more about the 13 characteristics of self-actualisers as written down by Abraham Maslow. This knowledge will help you to stay above your environment.

 

Excellence despite environment

The time is now to stop talking about the limitation of our environment. The attention should now be focused on the individuals and his or her desire to be self-actualised.

According to Abraham Maslow, ‘what is necessary to change a person is to change his awareness of himself’. Since you left school, have you taken a self-examination about who you are and what you have achieved so far? What is stopping you from getting to highest point of the ‘life ladder’, i.e. a higher purpose of human existence?? This self-examination includes answering several questions about yourself and your life journey:

  1. What do you want in life?
  2. If you do not GO after what you want or desire, you will NEVER have it.
  3. If you do not ASK, the answer will always sound like a NO.
  4. If you do not step FORWARD, you will ALWAYS be in the same place.
  5. If you REMAIN in the same place, you will NEVER SEE what lies ahead of you.
  6. If you DO NOT KNOW what lies ahead of you, you will never ASPIRE.
  7. Do you really know yourself?
  8. Who are you (talents, competencies, skills, knowledge, contacts, strengths, weaknesses, aspirations, etc.)?
  9. Why are you here (or what are you doing here): in the profession, work, societies, church/mosques, etc.?
  10. What is so special about me that I am chosen to perform this task? Are others not available?
  11. What is your destination?
  12. What can you make of your stay here?
  13. Do you have a plan for success?
  14. Where are you now? A situation analysis: defining life’s journey, successes, failures and opportunities.
  15. Where do you want to be? Statement of intent describing the expected output of a plan. Mission, goals, objectives, targets.
  16. How will you get there? Implementation strategy, activities or tasks, etc.
  17. How will you that you have arrived? Measurement, discipline, monitoring and evaluation.
  18. A plan is your vision embodied. Seeing what others are not seeing and communicating between the present and the future. It is an evidence of hope, an expression of aspiration which prepares the planner for a journey into an unseen reality. It is an essential ingredient of success without which self-actualisation may be impossible to attain.
  19. Are you aware of the Do’s and Don’ts?
  20. Never undertake any task that was not planned (Failure is built in already)
  21. Never take NO for an answer.
  22. Do not underestimate or overestimate yourself.
  23. Always expect accomplishment and success.
  24. Do not enter into the train of procrastination.
  25. Live everyday conscious of who you are.
  26. Time is a precious gift that can never be regained when lost. Run away from time devourers.
  27. Don’t make friends with ‘planless’ people.
  28. Be focussed and remain diligent even in adversity.
  29. Document all your activities, thoughts and plans

Expanding your horizon

We may not be able to exhaust the list of things to know or to be done in a single piece. What is important is that you change the awareness of yourself and this could lead to a permanent change in your life. We will give more attention to planning in this column in the nearest future.

There is something you should always remember: ‘If the only tool that you have is a hammer, you tend to see every problem as a nail’ (Abraham Maslow). It is therefore important for you to constantly update your knowledge base, developing skills and competencies and stay above your environment. Surely and steadily, you will get there.

HealthPlus to open 48 branches in 2015

1

 – As JNC International boss canvasses harmony in health sector

Managing Director and Chief Executive Officer of the HealthPlus Group, Pharm. Bukky George, has announced that the company, rated as the fastest growing pharmacy chain in West Africa, would add 48 new branches to the existing ones in 2015.

HealthPlus
L-R: Pharm. Bolanle Adekoya, head of pharmacy department, Lagos University Teaching Hospital (LUTH); Pharm. Lekan Asuni, managing director of GlaxoSmithKline; Pharm. Bukky George, MD/CEO of HealthPlus Group; Pharm. Lolu Ojo, former chairman, National Association of Industrial Pharmacists (NAIP); and Pharm. Clare Omatseye, founder and Managing Director of JNC International Nigeria Limited.

 Speaking at the 7th annual thanksgiving dinner and awards ceremony which coincided with the company’s 15th anniversary, held at the Civic Centre, Victoria Island, Lagos on 15 December, 2014, the pharmacist remarked that she was happy that HealthPlus, Nigeria’s first integrative pharmacy store, had become the pride of Pharmacy.

“15 years is a major milestone for us,” Pharm. George recalled. “I still remember how we started from the 18 square-metre room in Ikeja, GRA, with three staff. We ensured that there was a pharmacist always on duty. We never paid lip service and, in 2011, we opened our first branch outside Lagos in Abuja. Today, with 40 branches nationwide, HealthPlus has become the pride of Pharmacy and the beauty industry.”

While crediting the success of the chain to her ‘people’ (the staff), the pharmacist said she was proud that HealthPlus was no longer about herself alone, adding that with the company’s current growth rate, past successes would seem insignificant in comparison with future prospects.

“We have a target to start 48 new branches next year [2015]. That is, 12 branches every quarter. It is going to be a challenge but it is achievable as we trust God for everything. It might also interest you to know that we have finally signed an agreement with International Financial Corporation (IFC),” she disclosed.

Lamenting the incessant conflicts besetting the health care sector, George said the time had come for health practitioners to stop fighting each other and work in the best interest of the patient.

She added: “On our part, we will continue to contribute our own quota. Just yesterday, we opened a new branch at Magboro along Lagos-Ibadan expressway. From next year, we will also target areas like Akowonjo, Tejuosho, Agege and several others.”

While delivering the keynote address for the occasion, Pharm. Clare Omatseye, founder and Managing Director of JNC International Nigeria Limited, disclosed that she almost screamed when she heard that HealthPlus was planning to open 48 additional branches in just one year.

“But knowing Bukky for who she is, a woman full of passion and vision, I believe she can achieve it,” she enthused.

The seasoned pharmacist with years of pharmaceutical, public health and medical device experience, recounted the sad event of an asthmatic young man who relapsed while driving along the Lagos-Ibadan expressway.

“All efforts made to get a quality patent medicine store, let alone a pharmacy, proved abortive. In the end, the young man died. Today I am happy somebody like Bukky George has taken care of that problem by opening a HealthPlus branch along the express,” she noted.

Omatseye also called on healthcare practitioners to put their differences aside and work in the collective interest of the patient. According to her, hospitals and doctors cannot make everything happen by themselves. What makes things happen is harmonisation, if the health sector is ever to break free from its vicious cycle.

“We cannot continue to do the same thing in the same way, day in, day out. We need to start creating new frontiers,” she said.

Also at the event were Pharm. Bolanle Adekoya, head of pharmacy department, Lagos University Teaching Hospital (LUTH); Pharm. Ike Onyechi, managing director of Alpha Pharmacy; Pharm. Lekan Asuni, managing director of GlaxoSmithKline; Pharm. Femi Soremekun, chairman of Biofem Pharmaceuticals; and Dr Lolu Ojo, former chairman of National Association of Industrial Pharmacists (NAIP).

Commenting on the thanksgiving dinner and award ceremony, Dr Lolu Ojo described it as laudable.

“Bukky is somebody one can describe as the best of the best. I think she has succeeded in bringing what we (pharmacists) dream about to reality,” he remarked.

On whether the HealthPlus boss could achieve the target of 48 new branches, the immediate past NAIP chairman was optimistic, citing Pharm. George past records.

“Although it is a very big and expansive ambition, she has the commitment to do it. Just as she vowed to increase HealthPlus Pharmacy from 17 to 40 branches in the past, this won’t be an exception. Don’t forget she just signed an agreement with the IFC,” he said.

Corroborating Dr Lolu Ojo’s view was Pharm. Chukwuemeka Obi, operations manager of PharmacyPlus Nigeria Limited, who said Bukky George had succeeded in revolutionising retail pharmacy in the country.

Obi disclosed that he knew the enterprising pharmacist way back when she left GSK and pitched tent with London’s popular pharmacy – John Bell and Croyden – to learn the ropes of managing a retail chain. He described her as a focussed pharmacist and go-getter.

Towards the end of the programme, some of the company’s staff were given awards and special recognition for their commitment over the years. They included Adebimpe Odesanya (2014 Outstanding Manager), Sandy Augustina (2014 Outstanding CasaBella Beauty Manager) and Sola Subair (Long Service Award).

HealthPlus was incorporated in 1996 four years after Pharm. Bukky George graduated from the School of Pharmacy, University of Lagos as the best student of the college. It officially started operations in May 1999 and CasaBella Beauty, a retail beauty business, was incorporated into the chain soon after.

 

MAS at five: Biofem, Sproxil celebrate

1
Biofem
L-R, Mr Chinedu Chidioke, managing director, Sproxil; Mrs Abiodun Soremekun, executive director, Biofem Group; Mr Femi Soremekun, managing director, Biofem Group; and Pharm. Austin Osifo, head of marketing, Biofem Group, at the event.

It was celebration galore as Biofem Pharmaceuticals, a subsidiary of Biofem Group, marked five years of Mobile Authentication Service (MAS) in Nigeria.

MAS, which was advocated by the National Agency for Food and Drug Administration and Control (NAFDAC), in response to the spate of fake drugs sold in the country, is a technology-based service which allows individuals with mobile phones to verify the genuineness of a drug, without direct contact with the manufacturer. It was launched in Nigeria on 2 February, 2010, by Biofem Pharmaceuticals Ltd.

Speaking at the event, which took place within the company’s premises in WEMABOD Estate, Ikeja, Lagos last December, Managing Director of Biofem Group, Mr Femi Soremekun, disclosed that the decision taken by Biofem to be the first company in Nigeria to adopt MAS on its Type 2 Diabetes drug, Glucophage, was a bold move. He noted that prior to the adoption of MAS by Biofem, many pharmaceutical companies were reluctant to test the technology on their drugs.

“Our sincere appreciation goes to Sproxil for bringing MAS to Biofem at the time they did. We all know that it takes two to tango. Right from the day we started, it was like a risk. Actually, what we had in mind was that if it didn’t work at the end of the day, we would walk away, but if it worked, we would stay on it and do our best with it. Thank God, today, the success story after five years is here for all to see,” he said.

Corroborating the MD, Biofem’s Executive Director, Mrs. Abiodun Soremekun disclosed that Sproxil came to the company at a time when the company was in dire need of a lifeline from grasp of counterfeiters.

“Although it was highly challenging at the initial stage as so many consumers thought that by scratching the panel they were going to win prizes, we took time to explain to them, coupled with series of campaigns in the media. Gradually, they were able to realise that it was all for their good. We have every reason to thank God because, as at today, I don’t think there is any pharmaceutical company in the country that has as many as 23 of their products covered by MAS like we have in Biofem,” she said.

Also presenting a speech at the event, Mr Chinedu Chidioke, managing director of Sproxil, said MAS was developed by Sproxil in order to tackle the menace of drug counterfeiting in the country. He said Sproxil decided to develop a simple, efficient and cost-effective of helping consumers to verify the genuineness of their products prior to purchasing them.

“Our appreciation goes to Biofem for believing in MAS and for working with Sproxil in making MAS acceptable by all in the fight against counterfeiting and faking in the country and beyond,” The Sproxil boss said, adding that “relief has come the way of consumers now because all that is required of a buyer is to scratch off the label revealing a pin and then text the pin to a certain code for free. This gives an individual the power to authenticate what he or she is buying and also leads to customer satisfaction.”

Emzor marks thanksgiving dinner in style

0

 – As GMD marks 70th birthday anniversary

It was a grand spectacle as hundreds of top government functionaries, pharmacists, captains of industry, technocrats and professionals from all walks of life gathered to mark the 2014 edition of Emzor Pharmaceuticals’ annual thanksgiving dinner.

Emzor
L-R. Head, Sales, Marketing & Strategy, Gerald Oputa; National Sales Manager, Folorunsho Alaran; Mrs Chinelo Umeh, Regulatory Affairs Manager; MAXWELL, the Wellocrat; GMD/CEO,Dr Stella Okoli; ED, General Duties/ Finance; Muyiwa Kayode, MD USP Brand Management.

The colourful event which took place at the Muson Centre, Onikan, Lagos, also had in attendance, Dr Alex Ekwueme, former vice president of Nigeria; Lady Onyeka Onwenu, representative of the Nigerian First Lady, Dame Patience Jonathan; Princess Adejoke Orelope-Adefulire, deputy governor of Lagos; Dame Abimbola Fashola, wife of Lagos State governor, Babatunde Fashola; and Dr Alex Otti, former chief executive officer of Diamond Bank.

While giving the opening address, Otti, who was also chairman of the occasion explained that Emzor had continued to demonstrate what leadership is all about. According to him, the 2014 edition of the annual thanksgiving was the 10th year.

“Sometimes we wonder what makes some people different from others. The reason is not far-fetched. To say “thank you” is something we humans find quite difficult to do.

He continued, “You remember the biblical story of the 10 lepers, where only one returned to show appreciation? The same is happening here. Since Dr Stella Okoli has decided to come back and say “thank you”, things will always turn out right for her.”

Corroborating Otti’s remarks, Pharm. Nnamdi Obi, managing director of Embassy Pharma stated that Emzor had excelled in the industry.

“In fact, there is no way the history of Nigerian pharmaceuticals would be narrated and Emzor would not be mentioned. I join every pharmacist to wish Dr Okoli more wonderful years ahead,” he said.

Appreciating the accolades, Emzor’s founder and Group Managing Director, Pharm Okoli noted that Emzor’s success story had divine backing, adding that the company strives to take a giant stride every year.

“That is why today we have over a hundred new products. We all know that the Nigerian pharma industry is quite unpredictable. But we serve a great God, a mighty one indeed. That is why we want to declare his unfaithfulness publicly each year,” she emphasised.

Towards the end of the programme, a handful of guests also used the opportunity to congratulate the Emzor’s GM Don her 70th birthday.

The company’s management equally used the occasion to unveil Wellocracy, the company’s vision of a new world where unlimited wellness would be available and affordablefor everyone.

Emzor Pharmaceutical Industries Limited is a wholly indigenous pharmaceutical manufacturing group founded by Dr Stella C. Okoli, OON, in 1984 and starting pilot production in 1985. By 1988 it had become an established pharmaceutical manufacturing company especially with the introduction of Emzor Paracetamol which is today a leading brand of analgesic not only in Nigeria but across Sub-Saharan Africa.

The colourful event which took place at the Muson Centre, Onikan, Lagos also has Dr Alex Otti, former chief executive officer of Diamond Bank; Princess Adejoke Orelope-Adefulire, deputy governor of Lagos; Dame Abimbola Fashola, wife of Lagos State governor; Dr Alex Ekwueme, former vice president of Nigeria; Dr (Mrs) Stella Okoli, founder/group managing director of Emzor Pharma and Lady Onyeka Onwenu, representative of the First Lady in attendance.

Also in attendance were Pharm. Bukky George, managing director of HealthPlus Group; Mrs Taiwo Taiwo, managing director of Shonny Properties Limited; Mrs Olufunke Amosun, first lady of Ogun State; Prof. Boniface Egboka, vice chancellor, Nnamdi Azikwe University, Awka and Dr Emmanuel Egbogah, former special adviser to the president on petroleum matters

 

 

 

Avian Influenza:Nigeria’s Agriculture Ministry introduces preventive measures

0

bird flu

Following the re-emergence of the Avian Influenza popularly known as Bird Flu in some parts of Lagos and Kano last week, the Nigeria’s Ministry of Agriculture and Rural Development had taken some initial steps to curb the spread by quarantining the infected premises as well as placed restriction of movement of poultry and poultry products into and out of areas around infected premises.

For proper implementation of this, all state directors of veterinary services and the Federal Capital Territory, Poultry Association of Nigeria and other stakeholders have been informed and advised to be on alert with intensified bio-security measures to avert possible spread of the disease to other states.

Addressing journalists on the development at the weekend, the Lagos State commissioner for Agriculture and Cooperatives, Mr. Gbolahan Lawal, confirmed the resurgence of the epidemic in Badore- Ajah axis of the state, as a Zoological Park in Victoria Garden City is on the watch list following high mortality of wild birds.

The commissioner further stated that investigations revealed that the bird flu outbreak in the state might not be unconnected with birds transported from the North during the yuletide season.

However, citizens have been cautioned on the consumption on birds, ensuring that their chickens are well boiled before consumptions.

 

 

 

 

Abalaka, ready to offer his vaccine to FG on conditions

4

HIV Vaccine

In what sounds like good news to HIV/AIDS patients in Nigeria, Dr. Jeremiah Abalaka, a surgeon cum researcher, who claimed to have developed a vaccine for the treatment and prevention of Human Immunodeficiency Virus (HIV), has agreed to release the product of his brain child to the Federal Government of Nigeria, but not without terms of agreement.

Abalaka who had rejected a partnership with the government over the breakthrough last year, due to some illegal actions that welcomed the innovation from different quarters, said “when the FG discovered that the vaccines were potent, it sent agents to me with the sum of N10million for the breakthrough to be announced in Atlanta Georgia, USA, but I refused”.

However, while fielding questions from journalists at the weekend, Abalaka disclosed his willingness to now partner with various interested government agencies, in order to ensure the effective use of the vaccine, on negotiation with the government.

His vaccine recipe, he said, will be released to a chosen representative of the Nigerian government – a person of relevant profession for whom he will organize a workshop with practical sessions, while the workshop will focus on the production, storage and administration of the vaccines.

Recounting his ordeal over the development of the vaccine for the past 16 years of legal hurdles and tussles, he said although he feels pained that millions of people should have benefitted from his discovery before now, but it’s never late.

He said his attempt at finding a way forward in fighting the HIV pandemic came after attending a World Health Organization-sponsored workshop in 1974 in Geneva.

The WHO workshop formed a solid foundation of the conception of his innovation for safe and effective HIV vaccines.

He recommended that a national or state emergency vaccination programme for HIV control be created. He said the agency must be completely independent directly under the presidency or the state governor. The agency, he said, should also be funded by the Nigeria government in collaboration with private sector contributors.

It will be recalled that in 2000, the Olusegun Obasanjo administration suspended the use of all drugs or vaccines claimed to be used for the prevention, cure or treatment of HIV/AIDS until proper guidelines are approved for the assessing and verification of the claims.

However, a Federal High Court in Makurdi in November 2014 ruled against the ban on the controversial HIV vaccine developed by Mr. Abalaka.The judge ruled that the Federal Government was wrong to have banned Mr. Abalaka’s vaccine.

The court in its ruling then said there was no evidence that such guidelines were put in place after 15 years. It said the ban on Mr. Abalaka’s vaccine was done arbitrarily and therefore illegal, null and void.

However, it said Mr. Abalaka could only administer his vaccine with patient’s consent.

 

 

 

 

 

 

 

 

Why People Buy Garcinia Cambogia

0

HCA is actually mostly in charge of corroding fatty tissue, which supplies the system along with energy to sustain it. These items are actually marketing like hot bread. Dietary supplements – Ipads or even pills along with or even without various other active ingredients.

There are actually a lot of ways to decrease as well as control the body weight. For some it is actually longings for unhealthy as well as sugar rich meals and also for others that is actually merely a slow metabolic rate. However, what subject extra is your big problem and also approach in the direction of these solutions as most of all of them end up phony.

To give you some history on what hoodia is actually, on November 21, 2004, television’s CBS – 60 Minutes aired a plan regarding this diet regimen tablet and also for the first time a lot of folks were actually offered to this typical organic. So, the drug firms run out this market and also the item is actually being actually marketed by a handful of big private associates instead. You might likewise prefer to garcinia cambogia extract try this supplement out if you are prone to depression and anxiousness! The HCA will definitely do all the ‘rekindling’ in every nerve cell in the mind, therefore resulting in the disheartened individuals to not concentrate on their principal problems anymore. If you have any queries relating to where by and how to use miracle garcinia cambogia extract pure, you can get in touch with us at our own web-page. The naked truth is actually, pure garcinia extract is harmless.

Reports, as to be actually anticipated, have actually mixed evaluations. To start with, that works through decreasing hunger as well as restricting hunger pangs. If you’ve never ever found garcinia cambogia previously, that resembles a little fruit. There are actually a lot of weight reduction supplements that detail it as an active ingredient.

If you are actually planning to decrease body weight, you have likely know Garcinia cambogia Cambogia – everyone in the excess weight management globe is discussing that. Whenever you check out http://puregarciniashop.com/the-shocking-secrets-behind-garcinia-cambogia.html/ you can definitely find your self overwhelmed by simply garcinia cambogia details. In a lot of overall health researches conducted typical natural and organic supplements are actually claimed to become to have potentials in managing obesity. Hoodia gordonii eating plan tablets doesn’t possess dairy products, peanut, shellfish or even wheat that can produce allergy symptom for some folks.

Effectively, do certainly not have exactly what the media must claim about that, neither have just what the ads state. Hydroxycitric acid, the chemical drawn out from this fruit, is actually believed to function as a weight-loss supplement. And often, you don’t also have to create it.

It also helps minimize the body fat and cholesterol amounts in your blood, which hinders the system coming from keeping a lot of excess fat. Do not rush off to get hoodia gordonii plus yet, considering that for a minimal time, you could acquire a cost-free trying time. Several of them merely quit as well as a handful of would go for cosmetic surgical operation simply to appear healthy.

Aasonn Buyer Profile – Alexion Prescription drugs

0



Lissa Legislation, Affiliate Director of HR Methods for Alexion Prescription drugs shares why she loves Aasonn’s MyConsultant Plan.

supply

SAP Provide Chain Integrity Options for Prescription drugs

1



Pharma corporations face many challenges regarding Provide Chain Administration: They have to management globally distributed manufacturing websites in addition to numerous distribution channels. They’ve to observe your cold-chain and guarantee protected transport of narcotics and medicines and now additionally must take care of much more new legal guidelines and laws round serialization and monitor & hint. Study on this video how SAP options might help pharma corporations securely overcome all these challenges and obtain compliance effectively.

supply

Bulama tasks practitioners on harnessing herbs for economic development

2

          … As Bioresources holds Herbfest 2014

For economic development to be a reality in the country, researchers, entrepreneurs, traditional medicine practitioners, and other stakeholders in the health sector, must strive to promote and improve on our indigenous bioresources, natural medicine knowledge, natural products resources as well as initiate means of connecting these resources for the wellbeing of the citizens, Dr. Abdul Bulama, minister of science and technology has said.

The minister, who was also the chairman at the Herbfest 2014, made this submission while addressing the audience at the opening ceremony of the 3-day international symposium, which took place at the Nigeria Natural Medicine Development Agency (NNMDA), Vitoria Island Lagos, on November 25, 2014.

Speaking on the theme of the workshop titled : “Herbs, health foods, herbal and natural products: shifting the boundaries of health care”, he said it is very relevant at such a time as this, when the government is aiming at using all available resources of the nation to improve on the welfare of citizens.

He described Herbfest as a laudable initiative which has potentials to promote the production of healthy indigenous foods and herbal therapies that will assist in addressing local and global food nutrition and health challenges, encourage sustainable utilization of our vast biological resources, facilitate conservation of our environment and assist the creation of job and wealth creation to the nation through industrial expansion, commerce, science, technology and innovation development.

Bulama, who was represented by Dr. Menesa Gwoza noted that Nigeria possesses about 40 per cent of medicinal plants and assured that the Federal Ministry of Science and Technology will continue to provide a credible platform for the development of these natural resources as well as support innovative research to assist in developing these herbal resources research and development outputs which will indeed contribute to create jobs, wealth and improve the lives of the people.

In his own contribution, Director General of NNMDA, Dr TF Okujagu, who is a co-host of the event, said the overall goal of Herbfest is to showcase the rich biodiversity and investment opportunities of Nigeria and the West African sub-region in general to the world and enhance the patronage /recognition, productive capacity and income status of small producers of herbal and other natural products through a combination of market promotion, enterprise development, scientific session and training and simultaneously promote trade and investment in the bio-business sector.

He emphasised the uniqueness of Herbfest 2014, stating that it is targeted on bridging the health gaps created by inefficient use of natural products, showcasing research and products used from nutrition to health and promoting the activities of traditional practitioners and community health workers as well as stimulate investment in the herbal, natural products field and contribute to transforming the country by improving healthcare delivery, creating jobs, wealth and contributing to national socio-economic growth and development.

The main host of the programme, Dr Maurice Iwu explained the essence of Herbfest, as an initiative to bridge the gap between the production of medicinal herbs and pharmaceutical products manufacturing. He acknowledged the fact that many researches have been done, but they are insufficient in quantity and quality to break the barrier frontiers, as there is no integration of scientific components to empirical information available.

The renowned scientist who spoke to pharmanews in an exclusive chat during the conference further said the other challenging aspect of natural medicine is the business component, as there are no many success stories of people making money from medicinal plants, thus there are no industry drivers. “This is why Herbfest now holds annually to motivate and drive inventors into the vast bioresources of our nation, thereby initiating economic growth through plants”.

On the issue of substandard herbal products in circulation, he said NAFDAC is doing a lot to check the activities of these unscrupulous men, by insisting that they submit their products for verification before they circulate in the market.

 

 

 

Shocker: 5,000 Nigerians travel abroad for treatment monthly – WWCVL boss

2

Managing director of World Wide Commercial Ventures Limited (WWCVL), Anant Narayan, has said that no fewer than 5,000 Nigerians travel abroad for medical attention every month.

Speaking during the opening ceremony of the Annual National Conference of the Pharmaceutical Society of Nigeria (PSN) in Uyo, Akwa Ibom State capital, the Indian technocrat lamented that seeking treatment in foreign countries comes at a huge cost.

While observing that renal problems and cancer top the list of illnesses prompting foreign medical trips, Narayan added that such trips gulp an estimated $5 billion (N80 billion) annually.

He further remarked that 80 per cent of renal problems in the country were related to counterfeit products usage.

“It is pertinent to note that at the point of medical advice; only 23 per cent of patients use government hospitals. While 15 per cent turn to pharmacists for assistance; 13 per cent make use of private clinics, 43 per cent resort to use of chemists/traditional medicine vendors/self medication and 6 per cent do not seek medication at all,” he stressed.

According to the WWCVL boss, for every 4,000 people there is only one physician in Nigeria as against 10 in the United Kingdom and America.

Narayan however noted that prevalence of fake drugs was a global phenomenon, adding that the World Health Organisation (WHO) estimates eight per cent of drugs sold around the world are counterfeits.

“Some African, South-East Asian and Latin countries have as high as 50 percent fakes in the market just as global counterfeit market estimates equally vary from $50 – $70 billion,” he noted.

The WWCVL MD also took a swipe at the chaotic nature of the drug distribution channel in the country.

“The present distribution system is modelled on a disorganised structure where an importer/manufacturer deals directly with wholesalers, semi wholesalers, retailers, hospitals and clinics,” he said.

The health expert remarked that the resultant implication of such arrangement is that it gives pharmacies very high investment but the running cost gives low return on investment.

“Secondly, it leads to variable prices of products in the same locality as well as compels all pharmacies to start stocking non-pharmaceuticals to attract customers and make ends meet,” he added.

Narayan also expressed concern that if the importer-retailer chaotic distribution system is not curbed in time, it could either lead to depressed margins and distress sales (often termed ‘The Flood’), or overpricing, otherwise known as ‘The Famine.’

He was however optimistic that the new distribution chain proposed in the National Drug Distribution Guidelines would take care of the existing chaotic system.

“The new chain will see manufacturer/importer deal with Mega Drug Distribution Channel (MDDC), State Drug Distribution Channel (SDDC), and National Health Programme. The MDDC & SDDC, in turn will service the wholesale chain, which in turn will attend to community pharmacies, primary health care and PVT health institutions,” he emphasised.

The expert opined that Nigeria is a geographically diverse country with extreme climates that make distribution a critical function.

He further added that the long channel of distribution and high incidence of brand substitution makes it mandatory for a company to make all its stock keeping units (SKUs) available at all channels at all times which also ensures stable prices.

The WWCVL boss lauded the collective efforts of the PSN, federal ministry of health, Pharmacists Council of Nigeria (PCN) and the National Agency for Food and Drug Administration and Control (NAFDAC) at sanitising the health and pharmaceutical industry in Nigeria.

WWCVL, a subsidiary of Eco Health Limited, has, since inception in Nigeria, partnered with over 16 multi-national companies, maintaining 10 strategic distribution hubs scattered across the six geo-political zones, as well as servicing 144 wholesalers and depots nationwide.

Aside being a licensed vendor to all major healthcare providers in the country, it has also been described as a one-stop solution for warehousing, pharma marketing, supply chain, leads, delivery and sales, regulatory and port clearance, transportation logistics and inventory management.

Its consistency over the years has facilitated its success with great companies such as GSK, AstraZeneca, Bayer, Novartis, Johnson & Johnson, Abbot Nutrition, Sanofi, Pfizer, MSD, Novo Nordist, Himalaya, Boehringer Ingelheim, Janssen, Allergan, 3M and Roche.

 

 

And the 2014 May & Baker Professional Service Award goes to…Pharm. Obono!

3

May & Baker 2014 Award

Assistant Director and Head of pharmacy department, National Orthopaedic Hospital, Igbobi, Lagos, Pharm. (Mrs) Margaret O. Obono, has won the 10th edition of the prestigious May & Baker Professional Service Award in Pharmacy.

Mrs Obono was announced winner of the award at the opening ceremony of the 87th PSN Conference held at Ibom Hall, Uyo, Akwa Ibom State, on 4 November, 2014 and was also presented with the plaque, certificate and a dummy cheque of N250, 000.

Mrs Obono hails from Idomi, Yakur Local Government Area of Cross River State and had her education at Saint Michael’s Primary School, Kaduna; Federal Government Girls College, Calabar; University of Nigeria, Nsukka and the West African Postgraduate College of Pharmacists (WAPCP).

She has won other various awards, including the Merit Award from the Association of Lady Pharmacists (2007); Merit Award from the Women’s Wing of Christian Association of Nigeria (WOMICAN) – 2001; Pharmaceutical Society of Nigeria (PSN), President’s Award 2006; Young Pharmaceutical Forum Gold Mentor Award (2008); Merit Award, PSN, Lagos (2009); and the Pharmaceutical Association of Nigeria Students (PANS) Award (2009).

She is a Fellow of the West African Postgraduate College of Pharmacists and member of the International Pharmaceutical Federation.

Why PharmD should be minimum qualification for pharmacy graduates – Pharm. Bob-Manuel

0

When young Elizabeth Boma Bob-Manuel announced her intention to study Pharmacy in the university, nobody in her family saw it as a big surprise. For someone born of a revered pharmacist father and a mother whose nursing practice was well appreciated in the community, she must have been impressed by the influential synergy exhibited by the commitment of both parents. But in following her parents’ footsteps, the veteran pharmacist resolved not to be a mere “also-ran”; she worked hard to distinguish herself in the profession, until her retirement in 2009 as Rivers State Director of Pharmaceutical Services. In this interview with Adebayo Folorunsho-Francis, the 64-year-old native of Abonnema, Akuku Toru LGA of Rivers State, recalled some notable milestones in the growth of pharmacy practice in Nigeria and reveals why she thinks Pharm.D degree should be the minimum qualification for pharmacy graduates. Excerpts:

How did having a pharmacist father affect your upbringing?

Recalling my growing up years brings back fond memories. I am the eldest in a family of 12 children. My parents ensured that we were well catered for, even though my father was a strict disciplinarian and instilled in us the right moral principles. He worked with big pharmaceutical companies like Pfizer and Eli Lilly, detailing drugs. I was always awed by the type of confidence he exuded whenever he talked, especially about drugs. This contributed to my decision to study Pharmacy in the university. Good education was of utmost importance to my parents; so they ensured that every one of us was well educated. We were also taught the fear of God. We remain a close knit family and I thank God for His numerous blessings.

What about your work experience as a pharmacist?

After I left the University of Ife (now Obafemi Awolowo University), Ile-Ife, I started work as an intern pharmacist in 1974 at the General Hospital,Port Harcourt,and later went to Sokoto for my National Youth Service. On return to Rivers State, I worked in a couple of hospitals and later decided to leave hospital practice. I thereafter proceeded to the UK for a one-year Industrial training programme in drug production at Regent Laboratories,through the sponsorship of the Rivers State Government. This exposed me to Good Manufacturing Practice and, when I resumed duties after my training, I was posted to the Rivers State Pharmaceutical Manufacturing Laboratory, which was responsible for producing drugs for government-owned hospitals.

I was in charge of this establishment till 1994 when I was deployed to the Hospitals Management Board as Director of Pharmaceutical Services. In 1997, I returned to the Ministry of Health and was made the Rivers State Director of Pharmaceutical Services; a position I occupied until my retirement in 2009.

 

Can you confidently say that studying Pharmacy was a good decision for you?

Oh yes, there is no doubt in my mind that I made the right decision. If I were to choose all over again, I would still go for Pharmacy. It is a profession that remains relevant all through one’s life.

 

A veteran pharmacist like you must have gone through a lot. How would you compare Pharmacy in your day to today?

There was more sanity in the practice in my day. This was probably due to the fact that we as Nigerians then had our values right. There was more sanity in the country. People had more respect for the law, unlike what is happening today; so much lawlessness and love of money. Nowadays, people do whatever they like and get away with it. Honesty and integrity have been thrown to the dogs. We cannot isolate Pharmacy practice from the larger society because the profession is practised in this country by Nigerians.

 

Could you explain this further?

Yes. During my time, a young pharmacy graduate had no problem getting a job because there were so many openings, and we as a country placed premium on education and merit. We were comfortable with what we earned and so had no need to be lawless. However, I must admit that Pharmacy as a profession has come a long way from my time. The curriculum in the schools is better and the general populace is more aware of who a pharmacist is. Today, patient counseling is also commonplace.

 

Were there no instances of controversies and scandals during your time?

Well, not really. As young pharmacists, we did not have too many controversies because there was mutual respect amongst the different health professionals and we also saw our elders in the profession as role models. However, as the years went by, I started observing so much turmoil in the pharmacy profession. This mainly had to do with patent medicine licensing. Trading in drugs suddenly became everybody’s wish and there was the proliferation of drug stores, both legal and illegal. Many court cases and injunctions emanated from licensing issues and this incapacitated our regulatory body, the Pharmacists Council of Nigeria (PCN). It became a free-for-all affair and pharmacists blamed the Directors of Pharmaceutical Services for their woes since they represented the Council in the states. This led to a lot of distrust between the pharmacists who were the regulated and the DPSs who were the regulators. Our profession suffered a huge setback during this period.

 

In what ways?

Two major controversies which I cannot forget had to do with problems between the PSN and the PCN – first in 1997, when I first became DPS, and the in 2010. Incidentally, I was made the chairman of the Peace Committee which was set up by the PSN to try and resolve the 2010 issues that concerned PSN representatives in the governing board of the Council. Unfortunately, we did not succeed as there were court cases involved and this really saddened me because it set the practice backwards. Regulatory activities were almost at a standstill as there was no functional investigating panel and disciplinary tribunal. I am happy that things seem to have settled now with the appointment of the new registrar.

 

How best do you think some of the numerous challenges facing pharmacy practice in Nigeria can be curbed?

The challenges are enormous because they come from within and outside. The biggest challenge, as far as I am concerned, is the inability of the government to deal with the problem of drug proliferation and the open drug markets that are all over the place. I am yet to see any country in the world that compares with Nigeria in illegal sale of drugs. There seems to be no political will to address the problem.

One way Pharmacy practice can be improved is if the National Drug Distribution Guidelines (NDDG) can come into effect; but, unfortunately, we are nowhere near implementation. I don’t even know whether many pharmacists know what it is all about. Many have never seen the document and most states are not ready. The appropriate implementation of the National Health Insurance Scheme at all levels will also improve our practice. Luckily, a pharmacist is now the chairman of the Board. I am hoping for improvement.

 

Is that all?

Another way improvement can come is if pharmacists get more involved in pharmaceutical care and less in trading, as this will distinguish the pharmacist from the quack. This is why the Pharm.D degree should be the minimum qualification for the pharmacy graduate of today. I am a strong advocate of this programme. I think it gives the pharmacist more confidence whether in the hospital or the community.Pharmacists should also get involved in politics so that they can influence policies.

 

What about the influx of fake and counterfeit drugs into the country?

This problem can be curbed if it is given the seriousness it deserves in this country. The drug markets must be addressed. We cannot have every Tom, Dick and Harry trading in drugs because he can afford it or he seems to feel it is his birthright. We endanger the lives of our people when we ignore this monster. There must be very stiff penalties for violations; those who are caught must be prosecuted. The regulatory bodies concerned should be adequately empowered. How can you address the issue of inspections when there are no vehicles for surveillance, inadequate protection for inspectors and gross underfunding?We can all see that if there is political will we can achieve a lot in this country. The containment of the Ebola Virus Disease in Nigeria is a good attestation to this fact.

 

Has any PSN president made a lasting impression on you over the years?

The answer is yes. Lady Eme Ufot Ekaette made a lasting impression on me. She was the very first female president the PSN had and she took over at a time when the DPSs and the PSN were at loggerheads. The PPMVL (Patent & Proprietary Medicines Vendors Licence) problem was also rife then and she had a lot of challenges; but she did creditably well. The year she took over the mantle of leadership was also the year I became the DPS of my state and it was also during her tenure that I was made a Fellow of the PSN.

 

How active are you in pharmaceutical activities?

I have always been fully involved in pharmaceutical activities, especially in my state. Having served as DPS for 12 years, it was inevitable that I got involved as I was the number one pharmacist in the state all those years. It was a big responsibility because the pharmacists looked up to me as the chief implementer of the drug laws. As a Fellow, I give all the support in every way I can to the PSN in the state whenever the need arises and I take part in the activities of the Society.

 

Were there some major laurels given to you in recognition of your selfless service?

Yes. I had several awards while serving in the Pharmacists Council. I also had Merit Awards from the Association of Lady Pharmacists and NAHAP. There was one from ACPN for being a friend of the Association. I appreciate them all.

 

How do you see the annual PSN conferences?

I think too many activities are fixed for each day. We do not seem to get the full benefits of the conference because of this since various programmes take place concurrently. Another thing is that many pharmacists just go there to buy drugs and so you find the drug stands very busy while lectures and other programmes are going on in the halls. Apart from these, the conferences are enriching.

 

If you were not to be a pharmacist, what other profession would you have opted for?

I would have opted for Law because I hate injustice.

 

Is there any particular age an active pharmacist should retire?

I don’t think so. It all depends on the sort of work the pharmacist does and the health status. Some jobs are more strenuous than others. After active service, one could get involved in some part time work in any area of interest. We all know that a sedentary lifestyle is not good for the health.

 

As an elder in the profession, what is your advice to young pharmacists?

My advice to young pharmacists is that they should know that they have a highly valuable profession into which only brilliant minds graduate and so they should be confident of themselves. A pharmacist’s job affects the lives of people which, therefore, means that the licence should be jealously guarded. Despite the unfriendly environment, any hardworking pharmacist who knows his stuff will succeed. Finally, they should remember that a good name is better than riches.

 

 

UNIZIK Ebola research team announces seven potential cures

1

In what seems to be a major breakthrough in the fight against Ebola, a team of investigators and research assistants sponsored by the Nnamdi Azikiwe University (UNIZIK)’s Faculty of Pharmaceutical Sciences has affirmed the discovery of seven drugs that can be used in the treatment of the dreaded disease.

Speaking at the 2014 Faculty of Pharmaceutical Sciences Research Fair and Luncheon, held at the Juhel auditorium of UNIZIK, Awka, Anambra State on 9 October, 2014, acting dean of the faculty and principal investigator of the UNIZIK-Nigerian Young Academy Ebola Drug Discovery Project Team, Dr Ikemefuna C. Uzochukwu, disclosed that the project team was willing to share the identities of these drugs with interested partners for further studies.

“The Ebola drug discovery project, which commenced on 1 September, has presently identified seven approved drugs with concurrent strong binding affinities for four different Ebola viral molecular targets (VP24, VP30, VP35 and VP40),” Uzochukwu said.

The principal investigator revealed that the team used two approaches – Computer-Aided Drug Design (CADD) and Drug Repurposing (DR) – to achieve the promising results.

On the issue of funding, the acting dean noted, with a sense of gratitude, that UNIZIK Vice Chancellor, Prof Joseph Ahaneku, had approved two million naira for computational resources for the project, adding that the fund was being processed with TETFUND.

Also speaking at the luncheon, UNIZIK’s DVC, Prof. Charles Esimone,who represented the VC, announced to the delight of the audience that the school management was in full support of academic researches that would not only end up as published papers but also benefit the general public.

He revealed that the VC’s vision for UNIZIK was to make it a research-based institution where the resulting products would generate appreciable income.

Towards the end of the programme, some forms were distributed to the dignitaries, especially representatives of industries and organisations, to express interest if they wished to collaborate with the project team. One of the participants, Dr Harry Obi-Nwosu, expressed his readiness to support the project by pledging N100,000.

Others notables at the event include Dr Joe Akabuike, Anambra State Commissioner for Health; Prof. Emeka Ezeonu, UNIZIK’s Director of Innovations; and Dr Ifeanyi Okoye, chairman of the event.

The PSN conference and the burden of extension

2

Prior to the opening ceremony of the 87th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN), held in Uyo, Akwa Ibom State, from 3 to 8 November, expectations were high among pharmacists as they looked forward to a rewarding and exciting experience.

The PSN conference has, over the years, evolved to become a quintessential model of pragmatic planning for organisers of other conferences. This is because the PSN, which is arguably the oldest professional body in Nigeria, has always endeavoured to improve all facets of the annual gathering of pharmacists from all over the country and beyond.

From all indications, participants at the Uyo conference were not disappointed in their expectations, as many recall being thoroughly enlightened and empowered, with some even ranking it the best conference so far.

However, as we congratulate the leadership of the PSN on the success of the 87th PSN conference, tagged, “Transforming Pharmacy Practice for Better Outcomes,” we also wish to task the leadership not to rest on its oars, not only in replicating the successes recorded at the event but also in correcting lapses that were observed.

To begin with, the turnout of pharmacists at the just-concluded conference was spectacular. Considering the current level of tension and apprehension in the country, it is to the abiding credit of the PSN that attendance at the gathering was that impressive. Throughout the opening ceremony and virtually all the parallel sessions, the Ibom Hall venue of the conference was always full to capacity, while pharmacists participated actively in all the programmes lined up at the event.

The opening ceremony of the event was also quite glamorous in line with the PSN conference traditions, especially with the presence of the deputy governor of Akwa Ibom State, Lady Valerie Ebe, who represented the governor; as well as the gracing of the occasion by five past PSN presidents – Senator (Lady) Eme Ufot Ekaette, Pharm. (Alh) Yaro Budah, Pharm. (Dr) U.N.O. Uwaga, Pharm. (Sir) Anthony Akhimien, and Pharm. Azubike Okwor – aside other eminent Nigerians.

Perhaps, what may be described as the “icing on the cake” of the event actually came from the various speakers, starting from the keynote speaker, Pharm. Lere Baale, who delivered well-researched and thought-provoking papers to the delight of the participants.

The PSN must also be commended for giving awards of “Ambassadors of the Health Sector” to four distinguished Nigerians, who were non-pharmacists. This award is significant, as it is a proactive step in courting and building important relationships for the pharmacy profession in Nigeria.

However, despite these positives, there were certain aspects of the 87th PSN conference that were not impressive and should be avoided in subsequent editions of the event. Topping the list of drawbacks was the extainsion of the conference period by one day. The additional cost of the extension in terms of finance and time was not in any way justified. Participants demonstrated just how unpopular the decision was by largely shunning the closing banquet on Friday night. Many had left before the event and some who remained to take part in the AGM did not hide their lack of interst in the banquet. While it is commendable that the PSN has introduced more events, we believe that all the activities could be accommodated within the four-day period through judicious planning.

Also besmirching the memory of the conference was the choice of an open field for the exhibition. It is our view that the heavy downpour that disrupted much of the exhibition could have been envisaged and a better location provided to accommodate exhibitors. The inability of the exhibitors to carry out their businesses in a conducive environment led to the chaotic atmosphere that saw the conference venue turning to an open market for all sorts of traders.

In addition, the Ibom Hall venue was not spacious enough to accommodate participants, especially during the opening ceremony, with some pharmacists standing during the session because they had nowhere to sit. A very important precondition the Local Organising Committee (LOC) must guarantee when given the hosting right for the PSN conference in future is the provision of a decent a hall that can adequately accommodate participants.

The task facing the PSN is to ensure the 2015 conference in Abuja is an improvement on the last edition. and the best way to start is by ensuring the lapses observed are reviewed and prevented from recurring.

 

Professional character and integrity in pharmacy practice

66

(By Dr Lolu Ojo)

Let’s be blunt. Customers are the best judges of professionalism, not academic qualifications or certifying boards. Not everyone who practises a profession will be called a professional by the customers. And, while we may not all agree on who qualifies as a “professional”, most people know when they’ve been served by one. They also know when the person serving them, no matter the level of training and certification, is being less than ‘professional’ in their performance.

So, here’s a question for the pharmacist reading this article: Are you a true professional or just someone who has undergone the rigorous training and obtained the certifications to practice in this field? This is an important question with implications for the future of the pharmaceutical profession and other professional fields in Nigeria. My hope is that, as a society, we can start exploring, defining and re-discovering all the important attributes of a professional and injecting these back into all jobs.

A professional is more than someone ‘paid to undertake a specialized set of tasks’. He or she is,additionally, an expert with specialised knowledge base; a person with high standard of professional ethics, behaviour and work activities and; above all, an individual ‘who willingly adopts and consistently applies the knowledge, skills and values of a chosen profession’. The quality of being a professional, therefore, combines the basic knowledge in the chosen field with the attitudinal attributes of the person involved.

Character is the combination of qualities or features that distinguish an individual. It is the moral or ethical strength that defines the capacity, position or status or reputation of the person. It is the characteristic property that describes the apparent individual nature of something.

Integrity refers to the consistency of actions, values, methods, measures, principles, expectations and outcomes. It is the inner sense of wholeness, the honesty and truthfulness or accuracy of action. Honesty is ‘telling the truth to other people’ while INTEGRITY is ‘telling yourself the truth’.

With the definitions above, how do we discuss PROFESSIONAL CHARACTER AND INTEGRITY in Pharmacy? Are we true professionals who have willingly adopted and consistently applied the knowledge, skills and values of the pharmacy profession? What are we getting paid for: carrying out a specialised set of tasks with character and integrity OR simply for having a degree in Pharmacy?

The questions must also be directed to each of the technical groups or practice area in order for us to have a very clear view of the profession’s current situation:

  1. Academics:
  2. What do we teach and how is the knowledge measured?
  3. What tools are we using to teach and under what environment is the teaching taking place?
  4. Who are the teachers in terms of quality and quantity?
  5. What is the quality of the university products? What kind of feedback are we getting?Do we even care for the feedbacks?
  6. Is academic pharmacy only about teaching? Do we still do research?If yes, what research? To what purpose?
  7. Are we really contributing to the world body of knowledge on drugs and their application?
  8. Where is the Professional Character and Integrity in our practice?
  1. Hospital and Administration:
  • What do we do and how relevant are we to the hospital system?
  • What will the system miss if we are not there?
  • Which specialised set of tasks do we undertake?
  • Do we seek new way(s) to do the job better?
  • Can our job functions and duties pass the Professional Character and Integrity test?
  1. Community:
  • Are we community pharmacists or shop owners?
  • Even as shop owners, what manner of service do we provide?
  • When we work for non-pharmacists, what do we do?
  • What work do we really do? Are we princes or servants in our father’s palace?
  • Can our job functions and duties pass the Professional Character and Integrity test?
  1. Industry:
  • Industry, what industry? Do we exist in the world’s pharmaceutical map?
  • What is our contribution to the national GDP?
  • Who are the major players?
  • Who is a superintendent pharmacist and what does he do?
  • The market is so attractive but WHO are the beneficiaries?
  • Who are the regulators and what is the direction of regulation?
  • Can our job functions and duties pass the Professional Character and Integrity test?
  • To move forward and become true professionals with character and integrity, we must get excellent at the basics:
    1. Ask yourself the right questions and be honest about your answers.
    2. Resolve to be a professional, a pharmacistwith character and integrity in whatever area of practice you find yourself.
    3. Refuse to be assimilated by a stagnating, deteriorating and decaying system.
    4. Stay above your environment. Update your knowledge, experience and exposure base.
    5. STOP comparing yourself to others as we easily do. It is a defeatist approach.
    6. Reach out to the young pharmacists to renew their faith and refresh the profession.
    7. Collectively, we must kill ‘REGISTER AND GO’ through a deep understanding of the concept, fishing out the people involved, rehabilitating them where applicable and applying the right disciplinary measures.

We are certainly on the right track and we will get there: Building a pharmacy profession with character and integrity in Nigeria.

God bless Pharmacy in Nigeria!

 

Speed up Ebola vaccine production, Pearson tells multinationals

1

Managing director of Africess Nigeria Ltd and organiser of the Medic West Africa Exhibition, Mr Bryan Pearson, has called on multinational organisations to fast-track the research processes in developing an effective vaccine for the disease.

Pearson who spoke to Pharmanews in an exclusive interview during the Medic West Africa Exhibition held recently at the Eko Hotels, Lagos, said funding and producing usable vaccines to fight Ebola was a tall order for individual pharmaceutical companies, due to the capital intensive nature of R&D, as well as the lengthy process it required.

“Until this epidemic, there was no economic reason for an independent pharmaceutical company to be financially responsible for the vaccine, but that doesn’t mean multinational organisations shouldn’t have embarked on research on the disease 20 years back,” he explained. “However, that is the benefit of hindsight, because no one ever thought this could happen.”

Pearson noted that since the disease had continued to ravage parts of the continent, it was pertinent for multinationals to synergise and develop validated vaccine for the disease, adding that Ebola was not a complex virus like HIV.

Speaking on the exhibition, Pearson said it was a good platform for health care professionals who wished to acquaint themselves with the latest technology in the industry, adding that Nigeria and Kenya were the biggest economies and regional hubs for the annual event.

He noted that though the fear of Ebola kept some exhibitors away this year, the event was still very successful. While admitting that the exhibition was a profit-making venture, Pearson said his team in the UK and Dubai worked tirelessly to ensure the success of the fair.

A co-organiser of the event in Nigeria, Dr Adewale Balogun, further explained that the organisers run a continuous educational seminar for practitioners alongside the exhibition, with the aim of sharpening their skills.

“SME (the training module) is supposed to expose practitioners to current practices in laboratory management. It runs concurrently with the exhibition, for a full day. Though the Continuing Professional development (CPD) point for the medical laboratory scientists is 3 CPD points, other professions’ is 5 CPD points. Depending on the registration criteria for the council, for the medical council, 10 CPD points will qualify a participant for a re-registration, while participants; CPD hours must be related to their professional programmes”, he explained.

 

What I learnt from Miami lakes

1

When I was young, in the village, some places had no easy access to streams or spring water and, therefore, the people had to collect flood water during rainy season. A shallow trench was dug beside the house and, whenever it rained, water from the compound flowed into the trench. The water was then scooped into clay pots and left for the particulate matters to settle down. This water was then used for domestic purposes and drinking.

The reservoir for the collected water harboured various microorganisms, which we knew nothing about. Tadpoles, which we often saw in the water, were believed to purify it. At that time, we had no idea of water-borne diseases. It was indeed by God’s grace that the children, in particular, did not suffer from various diseases as a result of drinking such polluted water. Ironically, those who drank the water seemed relatively healthy. It was even believed that the water made people to be kind-hearted and generous

Let me compare these memories with what I observed during my recent visit to Miami, a city in Florida State of the USA. One main feature of Miami is the large number of lakes and canals. The lakes are man-made, to beautify the environment and promote air quality. Some canals are chanelled to run alongside the beautiful and spacious roads. Many residential estates are provided with lakes for fresh air and aesthetics. A clear notice at the lakes reads:”No swimming, no fishing, no boating”. Provisions are made for these activities elsewhere.

While in Miami, I watched the construction of a lake as heavy equipment was used to excavate and carry away sand and debris. The process was reminiscent of the way we dug shallow ditches with hoes to collect flood water those days in my village. The principle is the same – but more importantly, the process contains some vital spiritual lessons that can improve our lives.

Firstly, to collect and retain water, we must create a lower level; we must dig a trench. Spiritually speaking, this implies that you must bring yourself low – you must humble yourself -in order to receive from God. Just as hills cannot retain water, you cannot receive anything from God if you are full of yourself. Hebrews 4:6 says “…God resists the proud, but gives grace to the humble.”

Secondly, just as machines are used to dig and remove sand in order to create a lake, so also must we clear our hearts of injurious ideas, philosophies and prejudices in order to gainfully receive the Word of God. Ditches must be emptied to receive much water. Similarly, you must not allow the enemy to fill up the ditch of your mind with rubbish. The Bible reveals that Isaac once inherited some wells dug by his father, Abraham. But some Philistines, who were envious of Isaac because of God’s blessings on him, filled the wells with sand. Therefore, Isaac had to move to Gerar, where he dug a new well and found spring water.

Thirdly, the notice at the Miami lakes says, “No swimming, no fishing, no boating.” The reason is because, if allowed, these activities would disturb the serenity and beauty of the lakes and introduce some environmental hazards. In the spiritual sense, allowing hazardous elements like hatred, envy, bitterness, malice, fear, falsehood and dishonesty can affect the tranquillity of the mind. Such a mind cannot receive and retain the Word of God.

Also, the lakes were of various sizes and shapes. The larger the surface area and depth, the more water it can contain and, therefore, more fresh air and more aesthetics with a panoramic view. It is the same in the spiritual. When God wanted to bless a certain needy woman with financial resources, Elisha told her, “Go, borrow empty vessels abroad of all thy neighbours, even empty vessels; borrow not a few.” God caused all the empty vessels to be filled with oil, which the woman sold to pay her creditors and cater for her family (2 Kings 4). We, too, must present ourselves as large empty vessels to be filled with the Holy Spirit of God.

Lastly, water symbolises the Word of God, which gives life. Ephesians 5:25-26 (KJV) says, “Husbands, love your wives, even as Christ also loved the church, and gave himself for it; that he might sanctify and cleanse it with the washing of water by the word.”

God’s Word is the water that cleanses our heart from impure thoughts and unhealthy emotions. Jesus emphasised this cleansing power of the Word, when He told His disciples in John 15:3, “Now ye are clean through the word which I have spoken unto you.”Our world is filled with sights and sounds that have the tendency to defile our hearts and imaginations. Daily, we are bombarded with images and ideologies that are unwholesome for our spiritual growth and development. However, as we daily study and meditate on God’s Word, our hearts are constantly purified and preserved from all corrupting infiltrations.

Of global economics and pharmaceutical innovation in Nigeria

0

Of global economicsEarlier this year in April 2014, the Federal Government of Nigeria rejected the Economic Partnership Agreement (EPA) ­ between West African States and the European Union (EU). This decision, hailed by the Manufacturers Association of Nigeria, is estimated to have saved the country from losing N208 trillion ($1.3 trillion) revenue in one year alone, had the partnership materialised.

Economic Partnership Agreements (EPAs) are legally binding bilateral contracts between the EU and individual African countries. They are free trade agreements which the EU is negotiating with countries in Africa, the Caribbean and the Pacific. Once signed, EPAs warrant that, within a decade, about 80 per cent of the country’s market should open to European goods and services.

Essentially, the EPA represents the concept of trade liberalisation, a concept that has come to represent the current global economic pill of “reform” agendas that developing nations have been made to swallow. Nigeria got its first dose of the bitter pill with the Structural Adjustment Programme (SAP) of the 80s. Fortunately for us this time, the current Minister of Trade and Investment, Dr Olusegun Aganga, is of the same mind with some of us that a second “bailout” might just kill us completely.

Trade liberalisation in context

Most industrialised nations – United Kingdom, USA, France, Germany, Japan etc. -developed on the principle of protectionism. Essentially, protectionism is the economic policy of restraining trade between states (countries) through methods such as tariffs on imported goods, restrictive quotas, and a variety of other government regulations designed to allow fair competition between imports and goods and services produced domestically. In summary, the goal of protectionism is to protect the domestic industry.

A strong central government is required to achieve such, with the duty to promote and protect the nation’s manufacturing industries. In America, for instance, the leaders established a healthy credit system by the creation of a national bank to facilitate the expansion of both public and private credit. Also, they instituted a subsidy regime for domestic industries, promoting internal developments and imposed tariffs or duties on foreign products. Similar protectionist interventions were undertaken in Japan to protect domestic economy from foreign competition.

Against this protectionist agenda is the concept of Free Trade and Trade Liberalisation. Free trade is a policy in international markets in which governments do not restrict imports or exports. Essentially, the EPA that Nigeria rejected was to achieve free trade which is founded on the principle of comparative advantage.

Comparative advantage, a product of David Ricardo’s original insights, stresses that nations need not produce everything which they have the capacity to produce, but rather those for whom they have the greater comparative advantage. Basically, Ricardo showed that even when one country (say country ‘A’) can produce each of two products at less cost than another country (country ‘B’); it will still be worthwhile for them to trade.

Ricardo’s conclusion is that, in the long run, both countries win and this assumption is the backbone of liberalisation policies – that the state, acting in its best interest should compete where it has the best comparative advantage. The belief is that market forces will lead to efficiency.

This theory assumes that all nations have similar competencies in knowledge base, infrastructure and stable political structures. This mindset is noticeable in the IMF-led reforms in the 1980s which stressed trade liberalisation, privatisation, deregulation and removal of protectionist policies. They brought disaster to a lot of developing countries, including Nigeria. Free trade neglects a solid fact upon which most protectionist agendas are based, which is that it is not wealth per se that is important to a nation, but ‘productive power’.

What is implied by ‘productive power’ is the capacity to actually make or manufacture a good, rather than the mere possession of that good or of the specie—e.g., gold and silver—to buy it. This power to produce is important because it develops the necessary foundation of human skills, technological know-how, and industrial expertise necessary for long-term prosperity.

To develop this capacity, however, is not so simple. It requires a nation to sacrifice and give up a measure of material prosperity in the short run in order to gain culture, skill, and powers of united production in the long run.

For a developing nation to develop this capacity, the leadership would need to have a strong central government because people, on their own, would not sacrifice material prosperity for the sake of the nation at large; even when they do sometimes, they would not channel the extra resources into the ‘right’ areas.

The advantage of having a strong central government intervening to increase the productive power is what is consistently being weakened by most “global economic reforms”with their emphasis on subsidy removals, tariffs removal and privatisation. It is therefore not surprising that the biggest advocates of trade liberalisation are not developing nations; they are the already developed ones – it is in their best interest.

 We are just not in a position to compete

Trade liberalisation is a great idea between states of similar competence; but between developed and developing nations, it would be tantamount to sugarcoated exploitation, especially when there are no restrictions from the developing nation for particular industry segments.

That said, trade liberalisation is already a fact of our existence, Nigeria is already a signatory to some international trade agreements that limits the capacity of the central government to protect domestic industry. Note, however, that the presence of protection is not a guarantee that an industry would develop quickly, but that, without it, the industry may not even exist.

In a paper presented at the 2011 national conference of the Nigerian Association of Industrial Pharmacists (NAIP), Professor Chukwuma Charles Soludo, erstwhile Governor of the Central Bank of Nigeria, stated, in clear terms, that one of the major challenges of the Nigerian manufacturing industry is that the operating environment is simply not competitive. He specifically outlined that the EPA, which was then being debated, would simply reduce Nigeria to a mere consumption post.

The big challenge for policy makers and business owners is to figure out how to create islands of competitiveness, with states like those in the EU breathing down our backs with their EPA offer and the Asian countries making the most of existing trade agreements. This is not only a Nigerian challenge; it is a challenge for all developing nations.

 Pharmaceutical innovation

There is a lot to learn from the industrialisation of Japan. Their development was not from any foreign direct investment or grant but more from indigenous fortitude, nationalism and a fondness for making things. Much more than government policies, which must find room for “protectionist” interventions – the kind we are seeing with the National Automotive Industry Development Plan – there is need for a cultural shift.

For example, though the cost of automobiles in Nigeria could rise from increased import duties and tariffs on fairly used cars, it would eventually lead to increased domestic productivity. It would require a cultural shift to accept to pay this price for increased productivity.

The argument that the introduction of protectionist measures to boost the Nigerian pharmaceutical industry manufacturing capacity would lead to an increased cost of medicines in a “poverty-ridden” country has been the strongest position against greater government intervention. This argument exists because the “market” has been made the decision maker for global economics. In other words, the market should decide who would become a manufacturing economy and who should continue to be a consumption-driven economy.

Considering that all nations still retain sovereignty and have the promotion of the wellness and prosperity of their citizens as the core objectives of their governments, this argument is a suitable one only for an already developed nation. It offers no long–term solution to developing nations like Nigeria, as a consumption mode is simply not sustainable regardless of whether the market requires it or not.

The decision of the United States to deny us access to antibody serums for the treatment of Ebola (even though it is not yet fully tested) and the more recent decision not to sell sophisticated military weapons to Nigeria buttresses my point – that a position of consumption is a dangerous one if we believe ourselves to be a sovereign state not eager to be recolonised.

 What can we do?

We need a stronger government and we need it now! Next, we need a cultural shift – that is the “we” consciousness. It takes a cultural change to make the sacrifices that must be made for us to leave this treacherous position of consumerism.

Japan, for example was not built by just having the right government policies; it was more from the resilience and nationalistic spirit of the private sector that simply loved Japan. They had a love for making things and for making them in Japan. Also, they succeeded in fostering massive domestic private investment.

In my opinion, Nigeria doesn’t need the volume of foreign direct investments it thinks it needs to really develop. What we need to achieve is more of capacity development, indigenous investment and technology transfer than anything else. It takes a cultural shift to achieve this as most times, the focus on technology transfer and capacity development is a decision made not by the government policies but in the board room, by entrepreneurs who would have to consider whether they could suffer a little in the hands of market forces but ultimately help us overcome our present challenges. The government on its part would have to structure models for increasing access to capital.

 

 

Improved data reveals higher global burden of tuberculosis – WHO

6

Recent intensive efforts to improve collection and reporting of data on tuberculosis (TB) are shedding new light on the epidemic, revealing that there are almost half a million more cases of the disease than previously estimated. WHO’s ”Global Tuberculosis Report 2014″, published recently, shows that 9 million people developed TB in 2013, and 1.5 million died, including 360 000 people who were HIV positive.

The report stresses, however, that the mortality rate from TB is still falling and has dropped by 45 per cent since 1990, while the number of people developing the disease is declining by an average 1.5 per cent a year. An estimated 37 million lives have been saved through effective diagnosis and treatment of TB since 2000.

“Following a concerted effort by countries, by WHO and by multiple partners, investment in national surveys and routine surveillance efforts has substantially increased. This is providing us with much more and better data, bringing us closer and closer to understanding the true burden of tuberculosis,” says Dr Mario Raviglione, Director of the Global TB Programme, WHO.

Although higher, these revised figures fall within the upper limit of previous WHO estimates. The report, however, underlines that a staggering number of lives are being lost to a curable disease and confirms that TB is the second biggest killer disease from a single infectious agent. In addition, around 3 million people who fall ill from TB are still being ‘missed’ by health systems each year either because they are not diagnosed, or because they are diagnosed but not reported.

Insufficient funding is hampering efforts to combat the global epidemic. An estimated US$ 8 billion is needed each year for a full response, but there is currently an annual shortfall of US$ 2 billion, which must be addressed.

 

Don’t relent on Ebola fight, pharmacist counsels Nigerians

0

Following the recent declaration by the World Health Organisation (WHO) that Nigeria had become free of the dreaded Ebola Virus Disease (EVD), prominent pharmacist, Pharm. Uche Eddy Igwe, has called on Nigerians to remain watchful, as the disease could still find its way back into the country if proper care is not taken.

Pharm. Igwe disclosed this while presenting a paper titled “Ebola Virus Awareness Campaign” at the 87th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN), held in Uyo, Akwa Ibom State.

Igwe particularly advised health workers who, according to him, were more at risk of contracting the disease, to observe universal basic precautions when attending to suspected or confirmed cases and refer such to the appropriate care centre for treatment.

Explaining that there was no specific treatment for Ebola virus disease, Pharmacist Igwe further explained that blood infusion of recovered patients were being evaluated, while immune therapies were also being examined.

“No vaccines are approved yet for the diseases, but supportive care, rehydration with oral or intravenous fluids coupled with early treatment of specific symptoms improves survival rate, while immunity status equally influences the survival rate”, he said.

He added further that for Nigeria to maintain its Ebola-free status, complacency must be avoided by all.

“We must remain watchful, especially at our various borders. We also enjoin the people to continue to maintain high personal and public hygiene, as if the disease is still around. Government should also not relax in regularly dishing out necessary public health information. We should keep up all those good practices that contributed to the Ebola success story. All states and local governments should strive to ensure high level of public hygiene in their domain, and continue to pay special attention to the prevention of the spread of diseases in their schools and other public places,” he counselled.

 

 

New approaches in HIV/AIDS and STDs treatment

3

Worried by the high prevalence of HIV/AIDS in country, various international and national organisations have launched programmes to combat the incurable disease at different times – though not much impact has been felt in the country, as Nigeria still remains the second largest country with the highest incidence of the disease.

Recently, the country witnessed the launch of the national operational plan for the elimination of mother to child transmission of HIV in Nigeria (2015-2016) with the theme, “No child should be born with HIV in Nigeria.” Lamenting the scourge of the virus at the launch, President Goodluck Jonathan explained that the epidemic had gone beyond the health sector and had significantly threatened the economies and developmental efforts of many countries in the world, including those in the sub-Saharan countries with over three million people living with HIV, having more than half of the people infected as women and young people within the productive age group.

The president, who assured Nigerians that the government would step up its support systems to quicken the eradication of mother-to-child HIV/AIDS transmission by the year 2016, said government had begun the release of fund for the implementation of the President’s Comprehensive Response Plan for HIV/AIDS (PCRP).

 Understanding HIV/AIDS

Human immunodeficiency virus, or HIV, is the virus that causes acquired immune deficiency syndrome (AIDS). The virus weakens a person’s ability to fight infections and cancer. People with HIV are said to have AIDS when they develop certain infections or cancers or when their CD4 (T-cell) count is less than 200. CD4 count is determined by a blood test in a doctor’s office.

Having HIV does not always mean that you have AIDS. It can take many years for people with the virus to develop AIDS. HIV and AIDS cannot be cured. However, with the medications available today, it is possible to have a normal lifespan with little or minimal interruption in quality of life. There are ways to help people stay healthy and live longer.

HIV attacks and destroys a type of white blood cell called a CD4 cell, commonly called the T-cell. This cell’s main function is to fight disease. When a person’s CD4 cell count gets low, they are more susceptible to illnesses.

AIDS is the more advanced stage of HIV infection. When the immune system CD4 cells drop to a very low level, a person’s ability to fight infection is lost. In addition, there are several conditions that occur in people with HIV infection with this degree of immune system failure – these are called AIDS-defining illnesses.

 Transmission of HIV

A person gets HIV when an infected person’s body fluids (blood, semen, fluids from the vagina or breast milk) enter his or her bloodstream. The virus can enter the blood through linings in the mouth, anus, or sex organs (the penis and vagina), or through broken skin.Both men and women can spread HIV. A person with HIV can feel alright and still give the virus to others. Pregnant women with HIV also can give the virus to their babies.

 Means of contracting HIV:

  • Sharing a needle to take drugs
  • Having unprotected sex with an infected person

You cannot get HIV from:

  • Touching or hugging someone who has HIV/AIDS
  • Public bathrooms or swimming pools
  • Sharing cups, utensils, or telephones with someone who has HIV/AIDS
  • Bug bites

Anyone can get HIV if they engage in certain activities. You may have a higher risk of getting HIV if you:

  • Have unprotected sex. This means vaginal or anal intercourse without a condom or oral sex without a latex barrier with a person infected with HIV.
  • Share needles to inject drugs or steroids with an infected person.The disease can also be transmitted by dirty needles used to make a tattoo or in body piercing.
  • Receive a blood transfusion from an infected person.
  • Are born to a mother with HIV infection. A baby can also get HIV from the breast milk of an infected woman.

Health care workers are at risk on the job and should take special precautions. Some health care workers have become infected after being stuck with needles containing HIV-infected blood, or less frequently, after infected blood comes into contact with an open cut or through splashes into the worker’s eyes or inside his or her nose.

 Statistics of people living with HIV/AIDS in Nigeria

According to the Director General of the National Agency for the Control of AIDS (NACA), Professor John Idoko, 3.4 million Nigerians are living with HIV/AIDS, with Benue emerging as the state with the highest number of HIV/AIDS cases, while Kebbi is the lowest.

Clinical experiences have shown that young women have higher risks of contracting the virus than young men. Young adults in Nigeria are more susceptible to contracting HIV/AIDS, possibly due to being more sexually active. Some of the factors that predispose Nigerians to contracting the HIV/AIDS virus include the high prevalence of other STIs (Sexually Transmitted Diseases), prostitution, clandestine high-risk homosexual and heterosexual practices, international women trafficking, irregular and inept blood screening and risky practices among itinerant workers.

From a 2011 report, Nigeria accounts for 10 per cent of the global HIV burden, as It is estimated that about 210,000 people die yearly in Nigeria from the condition. In Men who have sex with men (MSM), the HIV prevalence in Nigeria is 17.2 per cent. Brothel and non-brothel female sex workers (FSW) have a HIV prevalence of 24.5 per cent, while people who take intravenous drugs (IDUs) have a HIV prevalence of 4.2 per cent.

 HIV tests

The only way to know if you have HIV is to take an HIV test. Most tests look for signs of HIV in your blood. A small sample of blood is taken from your arm. The blood is sent to a lab and tested for HIV.

Clinics that do HIV tests keep your test results secret. Some clinics even perform HIV tests without ever taking your name (anonymous testing). You must go back to the clinic to get your results. A positive test means that you have HIV. A negative test means that no signs of HIV were found in your blood.

  • Standard tests. These blood tests check for HIV antibodies. Your body makes antibodies in response to the HIV infection. These tests can’t detect HIV in the blood soon after infection because it takes time for your body to make these antibodies. It generally takes two to 8 weeks for your body to produce antibodies, but in some cases it can take up to six months.
  • In standard tests, a small sample of your blood is drawn and sent to a lab for testing. Some of the standard tests use urine or fluids that are collected from the mouth to screen for antibodies.
  • Rapid antibody tests. Most of these are blood tests for HIV antibodies. Some can detect antibodies in saliva. Results are available in under 30 minutes and are as accurate as standard tests.
  • Antibody/antigen tests. These tests can detect HIV up to 20 days earlier than standard tests. They check for HIV antigen, a part of the virus that shows up 2-4 weeks after infection. These tests can also detect HIV antibodies. A positive result for the antigen allows treatment to begin earlier and the patient to avoid infecting others. These are blood tests only.
  • Rapid antibody/antigen test. One antibody/antigen tests delivers results in 20 minutes.
  • In-home test kits. These kits screen blood and saliva for HIV antibodies. The Home Access HIV-1 Test System requires a small blood sample that is collected at home and sent to a lab. The OraQuick In-Home HIV Test can detect HIV antibodies in saliva, if the antibodies are present (which can take up to 6 months). The user swabs the upper and lower gums of their mouths, places the sample in a developer vial, and can get results in 20-40 minutes. A follow-up test should be done if the result is positive.
  • HIV Testing for Pregnant Women. If a woman has HIV while pregnant, she can work with her health care provider to help reduce the risk that her baby will have HIV, too. With treatment, less than 2 out of 100 babies born to women who have HIV will be infected. Without treatment, about 25 out of 100 babies will be infected.

 

Symptoms of HIV

Some people get flu-like symptoms within a month after they have been infected. These symptoms often go away within a week to a month. A person can have HIV for many years before feeling ill.

As the disease progresses, both women and men may experience yeast infections on the tongue (thrush), and women may develop severe vaginal yeast infections or pelvic inflammatory disease. Shingles is often seen early on, often before someone is diagnosed with HIV.

 Symptoms of AIDS

  • A fever that won’t go away
  • Sweating while you sleep
  • Feeling tired all the time (not from stress or lack of sleep)
  • Feeling sick all the time
  • Losing weight
  • Swollen glands (neck, groin, or underarms)
  • Oral thrush

 Other infections affiliated with AIDS

People with AIDS are extremely vulnerable to infection, called AIDS-defining illnesses, and often exhibit the following conditions:

  • Kaposi’s sarcoma, a skin tumour that looks like dark or purple blotches on the skin or in the mouth
  • Mental changes and headaches caused by fungal infections or tumours in the brain and spinal cord
  • Shortness of breath and difficulty breathing because of infections of the lungs
  • Dementia
  • Severe malnutrition
  • Chronic diarrhea

 

 

 Treatment of HIV

Today, there are a variety of treatments that, when used in combination can significantly slow down and in some cases stop altogether, the progression of HIV infection.

After HIV infection is confirmed, your doctor will start you on a drug regimen consisting of several drugs; combinations of different types of anti-HIV drugs sometimes are called HAART, for highly-active antiretroviral therapy (HIV is a kind of virus called a retrovirus).

Taking HAART therapy is very manageable yet isn’t necessarily easy. These drugs must be taken at the right time, every single day. Also, a range of side effects may occur, including: diarrhoea, nausea, rash, vivid dreams, or abnormal distribution of body fat. And, especially if medications are taken incorrectly or inconsistently, the virus can mutate, or change, into a strain resistant to treatment. The good news is that there are now several HIV medications that are only taken once a day. If there is resistant virus, however, these may not work and other medication options must be used.

If your disease has progressed to AIDS, your treatment may also include drugs to combat and prevent certain infections.Your doctor can monitor how well your HIV treatment is working by measuring the amount of HIV in your blood (also called the viral load.) The goal of treatment is to get the viral load undetectable on labs tests; ideally less than 20 copies. This does not mean the virus is gone or cured, it means the medication is working and must be continued.

 Prevention of HIV/AIDS

The best way to protect yourself from HIV is to avoid activities that put you at risk. There’s no way to tell by looking at someone if he or she has HIV. Always protect yourself.

  • Use latex condoms (rubbers) whenever you have any type of sex (vaginal, anal, or oral).
  • Don’t use condoms made from animal products.
  • Use water-based lubricants. Oil-based lubricants can weaken condoms.
  • Never share needles to take drugs.
  • Avoid getting drunk or high. People who are drunk or high may be less likely to protect themselves.

You can help prolong your life by taking good care of yourself and developing a good relationship with an experienced doctor specialising in HIV and AIDS. Also, be consistent about taking your HIV medications as prescribed and getting regular lab work to catch any problems early.

 

Sexually Transmitted Diseases (STDs)

Sexually transmitted diseases (STDs), or sexually transmitted infections (STIs), are generally acquired by sexual contact. The organisms that cause sexually transmitted diseases may pass from person to person in blood, semen, or vaginal and other bodily fluids.

Some such infections can also be transmitted non-sexually, such as from mother to infant during pregnancy or childbirth, or through blood transfusions or shared needles.

It’s possible to contract sexually transmitted diseases from people who seem perfectly healthy — people who, in fact, aren’t even aware of being infected. Many STDs cause no symptoms in some people, which is one of the reasons experts prefer the term “sexually transmitted infections” to “sexually transmitted diseases.”

 Symptoms

Sexually transmitted infections (STIs) have a range of signs and symptoms. That’s why they may go unnoticed until complications occur or a partner is diagnosed. Signs and symptoms that might indicate an STI include:

  • Sores or bumps on the private parts or in the oral or rectal area
  • Painful or burning urination
  • Discharge from the man-hood
  • Vaginal discharge
  • Unusual vaginal bleeding
  • Sore, swollen lymph nodes, particularly in the groin but sometimes more widespread
  • Lower abdominal pain
  • Rash over the trunk, hands or feet

Signs and symptoms may appear a few days to years after exposure, depending on the organism. They may resolve in a few weeks, even without treatment, but progression with later complications — or recurrence — sometimes occurs.

 Causes of STIs

Sexually transmitted infections can be caused by:

  • Bacteria (gonorrhea, syphilis, chlamydia)
  • Parasites (trichomoniasis)
  • Viruses (human papillomavirus, private part herpes, HIV)

 

Sexual activity plays a role in spreading many other infectious agents, although it’s possible to be infected without sexual contact. Examples include the hepatitis A, B and C viruses, shigella, cryptosporidium and Giardia lamblia.

 Complication of STIs

Possible complications include:

  • Sores or bumps anywhere on the body
  • Recurrent private part sores
  • Generalised skin rash
  • Pain during intercourse
  • Scrotal pain, redness and swelling
  • Pelvic pain
  • Groin abscess
  • Eye inflammation
  • Arthritis
  • Pelvic inflammatory disease
  • Infertility
  • Cervical cancer
  • Other cancers, including HIV-associated lymphoma and HPV-associated rectal and anal cancers
  • Opportunistic infections occurring in advanced HIV
  • Maternal-foetal transmission, which causes severe birth defects

 

Treatments and drugs

STIs caused by bacteria are generally easier to treat. Viral infections can be managed but not always cured. If you’re pregnant and have an STI, prompt treatment can prevent or reduce the risk of infection of your baby. Treatment usually consists of one of the following, depending on the infection.

  • Antibiotics. Antibiotics, often in a single dose, can cure many sexually transmitted bacterial and parasitic infections, including gonorrhoea, syphilis, chlamydia and trichomoniasis. Typically, you’ll be treated for gonorrhoea and chlamydia at the same time because the two infections often appear together.Once you start antibiotic treatment, it’s crucial to follow through. If you don’t think you’ll be able to take medication as prescribed, tell your doctor. A shorter, simpler treatment regimen may be available. In addition, it’s important to abstain from s*x until you’ve completed treatment and any sores have healed.
  • Antiviral drugs. You’ll have fewer herpes recurrences if you take daily suppressive therapy with a prescription antiviral drug, but you can still give your partner herpes at any time.Antiviral drugs can keep HIV infection in check for many years, although the virus persists and can still be transmitted. The sooner you start treatment, the more effective it is. Once you start treatment — if you take your medications exactly as directed — it’s possible to lower your virus count to nearly undetectable levels.

 

Partner notification and preventive treatment

If tests show that you have an STI, your sex partners — including your current partners and any other partners you’ve had over the last three months to one year — need to be informed so that they can get tested and treated if infected. Official, confidential partner notification effectively limits the spread of STIs, particularly syphilis and HIV. The practice also steers those at risk toward appropriate counselling and treatment. And since you can contract some STIs more than once, partner notification reduces your risk of getting re-infected.

  • Prevention

Don’t drink alcohol excessively or use drugs. If you’re under the influence, you’re more likely to take sexual risks.

  • Avoid anonymous, casual sex. Don’t look for sex partners online or in bars or other pickup places. Not knowing your sex partner well increases your risk of possible exposure to an STI.
  • Communicate. Before any serious sexual contact, communicate with your partner about practicing safer sex. Reach an explicit agreement about what activities will and won’t be OK.
  • Abstain. The most effective way to avoid STIs is to abstain from sex.
  • Stay with one uninfected partner. Another reliable way of avoiding STIs is to stay in a long-term mutually monogamous relationship with a partner who isn’t infected.
  • Get vaccinated. Getting vaccinated early, before sexual exposure, is also effective in preventing certain types of STIs.

 

Report compiled by TemitopeObayendo with additional information from:

Nigeria Bulletin, WebMD Medical Reference and Planned Parenthood Organisation

 

 

Chain drugstores: Strategic tool for business expansion

0

(By Pharm. Steve Okoronkwo)

 Nigeria’s healthcare system is undergoing rapid changes. The pharmaceutical industry is equally transforming to conform to these changes. According to John Strong (2011), the changing nature of pharmaceuticals, innovations in products and services and rising competition from new entrants and channels have prompted fundamental rethinking on strategy.

Pharmacy is a hybrid profession. It is a unique profession that shares almost, in equal proportions, the characteristics of a profession and a business. Little wonder, Denzin and Metlin (1968), say that Pharmacy has been identified as an occupation that may struggle to reconcile what has been argued to be the disparate aim of commercial profitability and professional altruism; while Lord Wilberforce in the Dickson’s case (1968) described Pharmacy as a trading profession.

The ownership and operating structures of retail pharmacy vary from one country to another. The United States is the most liberal, with pharmacists being employed by retail chain drug stores. In Canada, pharmacists own drug stores and it appears there are no restrictions on the number of establishments. Also, the organisational form this ownership takes is quite liberal. Europe operates a free market approach in which ownership can be separated from operations.

In Nigeria, the regulation guiding the ownership and operation of retail pharmacies is everything but liberal. Ownership and operation of retail drugstores in Nigeria is the exclusive preserve of the pharmacists. Although one can say that there has been some slight shift from this uncompromising stance in recent times, the justification for this rather rigid approach to ownership of retail pharmacies is however based on the constraints to the regulatory oversight by the government due to lack of enforcement staff, adequate finance, or the regulatory and judicial framework that exists in developed countries (Strong,2011).

Understanding chain drugstores

Retail pharmacies or drugstores have traditionally been run as independent pharmacies. An independent pharmacy is a retail drugstore that is not directly affiliated with any chain of pharmacies and is not owned or operated by a publicly traded company. Independent pharmacies are pharmacist-owned, privately-held businesses in varying practice settings. They include single-store operations, multiple-store locations and supermarket pharmacy operation.

Traditionally, retailing is local in nature and requires the knowledge of the needs and habits of a specific community. Community pharmacists took the advantage of regulatory and operational standards that were generally accompanied by restriction on ownership, entry and competition and established in various localities. With economic growth and advancement in medicine, pharmacies were able to take advantage of this environment and build profitable enclaves with limited competition. Pharmacies competed mostly on location, convenience and by claiming to provide better quality in practice.

However, with rising standards of living around the world, cost and productivity have become secondary concerns. Also, with globalisation of popular culture and development in technology, independent pharmacies which have held their own over the past decades are being driven out of business with the proliferation of chain drug stores. Another factor driving chain store retailing is the fact that some leading retailers are approaching saturation in their dominant market.

Chain drugstore is a group of retail outlets owned by one firm, with outlets nationwide or worldwide. Before being considered a chain, stores must meet the following conditions.

  1. The business or company must operate a number of local retail establishments, usually not less than four, in different geographical locations.
  2. The stores must have similar architecture.

III.  The design and layout of the stores must be similar.

  1. The stores must have the same choice of products.
  2. The stores must have a central head office/management.

In Nigeria, only few pharmacies can conveniently meet these criteria. We have ready examples such as Healthplus and Medplusin Lagos and, perhaps, Paxs Pharmacy in Onitsha.

Chain drugstores and business expansion

While chain stores can be viewed by many as the inevitable result of market forces, it is as well a competitive strategic tool that can be employed in retail business to drive expansion. Strategy is a choice on how to compete; competitive advantage drives from immediate fast-thinking responsiveness to market changes- which is what chain drugstore model represents.

Three generic strategies have been identified in the marketplace (Porter, 1980). These are:

  1. Focused (niche) strategy: This strategy targets a specific market intensively- usually a limited but highly profitable market with high entry barriers. Most retail drugstores or pharmacies in Nigeria adopt this strategy. It is common to find many community pharmacies providing pharmaceutical care services within a particular locality. These retail or community pharmacies make much profit from consultations, even when sales may be low. However, the major limitation of this mainstream approach is that the pharmacy, as well as the practice, is built around the pharmacist-owner. The pharmacy can hardly survive without the owner because patients’ and customers’ patronage and loyalty is to the particular pharmacist and not the pharmacy.Another drawback is that success in a particular location cannot guarantee success in sister outlets,since the pharmacist can only practice in a place at any particular time, and the pharmacy or drugstore does not enjoy any brand loyalty. Finally, market liberalisation and economic growth have transformed retailing from being a profit-driver to a traffic-driver. Hence, as appealing as creating a niche in practice by practicing pharmaceutical care is, focus strategy isunlikely to lead to market expansion because it does not take a population-outlook to marketing.
  1. Overall cost-leadership strategy: This involves offering products or services at the lowest cost. Emphasis may not usually be on quality. This strategy is a very difficult one to operate because success requires volume. Cost-leadership players are usually very few in every country. In Nigeria, Boluke Pharmacy in Lagos is a well-known example of a cost-leader.
  1. Differentiation strategy: Differentiation entails competing on the basis of value added to customers (quality, service, differentiation). This strategy requires creative flair, research capability and strong marketing. Research has shown that patients and customers choose their pharmacymost often because of location/convenience and brand/chain. It is only about 20 percent of the customers that report lowest price as the reason for shopping most often at a particular pharmacy (Strong, 2011).

While pharmacists in Nigeria may have done well in location selection and competitive pricing, majority have paid little or no attention to the concept of chain drugstores and branding. It is very important to note that knowledge/trust is not a primary driver of shopping behaviour in pharmacies/drugstores. However, the trust and reputation which pharmacies enjoy generally as compared to other retail stores is because of the nature of pharmacy as a profession.

Given the obvious limitation of focus and cost leadership strategies, community pharmacies in responding to new market demands are adopting the chain-storepharmacy model as a differentiation tool to create and deliver value to customers as well as convert payments to profit. Market expansion is the natural and probable result of chain drugstores because of its inherent ability to attract the following market advantages:

 i. Large network of channels

Chain drugstores aremodels of community pharmacy practice that can enable pharmacists extend their public health services to rural communities. This large network of stores can as well be seen as a means of delivering pharmaceutical services on a population basis as against the individualised approach in addressing the problem of preventing illness.It is also very important to mention that chain stores are heavily reliant on information technology for management. The focus on technology has shifted from automation as used in most single store operations to internal system integration.

ii. Economies of scale

Chain drugstores can order merchandise in much larger quantities than stand-alone retailers,making it possible for chain stores to offer greater selection of products at lower prices than independent competitors who do not have the same supply advantage. Product sourcing in chain stores isalso more centrally coordinated and chain retailers have sufficient volume to commission manufacturing which has removed the cost of middlemen in the distribution channel from manufacturer to the retailer.

iii.  Brand familiarity/equity

Chain store has the same architectural design and store layout that help build its brand and enable customers to identify with the particular store. Branding is a major differentiation tool by chain drug stores. Without branding, competition will be solely on price. Branding enables companies to actively influence the demand side of the equation by encouraging customers to base their purchase decision on factors other than price. Marketing is a battle of perceptions and chain stores create impressionable brands which enrich our lives.

Chain Drugstores and Promotion of Public health

Public health function is by stratification. The micro level is from the perspective of a health professional whose primary role is not in public health but who is performing some public health functions; while the macro level derives from the perspective of a health professional whose primary role is public health (Johnson, 2008). The pharmacist’s role in public health has mostly been at the micro level.

The lack of awareness of the role of pharmacists in public health can be attributed to the niche strategy which they mostly adopt in practice. This unfortunate position of pharmacists is clearly evident in the United States where pharmacists are not defined as health care providers under the state and federal laws.

Brazier(2001) captures the situation of pharmacists in public health succinctly thus: The pharmacist’s work reaches out to the entire community. The impact of his or her practice affects us all, but when pharmacists do their job properly we barely even notice its importance. Gallup polls have shown pharmacist as highly trusted professionals and thatPharmacy,as a hybrid profession is greatly admired, though pharmacists are the least appreciated in terms of their contribution to public health.

Chain drugstores/pharmacies are opening new vistas to the perception of pharmacists as public health providers. Pharmacists’ role in public health is about the delivery of pharmaceutical services on a population basis as against the nicheapproach in health promotion. In the United States, the National Association of Chain Drug Stores fills over 2.7 billion prescriptions annually, which is more than 72 percent of annual prescriptions in the United States. The overall economic impact of all retail stores with pharmacies transcends their over USD 1 trillion in annual sales.

Associates, inc. on behalf of the Cape Cod Commission

Johnson, W.C.N (2008): The Pharmacist in Public Health: A Regional Perspective. West African Journal of Pharmacy. Vol. 21 No1

American Society of Health- System Pharmacists. ASHP Statement on the role of health-system pharmacists in public health. Am J Health-Syst Pharm. 2008, 65: 462-7

42 U.S.Css1395 (2011)

Brazier, M (2005): Forward in Appelle, G and Wingfield, J. Dale and Applbe’s Pharmacy Law and ethics. London Pharmaceutical Press. Eight edition

NACDS (2013): Statement of The National Association of Chain drug Stores for U.S. House of Representatives Energy and Commerce Committee. Subcommittee on Health.Hearing on “Examining Public Health Legislation to Help Local Communities” November 20, 2013, 2:00 p.m 2123 Rayburn House Office building. www.nacds.org

Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19-22 June, 1046; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948

Ernst, ME, Bergus, GR, Sorofman, BA: Patients’ acceptance of traditional and non-traditional immunization providers. J. Am Pharm Assoc (Wash) 2001; 41: 53-9

Meyerson at al (2013): achieving Pharmacy- Based Public health: A call for Public Health engagement. Public Health Reports /May-June 2013/ vol.28

Teece, D.J (2009): Business Models, Business Strategy and Innovation. Long Range Planning 43 (2010) 172-194.http://www.elsevier.com/locate/lrp

 

Contact: steveokoronkwo@yahoo.com

E-commerce in pharmaceutical business: An overview

3

E-commerce in pharmaceutical business

There is no doubt that the Internet is changing the way we conduct business. The very nature of the web has made it possible for companies to interact and exchange information with each other and with their customers real-time in a seamless and efficient manner. Companies are using the Internet in a variety of ways to enhance their business performance by providing product and service information to customers; negotiating prices and contracts; placing, receiving and tracking orders; filling and delivering orders; paying and receiving payment.

The purchasing, selling, and exchanging of goods and services over the Internet is referred to as e-commerce. E-commerce can be broken into four main categories: Business-to-Business (B2B), Business-to-Customers (B2C), Customer-to-Business (C2B), and Customer-to-Customer (C2C), which are, in essence, various segments along the ecommerce value chain.

The “Click-and-Jump” character of web surfing has caused several changes in customer and vendor behaviour. For example, a shopper can easily navigate from one “storefront”to the other in a blink of an eye, making his/her comparative shopping easier. This before could have been impossible when considering the physical distance between the different retail stores.

Online product information allows a much faster time to market as a new product can be “introduced” as soon as its first unit is available. Providing online product and other information to customers allows flexibility on price, product portfolio and promotions. The Internet makes information located at a central source (the vendor’s web server) available to anyone with Internet access, so that a change in price, product portfolio or promotions only requires one database entry.

The pharmaceutical sector also is equally being increasingly influenced by the Internet. Online drug-stores are attracting attention to pharmaceutical companies as they continue to shape the future of drug purchasing and have created new relationships between patients/customers,retail/wholesale pharmacies and drug companies. Especially with the recent advocacy of cashless economy by the Nigerian central bank, e-payments and e-transactions are already taking roots in Nigeria, and some pharmaceutical businesses are already exploiting the opportunity and enjoying the benefits therein.

Many studies have shown that businesses are driven to gain competitive advantage by innovative technology. However, to enjoy the gains of e-commerce, it is important that the business model/strategy in operation is considered – how e-commerce would optimize the business strategy, the potential cost and revenue impact etc – all have to be considered.

 Revenue opportunities of e-commerce

E-commerce allows companies to boost revenues by direct sales to customers. Manufacturers and wholesalers/distributors that do not have direct contact with customers in traditional retail channels can use the Internet to shrink the supply chain by bypassing retailers and selling directly to customers.

Furthermore, the iniquitousness of the Internet permits access at any time from any place interms of order placement to online drug stores. Customers that are often busy at work and, thus, not be able to place orders during regular business hours can place orders at night when most physical retail stores are closed.

Another benefit of e-commerce is how it annihilates almost completely the factor of geographical location. For example, customers in Abuja can visit the online store of a wholesale pharmacy located in Lagos, go through the product catalogue and price list, put orders and make payments in real time.

E-commerce can also speedup revenue collection. When one considers the amount of time and effort taken in processing payments by cheques which usually takes up to 48 hours, online payments either by bank wire transfer or credit/debit cards which is processed instantaneously becomes much more appealing.

Cost impact of e-business

A firm considering integrating ecommerce into its business model should think about the cost impact on business processes. In other words, will the adoption of ecommerce result in a reduce cost in processing and fulfilling orders placed by customers? Will it reduce facility and transportation cost significantly and minimise wastages in the supply chain cycle?

For a firm whose business reach covers a large geographical area, e-commerce will enable it to centralise facilities because online sales allow the separation of order placement and order fulfillment. Site costs may decrease as direct customer-manufacturer contact and geographical centralization eliminates or reduces the number retail sites or warehouses.

E-commerce can also decrease processing cost as it increases the amount of customer participation. For example, customers purchasing online do all the work of selecting the product, placing an order, and paying.

Many e-businesses can also centralise inventories because they do not have to carry inventory close to the customer. This geographical centralisation reduces required inventory levels because of increased economies of scale in the supply and reduced aggregated variability in the demand. A major advantage of e-business is that, by separating ordering from fulfillment, increased flexibility in operations is gained to implement postponement.

Sanofi, PAN renew fight against pneumonia

1

– Celebrate World Pneumonia Day 2014

 

L-R: Dr Fifen Inousa, medical director, Sanofi; Dr Ekanem Ekure, consultant paediatrician, LUTH; and Prof. Adebiyi Olowu, president, Paediatric Association of Nigeria ( PAN), during the press parley held at Protea Hotel, Ikeja, Lagos, recently

 

Sanofi, a leading multinational pharmaceutical company, and the Paediatric Association of Nigeria (PAN), have restated their commitment to tackling pneumonia among children in the country.

The two organisations made the pledge during a media parley organised to mark the World Pneumonia Day (WPD) 2014, held at Protea Hotel, Ikeja, Lagos, recently. The theme of WPD 2014 was “Universal Access to Pneumonia Prevention and Care.”

Speaking at the press parley, Dr Fifen Inousa, medical director of Sanofi Nigeria and Ghana, announced a paediatric initiative, tagged, “Healthy Children, Happy Children”, which he said was being implemented in partnership with PAN.

Dr Inousa stressed that paediatrics was a priority for Africa because one child out of four in the world is in Africa and 50 per cent of the worldwide infant mortality occurs in Africa, adding that the Sanofi Paediatric Initiative was a crucial reinforcement of the company’s commitment to child health care.

Inousa stated that preventing pneumonia in Africa was a challenge Sanofi wanted to share in partnership with PAN and the Federal Ministry of Health.

According to Sanofi’s head of public affairs, Nigeria and Ghana, Oladimeji Agbolade, the initiative relies on three commitments, namely, development of medicines and vaccines by taking into account epidemiological profiles of countries; training and communication for healthcare professionals; and the deployment of information and educational activities for the general public, as well as follow-up tools for children.

Also speaking at the press parley, Prof. Adebiyi Olowu, president of PAN, urged the government to ensure that all children in the country had access to not only proper pneumonia care but free health care at all levels of government.

He specifically urged the federal government to ensure the availability of the Pneumococcus Conjugate Vaccine (PVC) by December as it had promised, bemoaning the repeated change of dates of introduction of the PVC.

Agbolade further noted that the rolling out of the vaccine was crucial to efforts aimed at ensuring that Nigeria exits the league of nations of high child mortality, adding that countries that are not as endowed as Nigeria like Ghana, Rwanda, Ethiopia, were already using the PVC.

 

 

 

Leadership competencies in the health care industry

0

Organisations are experiencing changes and health care organisations are not left out-health reforms, changes in technology, government policy and consumers’ expectations are transforming relationships among actors and impacting on operations in critical ways in the industry. These staggering twists, added with a sagging economy, poor Research &Development budgets and lacklustre sales pipelines are issues today’s leader must grapple with.

The pharmaceutical industry represents a major sub-sector of the health care industry. In a study conducted by the Centre for Creative Leadership, about a thousand leaders were evaluated and out of the major sixteen leadership competencies, respondents say there are eight top critical leadership competencies important in the pharmaceutical market.

 The traditional 16 critical leadership competencies include:

  1. Strategic perspective – Understands the viewpoint of higher management and effectively analyses                         complex problems.
  2. Having a quick study – Quickly masters new technical and business knowledge.
  3. Decisiveness – Prefers quick and approximate actions in many management situations.
  4. Change management – Uses effective strategies to facilitate organisational change initiatives and                  to overcome resistance to change.
  5. Leading employees – Attracts, motivates and develops employees.
  6. Confronting problem employees – Acts decisively and with fairness when dealing with problem                         employees.
  7. Participative management – Involves others, listens and builds commitment.
  8. Building collaborative relationships – Builds productive working relationships with co-                 workers and external parties.
  9. Compassion and sensitivity – Shows genuine interest in others and sensitivity to employee                         needs.
  10. Putting people at ease -Displays warmth and a good sense of humour.
  11. Respect for differences – Values people of different backgrounds, cultures, or demographics.
  12. Taking initiative – Takes charge and capitalises on opportunities.
  13. Composure – Demonstrates self-control in difficult situations.
  14. Balance between personal and work life – Balances work priorities with personal life.
  15. Self-awareness – Has an accurate picture of strengths and weaknesses and is willing to             improve.
  16. Career management – Uses effective career- management tactics, including mentoring,             professional relationships and feedback channels.

Common leadership derailment factors

Across culture and times, there have been five common leadership derailment factors that have been found to be fairly consistent.

  1. Problems with interpersonal relationship – Ineffective at developing good working relationships with others.
  2. Difficulty building and leading a team – Exhibits problems when attempting to select, develop and motivate a team.
  3. Difficulty changing or adapting – Shows resistance to change and to learning and developing from mistakes.
  4. Failure to meet business objectives – Finds it difficult to follow up on promises and complete a job.
  5. Too narrow a functional orientation – Lacks the depth needed to manage outside of current function.

Critical leadership requirements in the pharmaceutical sector

The following are the 8 critical leadership requirements essential to success in the pharmaceutical industry:

  1. Leaders must build collaborative relationships. People, they say, are more important than things. A leader should be able to establish a productive working relationship with co-workers and other external parties. He must ensure that his team builds cordiality while pursuing the common goal. The effective leader places value on the welfare of his team and sees their personal satisfaction as key to growing performance.
  2. Leaders must have a strategic perspective. According to the Forbes magazine, strategic leadership begins with understanding the complex relationships between an organisation and its environment. Today’s leader needs to be able to understand the organisation’s vision, the workings of top management officers and also be critical in dealing with issues. He must see beyond his nose and effectively harness informal relationships with top officers to effect some desired changes. He must anticipate and be prepared in his mind.
  3. Leaders must take initiative.It seems to be that the definition of a leader is one who takes initiative. He should take charge and must be alert to capitalise on opportunities.Harland Cleveland’s quote adds credence to the need for leaders to take prompt initiatives –”The leader must always lean forward on pushing the invisible.”
  4. Leaders must allow for participative management. The effective leader calls for meetings regularly in order to get others involved and to listen to them.This builds confidence in the team and enhances trust.
  5. Leaders must be able to manage change. Change management, most times, determines whether a pharmaceutical or any organisation stays afloat or sinks.They are expected to use effective strategies to facilitate organisational change.They must adapt, control and effect change.
  6. Leaders must lead their employees. An effective leader has a presence he has built over time from hardwork,discipline and professionalism.He or she attracts,motivates and develops employees.
  7. Leaders must be decisive. Today’s leader is expected to not hesitate in the face of situations but take quick and approximate actions in management matters.
  8. The effective leader must be a quick learner. He must develop strong listening skills to study new business and to acquire technical knowledge from team members and across competitors.

In light of these expected competencies, the study conducted by the CCL showed that leaders in the pharmaceutical industry struggle in some areas. The major derailment factors are as listed above in order of prevalence.

Major Derailment Factors

Too narrow functional orientation

Failure to meet business objectives

Difficulty building a team

Difficulty changing or adapting

Problems with interpersonal relationships

Narrow functional orientation

The study showed that the greatest potential derailment factor for pharma executives is “having too narrow a functional orientation.” This is most noticeable when the leader has risen up the ranks through sales, research, or some other functional “silo.” This leader may struggle when asked to take on a more general leadership role.

Often times, there is organisational pressure to keep top functional performers focused on their areas of expertise and these top performers may themselves prefer to remain in their functional comfort zones. To fulfil the promise of a leader’s potential, it is critical to have developmental assignments that broaden experience.

Organisations can help leaders avoid this by offering and encouraging “zigzag” career paths that feature lateral plus vertical movement. Allowing future leaders move to different areas within the organisation can help them develop a broader management perspective and learn how to build relationships with different people in different ways.

There is need therefore for organisations to invest in leadership development.

 

Our focus on leadership development

Our experience at the Pharmanews Centre for Health Care Management Development also confirms these observations and has informed our focus on health care management development as a critical step in advancing the quality of health care service provision in Nigeria. Therefore, we have focused on the following critical areas for intervention:

 

  • Fostering of system understanding

Here, we seek to help leaders and emerging leaders understand the different aspects of the health care industry – global best practices, financing structures and quality management processes. We understand that good leadersmust understand the global, regional and national environment within which their organisations. This provides the depth required to be able to engage others in achieving the organisational objectives. A good macro-economic perspective would help leaders develop interventions that maximises the best of their resources within the limits of their environment.

  • Development of collaborative partnerships

Characteristics of a manager who is effective at building collaborative relationships include:

  • Ability to relate with all kinds of people
  • Ability to treat people fairly
  • Gains support and trust of peers, higher management and customers
  • Uses good timing when negotiating with others
  • Can settle problems internally and externally

We have found these skillset to constitute essential components of the clinical leadership framework. To achieve organisational renewal, today’s leader must be able to enhance collaborative relationships, hold regular meetings, and develop performance standards and feedback processes for managers. They should learn to assign responsibilities, applaud staffers and reward hard work.

 

Business financing structures

Nigerian health financing system has been characterised by low government investment, extensive out-of-pocket payments, limited insurance coverage and low donor funding. Thus, achieving effective and successful healthcare financing system has been a major challenge in Nigeria.

Health care leaders need to understand the challenges, the National Health Insurance Scheme, global financing structures, the macroeconomic outlay of the Nigerian economies and the emerging opportunities. These are essential for both private, public and public–private organisations.

 Organisational development

In a Business Leader survey, four areas in particular where there are signiûcantopportunities for improvement in most organisations include: talent, culture, alignment, and engagement. These areas constitute our major areas of intervention.

  1. Talent – Leaders urgently need support in areas related to talent, including developing current and future leadership capacity, as well as attracting and retaining top talents.
  2. Culture – There is also an urgent need for support in effectively addressing organizational culture during organisational realignments, industry consolidations and the formation of private – public partnerships.
  3. Alignment – Another high priority area requiring more effective support is alignment. Successful ûrms must align and execute business strategies in ways that meet their ûnancial goals and are consistent with their core values. Moreover, strategies, people, systems and processes must be aligned organization-wide to enhance productivity and proûtability.
  4. Engagement – Finally, business executives and leaders need support to engage their workforce. An organisation can best achieve its business results when its workforce is engaged and committed to achieving its goals and objectives. An organisational leader must be able to clarify and communicate succinctly the purpose and mission of the organisation to inspire and engage the workforce.

 

Below is a summary of our services:

  • Scheduled and on-demand training at Pharmanews training facilities
  • On-site training at clients’ premises
  • Executive management training for health care administrators
  • Advanced care workshops (sponsored training for health institutions and professional groups)

 Reference

  • Wirtenberg et al, (2007). The Future of Organisational Development: Enabling Sustainable Business Performance Through People. Organisational Development Journal, Special Edition: Best Global Practices in Internal OD, Summer 2007, Volume 25: Number 2.
  • Leslie et al, (2014). The Leadership Challenge in the Pharmaceutical Sector What Critical Capabilities are Missing in Leadership Talent and How Can they be Developed? Center for Creative Leadership.

 

 

Community pharmacy in Nigeria must reflect global trends – Bukky George

0

Community pharmacy practice worldwide is being transformed in line with global trends, requiring practitioners in Nigeria to catch up with the pace of advancement in order to bring about overall improvement and better outcomes, Pharm. (Mrs) Bukky George, CEO, HealthPlus Pharmacy, has said.

Pharm. George, who spoke during a session at the 87th Annual National Conference of the Pharmaceuitcal Society of Nigeria (PSN), held in Uyo, Akwa Ibom State, recently, urged practitioners to benchmark community pharmacy practice in Nigeria with that of developed countries and be determined to embrace best practices.

Delivering a paper titled, “Transforming Community Pharmacy Practice for Better Outcomes”, Pharm. George tasked community pharmacists in Nigeria to raise the bar in order to achieve excellence in healthcare delivery.

Noting the vital role of of community pharmacists, the HealthPlus boss emphasised that community pharmacists form part of the frontline in the battle for better health and wellbeing because they are easily accessible, adding that some pharmacies are open for 24 hours.

Pharmacists, she said, are always readily available to give sound professional advice and to help to deal with everyday health concerns and problems.

She further added that pharmacies provide convenient and less formal environment for those who cannot easily access or do not choose to access other kinds of health service.

Explaining further on how to transform community pharmacy for better outcomes in Nigeria, Pharm. George,stated that there was no need searching for clues, as practitioners can easily adopt best practices from the United Kingdom (UK), United States of America (USA), and other developed countries.

The HealthPlus CEO also advocated for improvement in the training of pharmacists, adding that all stages of pharmacy training need to be revamped in line with global best practices while ensuring local relevance.

She also urged pharmacy regulatory agencies, pharmacy associations and key leaders in community pharmacy to engage with government and highlight the value of community pharmacy and their role in healthcare delivery to the public.

Pharm. George equally advised community pharmacists to consistently strive to improve their business knowledge and skills by reading books and magazines on entrepreneurship, management, strategy execution, leadership, and the likes.

While stressing the importance of collaboration among members of the healthcare team, Pharm. George also tasked government on proper implementation of the National Health Insurance Scheme (NHIS), to ensure that roles are clearly defined and that all members of the healthcare team are equitably remunerated.

 

 

General Manager needed at Pharmanews Limited

3
job Vacancy
General manager needed at Pharmanews limited

Pharmanews Limited requires the services of a General manager.
Job Title: General Manager

Location: Lagos

Job Description

  •  Direct internal operations to achieve targeted results
  • Develop operation policies and ensure their adequate execution
  • Supervise activities in compliance with company policies and professional regulations.
  • Oversee the interests and welfare of employees

 

Qualifications

  • Minimum of Bachelors in Pharmaceutical Sciences.
  • A post graduate qualification would be an advantage (MBA).
  • Excellent written and verbal communication skills, including technical writing skills.
  • Understanding of business processes.
  • Computer literacy
  • Managerial experience

Age: 30-40 years

Remuneration: Attractive

Application Closing Date: 15th December, 2014
Method of Application
Interested candidates should send their CVs and application letters to: jobs@pharmanewsonline.com before 15th December, 2014

Only shortlisted candidates will be contacted.

Don seeks overhaul of pharmacy school curriculum

1

  A lecturer in the department of Pharmacology and Toxicology, University of Benin (UNIBEN), Pharm (Prof.) Ray I.Ozolua has called for holistic change in the curriculum of pharmacy schools across the country, stressing that this would positively affect the entire pharmaceutical profession.

Prof. Ozolua, who was one of the speakers at the 87th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN), held in Uyo, Akwa-Ibom State, explored the topic, “Academic pharmacy practice: Time for change.”

Ozolua opined that the focus of pharmacy schools should always be on the relevance of a topic or subject to contemporary practice and research, rather than emphasising old and irrelevant issues.

“The world must not leave us behind, as many health professions have stepped up their game. Pharmaceutical medicine and herbal medicine are being introduced into the curricular of some schools of medicine. Therefore our type of Pharm.D should be a good blend of industrial, clinical practice and research,” he said.

He further asserted that a robust curriculum for pharmacy schools would be beneficial to national development as it would result in self-sufficiency and export of pharmaceutical products, including herbal products to other countries, while providing sound clinical basis for interpreting drug actions.

Prof. Ozolua also emphasised the need for improved teaching methodology, noting that lack of inspiration from some lecturers, low mental capacity, poor dress sense and lack of self-confidence were part of the challenges that must be surmounted for progress to be made.

“Absence of quality lecturing which ranges from dictating lecture notes without explanation, poor background preparation, failure to deploy ICTs and poor mentoringshould also change,” he urged, adding that “the change we are talking about cannot be achieved in academics if teaching methodology is not improved. Time for dictating lectures is over; time for telling students to ‘read up every topic’ is over; time for bullying students over minor acts of misdemeanour is over.”

The don, who defined pharmacists as professionals and group of persons with common background in training and who possess requisite skills that no other group possesses, however, lamented that pharmacists do not often defend their professionand colleagues.

“Pharmacists are expected to act as a vector, in one accord, in one direction, with a common focus and unrelenting force until the common goal is achieved. This is the main threat to our claim of professionalism,” he observed.

Recalling how Pharmacy started in Nigeria when diploma pharmacists were trained at the Yaba College of Technology, Lagos, up to 1962 when it started as a degree programme at the University of Ife, now Obafemi Awolowo University (OAU), Ife, Prof. Ozolua stated that the main thrust of pharmaceutical care is that pharmacists accept responsibilities for assisting patients get the best out of their medication, adding that, sadly, the current nature of pharmaceutical education in Nigeria is neither clinical nor industrial.

 

Alembic Pharmaceuticals Ltd’s Moments with the Innovation Express

1



“It has been a wonderful experience for us.The Innovation express has given us a glimpse of latest technology updates in the field. I compliment SAP for this great initiative” says Mitanshu Shah, Vice President- Finance Alembic Pharmaceuticals
For more information on how SAP can help you transform your business visit ~ http://theinnovationexpress.com/

source

How to manage diabetes mellitus

15

The rising incidence of diabetes mellitus (commonly called diabetes) in Nigeria has been a source of concern to health experts. Medicinal specialists ascribe the surge to poor way of life of individuals and consequently advised that individuals regularly assess their wellbeing through restorative examination.

“These days in our general public, particularly in the urban groups, most individuals rely on fast food,” Babatope Kolawole, a consultant doctor in Obafemi Awolowo University, Ile-Ife, said. “Most individuals work out their pancreas. They take dairy milk, consume a lot of greasy nourishment, unreasonable oil use, which incline individuals to diabetes and other serious infections.”

At a recent workshop on Strategies for Improving Diabetes Care in Nigeria, held in Ibadan, experts expressed shock that the level of attention given to the malady was very low, necessitating the joint efforts among stakeholders in the health sector to devise ways of curbing the trend.

 What really is diabetes?

Diabetes mellitus is a group of metabolic diseases characterised by high blood sugar (glucose) levels that result from defects in insulin secretion, or its action, or both. Diabetes was first identified as a disease associated with “sweet urine,” and excessive muscle loss in the ancient world. Elevated levels of blood glucose (hyperglycaemia) lead to spillage of glucose into the urine, hence the term “sweet urine”.

Normally, blood glucose levels are tightly controlled by insulin, a hormone produced by the pancreas. Insulin lowers the blood glucose level. When the blood glucose elevates (for example, after eating food), insulin is released from the pancreas to normalize the glucose level. In patients with diabetes, the absence or insufficient production of insulin causes hyperglycaemia.

Diabetes is a chronic medical condition, meaning that, although it can be controlled, it lasts a lifetime.

According to Prof. Alebiosu Olutayo, coordinator of Journalists Action Against Diabetes (JAAD), no fewer than three million Nigerians are living with diabetestoday.

“Many people are living with the condition unaware of the seriousness of the disease and its consequences as those diagnosed are often poorly managed due to lack of resources or because the health care professionals who care for them have poor knowledge about diabetes and how to provide good care,” he said.

He warned that with the rate at which diabetes is spreading, it might overtake tuberculosis, malaria, HIV/AIDS, and other terminal diseases by the year 2030, if adequate attention is not paid toward the provision of health education to the masses.

 

How serious is diabetes?

Over time, diabetes can lead to blindness, kidney failure, and nerve damage. These types of damage are the result of damage to small vessels, referred to as microvascular disease. Diabetes is also an important factor in accelerating the hardening and narrowing of the arteries (atherosclerosis), leading to strokes, coronary heart disease, and other large blood vessel diseases. This is referred to as macrovascular disease.

From an economic perspective, the total annual cost of diabetes in 2011 was estimated to be 174 billion dollars in the United States alone. This included 116 billion in direct medical costs (healthcare costs) for people with diabetes and another 58 billion in other costs due to disability, premature death, or work loss. Medical expenses for people with diabetes ate over two times higher than those for people who do not have diabetes. Globally, the statistics are staggering.

What causes diabetes?

Insufficient production of insulin (either absolutely or relative to the body’s needs), production of defective insulin (which is uncommon), or the inability of cells to use insulin properly and efficiently leads to hyperglycaemia and diabetes. This latter condition affects mostly the cells of muscle and fat tissues, and results in a condition known as insulin resistance. This is the primary problem in type 2 diabetes.

The absolute lack of insulin, usually secondary to a destructive process affecting the insulin-producing beta cells in the pancreas, is the main disorder in type 1 diabetes. In type 2 diabetes, there also is a steady decline of beta cells that adds to the process of elevated blood sugars. Essentially, if someone is resistant to insulin, the body can, to some degree, increase production of insulin and overcome the level of resistance. After time, if production decreases and insulin cannot be released as vigorously, hyperglycaemia develops.

Glucose is a simple sugar found in food. Glucose is an essential nutrient that provides energy for the proper functioning of the body cells. Carbohydrates are broken down in the small intestine and the glucose in digested food is then absorbed by the intestinal cells into the bloodstream, and is carried by the bloodstream to all the cells in the body where it is utilized. However, glucose cannot enter the cells alone and needs insulin to aid in its transport into the cells. Without insulin, the cells become starved of glucose energy despite the presence of abundant glucose in the bloodstream. In certain types of diabetes, the cells’ inability to utilize glucose gives rise to the ironic situation of “starvation in the midst of plenty”. The abundant, unutilized glucose is wastefully excreted in the urine.

Insulin is a hormone that is produced by specialized cells (beta cells) of the pancreas. (The pancreas is a deep-seated organ in the abdomen located behind the stomach). In addition to helping glucose enter the cells, insulin is also important in tightly regulating the level of glucose in the blood. After a meal, the blood glucose level rises. In response to the increased glucose level, the pancreas normally releases more insulin into the bloodstream to help glucose enter the cells and lower blood glucose levels after a meal. When the blood glucose levels are lowered, the insulin release from the pancreas is turned down. It is important to note that even in the fasting state there is a low steady release of insulin than fluctuates a bit and helps to maintain a steady blood sugar level during fasting. In normal individuals, such a regulatory system helps to keep blood glucose levels in a tightly controlled range. As outlined above, in patients with diabetes, the insulin is either absent, relatively insufficient for the body’s needs, or not used properly by the body. All of these factors cause elevated levels of blood glucose (hyperglycemia).

What are the different types of diabetes?

There are two major types of diabetes, called type 1 and type 2. Type 1 diabetes was also formerly called insulin dependent diabetes mellitus (IDDM), or juvenile onset diabetes mellitus. In type 1 diabetes, the pancreas undergoes an autoimmune attack by the body itself, and is rendered incapable of making insulin. Abnormal antibodies have been found in the majority of patients with type 1 diabetes. Antibodies are proteins in the blood that are part of the body’s immune system. The patient with type 1 diabetes must rely on insulin medication for survival.

In autoimmune diseases, such as type 1 diabetes, the immune system mistakenly manufactures antibodies and inflammatory cells that are directed against and cause damage to patients’ own body tissues. In persons with type 1 diabetes, the beta cells of the pancreas, which are responsible for insulin production, are attacked by the misdirected immune system. It is believed that the tendency to develop abnormal antibodies in type 1 diabetes is, in part, genetically inherited, though the details are not fully understood.

Exposure to certain viral infections (mumps and Coxsackie viruses) or other environmental toxins may serve to trigger abnormal antibody responses that cause damage to the pancreas cells where insulin is made. Some of the antibodies seen in type 1 diabetes include anti-islet cell antibodies, anti-insulin antibodies and anti-glutamic decarboxylase antibodies. These antibodies can be detected in the majority of patients, and may help determine which individuals are at risk for developing type 1 diabetes.

Type 2 diabetes was also previously referred to as non-insulin dependent diabetes mellitus (NIDDM), or adult onset diabetes mellitus (AODM). In type 2 diabetes, patients can still produce insulin, but do so relatively inadequately for their body’s needs, particularly in the face of insulin resistance as discussed above. In many cases this actually means the pancreas produces larger than normal quantities of insulin. A major feature of type 2 diabetes is a lack of sensitivity to insulin by the cells of the body (particularly fat and muscle cells).

In addition to the problems with an increase in insulin resistance, the release of insulin by the pancreas may also be defective and suboptimal. In fact, there is a known steady decline in beta cell production of insulin in type 2 diabetes that contributes to worsening glucose control. (This is a major factor for many patients with type 2 diabetes who ultimately require insulin therapy.) Finally, the liver in these patients continues to produce glucose through a process called gluconeogenesis despite elevated glucose levels. The control of gluconeogenesis becomes compromised.

While it is said that type 2 diabetes occurs mostly in individuals over 30 years old and the incidence increases with age, we are seeing an alarming number patients with type 2 diabetes who are barely in their teen years. Most of these cases are a direct result of poor eating habits, higher body weight, and lack of exercise.

Regarding age, data shows that for each decade after 40 years of age regardless of weight there is an increase in incidence of diabetes. The prevalence of diabetes in persons 65 years of age and older is around 27%. Type 2 diabetes is also more common in certain ethnic groups. Compared with a 7% prevalence in non-Hispanic Caucasians, the prevalence in Asian Americans is estimated to be 8%, in Hispanics 12%, in blacks around 13%, and in certain Native American communities 20% to 50%. Finally, diabetes occurs much more frequently in women with a prior history of diabetes that develops during pregnancy (gestational diabetes).

Diabetes can occur temporarily during pregnancy, and reports suggest that it occurs in 2% to 10% of all pregnancies. Significant hormonal changes during pregnancy can lead to blood sugar elevation in genetically predisposed individuals. Blood sugar elevation during pregnancy is called gestational diabetes. Gestational diabetes usually resolves once the baby is born. However, 35% to 60% of women with gestational diabetes will eventually develop type 2 diabetes over the next 10 to 20 years, especially in those who require insulin during pregnancy and those who remain overweight after their delivery. Patients with gestational diabetes are usually asked to undergo an oral glucose tolerance test about six weeks after giving birth to determine if their diabetes has persisted beyond the pregnancy, or if any evidence (such as impaired glucose tolerance) is present that may be a clue to the patient’s future risk for developing diabetes.

“Secondary” diabetes refers to elevated blood sugar levels from another medical condition. Secondary diabetes may develop when the pancreatic tissue responsible for the production of insulin is destroyed by disease, such as chronic pancreatitis (inflammation of the pancreas by toxins like excessive alcohol), trauma, or surgical removal of the pancreas.

Diabetes can also result from other hormonal disturbances, such as excessive growth hormone production (acromegaly) and Cushing’s syndrome. In acromegaly, a pituitary gland tumor at the base of the brain causes excessive production of growth hormone, leading to hyperglycemia. In Cushing’s syndrome, the adrenal glands produce an excess of cortisol, which promotes blood sugar elevation.

In addition, certain medications may worsen diabetes control, or “unmask” latent diabetes. This is seen most commonly when steroid medications (such as prednisone) are taken and also with medications used in the treatment of HIV infection (AIDS).

What are diabetes symptoms?

The early symptoms of untreated diabetes are related to elevated blood sugar levels, and loss of glucose in the urine. High amounts of glucose in the urine can cause increased urine output and lead to dehydration. Dehydration causes increased thirst and water consumption.

The inability of insulin to perform normally has effects on protein, fat and carbohydrate metabolism. Insulin is an anabolic hormone, that is, one that encourages storage of fat and protein.

A relative or absolute insulin deficiency eventually leads to weight loss despite an increase in appetite.Some untreated diabetes patients also complain of fatigue, nausea and vomiting.   Patients with diabetes are prone to developing infections of the bladder, skin, and vaginal areas.Fluctuations in blood glucose levels can lead to blurred vision. Extremely elevated glucose levels can lead to lethargy and coma.

 How is diabetes diagnosed?

The fasting blood glucose (sugar) test is the preferred way to diagnose diabetes. It is easy to perform and convenient. After the person has fasted overnight (at least 8 hours), a single sample of blood is drawn and sent to the laboratory for analysis. This can also be done accurately in a doctor’s office using a glucose meter.

Normal fasting plasma glucose levels are less than 100 milligrams per deciliter (mg/dl).

Fasting plasma glucose levels of more than 126 mg/dl on two or more tests on different days indicate diabetes.

A random blood glucose test can also be used to diagnose diabetes. A blood glucose level of 200 mg/dl or higher indicates diabetes.

When fasting blood glucose stays above 100mg/dl, but in the range of 100-126mg/dl, this is known as impaired fasting glucose (IFG). While patients with IFG do not have the diagnosis of diabetes, this condition carries with it its own risks and concerns, and is addressed elsewhere.

 The oral glucose tolerance test

Though not routinely used anymore, the oral glucose tolerance test (OGTT) is a gold standard for making the diagnosis of type 2 diabetes. It is still commonly used for diagnosing gestational diabetes and in conditions of pre-diabetes, such as polycystic ovary syndrome. With an oral glucose tolerance test, the person fasts overnight (at least eight but not more than 16 hours). Then first, the fasting plasma glucose is tested. After this test, the person receives 75 grams of glucose. There are several methods employed by obstetricians to do this test, but the one described here is standard. Usually, the glucose is in a sweet-tasting liquid that the person drinks. Blood samples are taken at specific intervals to measure the blood glucose.

 For the test to give reliable results:

*     The person must be in good health (not have any other illnesses, not even a cold)

*     The person should be normally active (not lying down, for example, as an inpatient in a hospital), and

*     The person should not be taking medicines that could affect the blood glucose.

*     The morning of the test, the person should not smoke or drink coffee.

The classic oral glucose tolerance test measures blood glucose levels five times over a period of three hours. Some physicians simply get a baseline blood sample followed by a sample two hours after drinking the glucose solution. In a person without diabetes, the glucose levels rise and then fall quickly. In someone with diabetes, glucose levels rise higher than normal and fail to come back down as fast.

People with glucose levels between normal and diabetic have impaired glucose tolerance (IGT). People with impaired glucose tolerance do not have diabetes, but are at high risk for progressing to diabetes. Each year, 1% to 5% of people whose test results show impaired glucose tolerance actually eventually develop diabetes. Weight loss and exercise may help people with impaired glucose tolerance return their glucose levels to normal. In addition, some physicians advocate the use of medications, such as metformin (Glucophage), to help prevent/delay the onset of overt diabetes.

Research has shown that impaired glucose tolerance itself may be a risk factor for the development of heart disease. In the medical community, most physicians are now understanding that impaired glucose tolerance is nor simply a precursor of diabetes, but is its own clinical disease entity that requires treatment and monitoring.

Glucose tolerance tests may lead to one of the following diagnoses:

Normal response: A person is said to have a normal response when the 2-hour glucose level is less than 140 mg/dl, and all values between 0 and 2 hours are less than 200 mg/dl.

Impaired glucose tolerance: A person is said to have impaired glucose tolerance when the fasting plasma glucose is less than 126 mg/dl and the 2-hour glucose level is between 140 and 199 mg/dl.

   Diabetes: A person has diabetes when two diagnostic tests done on different days show that the blood glucose level is high.

   Gestational diabetes: A pregnant woman has gestational diabetes when she has any two of the following:, a fasting plasma glucose of 92 mg/dl or more, a 1-hour glucose level of 180 mg/dl or more, or a 2-hour glucose level of 153 mg/dl, or more.

What are the chronic complications of diabetes?

These diabetes complications are related to blood vessel diseases and are generally classified into small vessel disease, such as those involving the eyes, kidneys and nerves (microvascular disease), and large vessel disease involving the heart and blood vessels (macrovascular disease). Diabetes accelerates hardening of the arteries (atherosclerosis) of the larger blood vessels, leading to coronary heart disease (angina or heart attack), strokes, and pain in the lower extremities because of lack of blood supply (claudication).

Eye Complications

The major eye complication of diabetes is called diabetic retinopathy. Diabetic retinopathy occurs in patients who have had diabetes for at least five years. Diseased small blood vessels in the back of the eye cause the leakage of protein and blood in the retina. Disease in these blood vessels also causes the formation of small aneurysms (microaneurysms), and new but brittle blood vessels (neovascularization). Spontaneous bleeding from the new and brittle blood vessels can lead to retinal scarring and retinal detachment, thus impairing vision.

To treat diabetic retinopathy a laser is used to destroy and prevent the recurrence of the development of these small aneurysms and brittle blood vessels. Approximately 50% of patients with diabetes will develop some degree of diabetic retinopathy after 10 years of diabetes, and 80% of diabetics have retinopathy after 15 years of the disease. Poor control of blood sugar and blood pressure further aggravates eye disease in diabetes.

Cataracts and glaucoma are also more common among diabetics. It is also important to note that since the lens of the eye lets water through, if blood sugar concentrations vary a lot, the lens of the eye will shrink and swell with fluid accordingly. As a result, blurry vision is very common in poorly controlled diabetes. Patients are usually discouraged from getting a new eyeglass prescription until their blood sugar is controlled. This allows for a more accurate assessment of what kind of glasses prescription is required.

 Kidney damage

Kidney damage from diabetes is called diabetic nephropathy. The onset of kidney disease and its progression is extremely variable. Initially, diseased small blood vessels in the kidneys cause the leakage of protein in the urine. Later on, the kidneys lose their ability to cleanse and filter blood. The accumulation of toxic waste products in the blood leads to the need for dialysis. Dialysis involves using a machine that serves the function of the kidney by filtering and cleaning the blood. In patients who do not want to undergo chronic dialysis, kidney transplantation can be considered.

The progression of nephropathy in patients can be significantly slowed by controlling high blood pressure, and by aggressively treating high blood sugar levels. Angiotensin converting enzyme inhibitors (ACE inhibitors) or angiotensin receptor blockers (ARBs) used in treating high blood pressure may also benefit kidney disease in diabetic patients.

Nerve damage

Nerve damage from diabetes is called diabetic neuropathy and is also caused by disease of small blood vessels. In essence, the blood flow to the nerves is limited, leaving the nerves without blood flow, and they get damaged or die as a result (a term known as ischemia). Symptoms of diabetic nerve damage include numbness, burning, and aching of the feet and lower extremities. When the nerve disease causes a complete loss of sensation in the feet, patients may not be aware of injuries to the feet, and fail to properly protect them. Shoes or other protection should be worn as much as possible. Seemingly minor skin injuries should be attended to promptly to avoid serious infections. Because of poor blood circulation, diabetic foot injuries may not heal. Sometimes, minor foot injuries can lead to serious infection, ulcers, and even gangrene, necessitating surgical amputation of toes, feet, and other infected parts.

Diabetic nerve damage can affect the nerves that are important for penile erection, causing erectile dysfunction (ED, impotence). Erectile dysfunction can also be caused by poor blood flow to the penis from diabetic blood vessel disease.

Diabetic neuropathy can also affect nerves to the stomach and intestines, causing nausea, weight loss, diarrhea, and other symptoms of gastroparesis (delayed emptying of food contents from the stomach into the intestines, due to ineffective contraction of the stomach muscles).

What can be done to slow diabetes complications?

Findings from the Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS) have clearly shown that aggressive and intensive control of elevated levels of blood sugar in patients with type 1 and type 2 diabetes decreases the complications of nephropathy, neuropathy, retinopathy, and may reduce the occurrence and severity of large blood vessel diseases. Aggressive control with intensive therapy means achieving fasting glucose levels between 70-120 mg/dl; glucose levels of less than 160 mg/dl after meals; and a near normal hemoglobinA1c levels (see below).

How is diabetes treated?

The major goal in treating diabetes is to minimize any elevation of blood sugar (glucose) without causing abnormally low levels of blood sugar. Type 1 diabetes is treated with insulin, exercise, and a diabetic diet. Type 2 diabetes is treated first with weight reduction, a diabetic diet, and exercise. When these measures fail to control the elevated blood sugars, oral medications are used. If oral medications are still insufficient, treatment with insulin is considered.

Medications for type 2 diabetes

WARNING: All the information below applies to patients who are not pregnant or breastfeeding. At present the only recommended way of controlling diabetes in women who are pregnant or breastfeeding is by diet, exercise and insulin therapy. You should speak with your doctor if you are taking these medications and are considering becoming pregnant or if you have become pregnant while taking these medications.

Based on what is known, medications for type 2 diabetes are designed to:

* increase the insulin output by the pancreas,

*   decrease the amount of glucose released from the liver,

*   increase the sensitivity (response) of cells to insulin,

*   decrease the absorption of carbohydrates from the intestine, and

*   slow emptying of the stomach to delay the presentation of carbohydrates for digestion and absorption in the small intestine.

When selecting therapy for type 2 diabetes, consideration should be given to:

*the magnitude of change in blood sugar control that each medication will provide;

* other coexisting medical conditions (high blood pressure, high cholesterol, etc.);

*adverse effects of the therapy;

*contraindications to therapy;

*issues that may affect compliance (timing of medication, frequency of dosing); and

*   cost to the patient and the health care system.

It is important to remember that if a drug can provide more than one benefit (lower blood sugar and have a beneficial effect on cholesterol, for example), it should be preferred. It’s also important to bear in mind that the cost of drug therapy is relatively small compared to the cost of managing the long-term complications associated with poorly controlled diabetes.

Patients with diabetes should never forget the importance of diet and exercise. The control of diabetes starts with a healthy lifestyle regardless of what medications are being used.

To this end, Alebiosu urged the government to give priority attention to the treatment of the silent killer-disease as being done to others.

He deposed that as part of its own efforts towards the control of the disease, his organisation through a health project would distribute enlightenment materials in form of posters and stickers to major markets, schools, motor parks and all available gatherings during its awareness campaigns nationwide.

Report compiled by Adebayo Folorunsho-Francis with additional reports from medicinenet.com/diabetes_treament and American Diabetes Association

 

 

How often do you need a mirror?

0

During the civil war (1967-1970) I worked as a pharmacist in the Biafran Army, under a medical doctor who was the Commanding Officer (CO) of the hospital unit. My CO was heavily bearded. I was bearded, too, but I did not allow my beard to outgrow his, being my boss. That was how careful I was not to permit anything to cause misunderstanding between us.

However, despite my efforts to maintain a cordial relationship, a misunderstanding occurred between us and he had to order for my transfer to another hospital unit. Luckily for me, the CO of the new unit was my schoolmate, although much senior to me. We related very well and I worked cordially with him until the war ended.

I remember my former bearded CO for one thing. He liked using chewing stick to clean his teeth. Nothing is wrong with that, actually; but my concern was that after chewing the stick he allowed some white bits of the stick to rest on his heavy black beard. On two different occasions, I had to help him remove the particles. I did so because such a thing could happen to me also. Anybody with a beard is always careful when eating to avoid food particles or streak of soup falling on it.

Apparently, my boss was not used to using, mirror to check his face in the mornings before leaving the house. That was why I had to often step in to help him. He should have observed the error himself, if he had used a mirror.

The use of mirror is common, especially among females. Many of them carry small mirrors in their handbags to check their faces when they apply and reapply their cosmetics. Mirrors of various sizes are usually provided in restrooms, offices, cars, hotel rooms, shops and other public places for people to check and correct or adjust themselves, if necessary.

We rely on the mirror because it shows us our true state. Your mirror can never deceive you. It presents a replica of anything and gives you true reflection. You see yourself exactly as you are. If you look into the mirror and see that the knot of your tie is one- sided, it is truly one-sided. If your lipstick is heavy in the mirror, it is indeed heavy.

A mirror does not distort any image. Someone can tell you that you need a haircut but that is merely his opinion. Your own opinion should be determined by the mirror when you look into it.

The Bible describes the Word of God as a mirror. James 1:22-24 says, “Be ye doers of the word, and not hears only, deceiving yourselves. For if anyone is a hearer of the word and not a doer, he is like a man who looks intently at his natural face in a mirror. For he looks at himself and goes away and at once forgets what he was like.”

God’s mirror gives you a true reflection of yourself. The closer you are to the mirror, the clearer you see yourself. Psalm 119:9 asks a pertinent question and then provides the answer: “How can a young man keep his way pure? By guarding it according to your word.”

You use the divine mirror to examine and evaluate yourself. This mirror reflects the thoughts of your heart and the condition of your soul. Do not depend on what people tell you about your moral or spiritual state. People’s opinion can distort, enlarge or diminish what you are on the inside because people can only see your outward appearance. You need the Word of God to check and reveal your spiritual state.

No right-thinking person looks into the mirror, notices a speck on his face, and does not quickly remove it. But many receive the Word of God, without taking necessary actions. If you do so, you are ignoring valuable counsels that could preserve your life and secure your destiny. You must not be only a hearer but also a doer of God’s Word.

2 Timothy 3:16 says, “All scripture is given by inspiration of God, and is profitable for doctrine, for reproof, for correction, for instruction in righteousness.” Just as you use the mirror to check and correct your physical body, so also must you use the spiritual mirror to check the condition of your soul. The spiritual mirror is the only instrument that tells you exactly the type of person you are and your true state before God, regardless of what people think of you.

Most of us use the mirror to make sure we are looking good before getting out of the house in the morning. We should also daily endeavour to check our lives in God’s mirror, the Word of God. I believe we will greatly enhance our physical, as well as spiritual conditions, if we use the two mirrors every time.

 

 

 

 

 

 

 

 

 

Why I don’t attend PSN conferences – Pharm. Adebutu

1

In this interview with Adebayo Folorunsho-Francis, Pharm. (Chief) Timothy Adebutu, a retired principal pharmacist, formerly in charge of the Lagos State Health Management Board (LSHMB) and current manager of his premises – Gem Pharmacy – reveals how he became a pioneer of LSHMB, how his wife’s untimely death cut short his dream of leaving the civil service, as well as his grievances against the Pharmaceutical Society of Nigeria (PSN). Excerpts:

 Tell us a bit about yourself, especially your early days

I was born on 24January, 1932, and attended St James Anglican School, Iperu, Remo, Ogun State, from 1938 to 1945. I proceeded to the Baptist Academy, Lagos (1947–1952) for further studies,after which I enrolled at the Pharmacy School, Yaba, where I qualified as a pharmacist.

 How about your work experience?

I had the privilege of sitting the London Matriculation Examination and passed. Not long after that, I joined Customs & Excise, Lagos. After working for close to a year, I was granted permission to write Cambridge Examination in December. Due to my passion for teaching, I was transferred to the education department in the civil service (Federal Ministry of Health) from 1957 to 1976.

Were you affected by the sudden change?

Well, as a senior pharmacist I was in charge of the health management board. I was made to retain the same position under the Lagos State Government (Lagos State Health Management Board) from 1976 to 1980. Until I retired in 1980, I was the principal pharmacist in charge of the board.

Do you have any regret spending your entire career in civil service?

I am not sure. You see, I planned to retire early in 1960. The reason was because, back then, it was quite attractive to work as a private practitioner than in civil service. Unfortunately, my wife’s death ended that dream forever.

 How did that happen?

Well, I got married to her in November 1959. She was then a London-trained nurse. Those days, nurses were being trained at the UCH (it was not yet owned by University of Ibadan). My wife was among the second set of nurses to be trained there before travelling to London for another one-year course. On her return, she became a nursing tutor in a school opposite Island Maternity, which was still under construction. That was the situation, until I lost her in 1960 when she died in the labour room, struggling to deliver our first child. That incident cut short my dream of moving out which further kept me in the civil service for another 20 years with little opportunity except to retire on pension.

 How do you feel as a pioneer of the modern-day Lagos State Health Management Board?

What else can I say other than “We did our best”? You see, the Lagos State Health Management Board (LSHMB) was actually created in 1972 by the Lagos Ministry of Health. All existing hospitals were drafted under its management and people like me were thrown into the system without proper training or a guideline on how to make the system work. Nevertheless, rather than complain, we poured our vexation into coming up with a grand structure. The health system was systematically organised and became a model of sort. So good was it that other states in Nigeria found it appealing and started adopting it. In fact, it is the same model that is still in use. I can confidently say that was the legacy we (pioneers) left behind. Interestingly, Massey Street was about the only maternity hospital we had in Lagos before the transformation.

 Looking back, can you confidently say studying Pharmacy was a good decision for you?

At that time, it didn’t really matter because I was just after the admission. I could have studied anything. Initially, I thought of studying marine engineering but changed my mind. So the idea of studying Pharmacy just came to me naturally. Besides it was one course where you are expected to finish everything the same day – examination, interview and offer of admission. It was also open to sponsorship.

What was the profession like in your day compared to today’s practice?

Of course, you cannot expect everything to be the same. The School of Pharmacy I attended was a remnant of the Yaba College. In that same Yaba environ, there was a medical school. Back then, when you entered a laboratory, you would see each student in full lab kit. Also it used to be one student to one microscope and other equipment. It is much different from what I have been seeing around today.

I think commerce has taken over the pharmacy profession. I remember in our time, only few hands were on ground and they were quite effective. We were respected because of how disciplined we were. Now, indiscipline has taken over. Although I want to agree that every profession has a black sheep, but among pharmacy practitioners, the act of indiscipline is gross.

Prior to the Nigerian Civil War, there was nothing like ethnic rift and what have you. I could be posted to Sokoto or anywhere. As government students (on scholarship), we were expected to serve the federal government for five years; otherwise you might have to refund the bond you took. Once you started working as a pharmacist, you were automatically required to register with the PSN to show you were qualified. Even Koreans who worked in the country had dual qualification. That should tell you how serious being a pharmacist was back in those days.

What has changed?

We are in a confused state, especially pharmaceutical companies. Everybody just does what he likes. When the expatriates and the multinationals were here, everybody knew how much he was expected to pay for a particular medicine. This is because all the drugs were standardised. We don’t have that professional class anymore. It has been wiped out completely. What we have today is political class. People are just after power. That is why it is quite hard to create a business today and expect to make profit.

What is your view about pharmacists in politics?

That would be ideal if we were in a regulated profession. We need to carefully look at those pharmacists moving into politics. Have they passed through the right channels such as hospital, community, academia or industrial pharmacy? If not, what do they want to contribute there? Politics is a cult. They bring you in and give you their rules and regulations. Tell me, what are you going there to influence? Please prove me wrong if you can – do we have a comprehensive health institution that is based on partnership in this country that succeeded? Only Eko Corp really stood the test of time.

Look at even Juli Plc. Ordinarily, it ought to be a public liability company. However, it is still being run as if it is private. Unfortunately, it has to in order to avoid collapse. I cannot really blame people for most of the things you see in society today. The incursion of the military in Nigerian administration added to our woe. It has not only worsened things but also succeeded in dragging us backward

How best do you think the issue of fake drugs and counterfeit medicine can be curbed?

Pharmacists sold off this profession. They are proving too big to manage it well. We don’t value our profession. What we only know how to do well is to employ labourers, assistant this, assistant that… to help us do something we can do ourselves. The same way we sold this country to the military to manage is the same manner we have traded off pharmacy practice.

The simple truth is that once you give somebody your responsibility, they would hijack it from you. What we call fake drugs is a source of livelihood to those practising it. To them, it is business. In other countries, there are strict laws guarding against counterfeiting. But here, there is laxity. Most of these pharmacists, customs officers and law enforcers know most of these people (counterfeiters) and their activities – right from inspection to delivery stage. However it is a long battle that can be won only when we are sincere to ourselves.

Were you given some sort of recognition for your selfless service?

I believe you know how civil service operates. There is nothing like special reward. My only joy lies in the fact that we pioneered the model of the modern-day Lagos State Health Management Board which is also used in others of the federation. You will agree with me that it is not easy to select few hands and throw them into a system to go and work wonders. We had no training, no prior experience of how to make it work. But we thank God that it all turned out well.

I recall vividly that Jay-Kay (Pharm. Jimi Agbaje) was just coming in as an intern when I was planning for my retirement in 1978. A fine gentleman he turned out to be. Anyway, I quietly retired in 1980.

Did you get any special recognition or award from PSN?

If you read about Pharm. Albert Brown (former registrar of the Pharmacists Board of Nigeria) biography, you will understand how long it took him before he was made a PSN Fellow. Well, that is a story for another day. If there is any honour I cherish more, it has to be the Nigerian Institute of Management which I joined in 1983 as an associate member. I later became a full member in 1997. Owing to my commitment, I soon became a Fellow in 2011.

How often do you attend the annual PSN national conferences?

What will I be doing there when I don’t get PSN’s invitation? Look, I am still a licensed pharmacist, but whenever it is time for renewal, you will be struggling to get it done. Only people who know you would offer to help. In other professions, like Law, this is not so. Barristers will always grant you grace and special recognition. Even in the Nigerian Institute of Management, I was made a Fellow and we are consulted from time-to-time for counsel. But the PSN is different.

What else does it take to get recognised as a Fellow? Have we suddenly forgotten how the PCN came into being? Was it not through the help of Prince Juli (Adelusi-Adeluyi)? It is as if we are not proud to have ourselves as colleagues. So sad.That was why I asked how I would attend PSN conferences when I have not been extended an invitation. If esteemed bodies like NIM can honour me with invitation for major events, what stops the PSN? It is that bad.

 How will you describe pharmacists working in civil service?

Again, you need to read about (Albert) Brown’s biography, you will know that the civil service doesn’t give any recognition to pharmacists. Only women still prefer working in the ministry. The reason is obvious – it affords them the luxury of working and raising a family at the same time. Notwithstanding, to gain experience, I think the civil service is still the best place to go. That is one of the benefits. In fact, the house I am staying was built with the housing loan I got from the ministry. I don’t know how many private companies can do that.

If you were not to be a pharmacist, what other profession would you have opted for?

I would have definitely turned out to be a teacher. I love the teaching profession to the extreme.

 Is there a particular age that an active pharmacist should retire?

It is only death that can separate a practitioner from his profession. Being in a profession does not necessarily mean that you are making millions from it. It is just the joy of doing something.

As an elder in the pharmacy profession, what is your advice to young pharmacists?

Well, I don’t know what to say. I have just observed children of these days (mine inclusive) don’t want to study Pharmacy anymore. Anyway, my only advice has always been “Do the right thing at all times”. Since I have limited time, everything I do now is on short-term basis.

 

WHO prequalification and pharmaceutical innovation

0

In 2005, the African Union (AU) assembly, comprising 55 African ministers of health, adopted a roadmap towards universal access to prevention, treatment and care. The AU policy position is “to pursue, with the support of our partners, the local production of generic medicines on the continent and to making full use of flexibilities within the Trade and Related Aspects of Intellectual Property Rights (TRIPS) and DOHA Declaration on TRIPS and Public Health.”

This decision by the health ministers is in the right direction and offers many advantages, which include foreign exchange savings, job creation, facilitation of technology transfer, prospects of developing cheaper raw materials, increased supply sufficiency and stimulation of export markets. This is besides the national pride and self-esteem that is very much needed in developing countries.

A 2008 International Finance Corporation (IFC) report showed that 70 per cent of Sub Saharan Africa’s estimated $1billion in annual pharmaceutical production is domiciled in South Africa; with Nigeria, Kenya and Ghana contributing only 20 per cent. Six years after, we believe this data is about to change, especially with three more pharmaceutical firms – May &Baker Plc., Chi Pharmaceuticals and Evans Plc. – achieving WHO prequalification status, bringing to four, the number of Nigerian firms accorded the status. Swipha attained the prestigious qualification some months earlier.

At the moment, WHO prequalification is critical to sustainable local productivity in Africa, given the low consumer and institutional purchasing power in the continent, especially for endemic diseases like malaria and HIV/AIDS, for which international funding has become the lifeblood. WHO prequalification is necessary for firms to be able to access these funds, for the local production of the necessary medicines.

While we applaud these achievements, it must be emphasised that, to achieve sustainable development in pharmaceutical innovation, much more efforts would be needed, particularly in the areas of research and development, adequate regulatory frameworks and funding structures. With the projected increase in chronic disease burden and rising infectious disease burden in Nigeria, there is a great need for increased funding of health care systems and research for health in a way that favours indigenous capacity development. Our R & D institutions are in dire need of domestic funding besides the usual international funding. In the pharmaceutical industry, adequate research – industry collaboration are critical for sustaining competitiveness.

At present, Nigeria unlike South Africa which invests 0.9 per cent of her GDP in R&D, invests less than 0.3 per cent. This focus on knowledge building is important as only South Africa possesses the capacity for development of Active Pharmaceutical Ingredients in Sub Saharan Africa. A situation where the greater majority of pharmaceutical research is sponsored by foreign organisations is simply not acceptable and amounts to rent seeking and explains why the few pharmaceutical research endeavours in academic institutions are not aligned with national priorities as “he that pays the piper dictates the tune”.

Nigeria must realise that our often repeated cry of “we don’t have enough resources” is a consequence of not having invested in research and development. “Lack” must not be allowed to hinder progress.

Also, there is an urgent need for a regional policy – especially for drug regulations. We recommend that Nigeria pursue the 2009 recommendation by NEPAD for dug registration efforts to be domiciled with regional economic communities, which, in the case of Nigeria, is ECOWAS. This will help minimise duplication of efforts and yield greater reach for pharmaceutical firms that have attained the WHO prequalification status. With such structures, medications manufactured and registered in Nigeria could easily be sold in every other West African nation and vice versa thereby increasing the competitiveness of the region.

Other crucial areas of focus include: development of human resources, knowledge management expertise and a focus on interdisciplinary interventions. While Africa bears 25 per cent of the world’s disease burden, it has only 1.3 per cent of the health care force, due to the brain drain syndrome. This focus is important because, to achieve quality access to care, we need professionals in our health care facilities. Also, to remain globally competitive, massive levels of skillset and technology transfers must be achieved.

May & Baker gets WHO GMP certification

0

Nigeria’s foremost pharmaceutical company, May & Baker Nigeria Plc, has joined the league of pharmaceutical companies whose manufacturing operations are certified by the World Health Organisation (WHO). The company recently earned the WHO GMP Certificate for its manufacturing facility in Ota, Ogun state, known as the Pharma Centre.

Breaking the news at a press conference on October 13, 2014, Prof. Onyebuchi Chukwu, minister of health congratulated May & Baker along with two other pharmaceutical firms for making the country proud.

The award of the Certificate coincided with the company’s celebration of 70 years of doing business in Nigeria, the first pharmaceutical company so established in the country.

The WHO is the arm of the United Nations that regulates healthcare practice worldwide on the application of international best practice. Its Certificate of Good Manufacturing Practice (GMP) is issued to companies that meet its standards and apply to it for certification. The WHO GMP Certificate will enable the company to offer its products for the pre-qualification process of the WHO and subsequently position for the sales of her products to every market in the world.

It opens the door for foreign countries, donors and agencies to procure the company’s drugs for various health intervention programmes worldwide.

Every year, hordes of patients in resource-limited countries around the world receive life-saving drugs procured through international agencies such as World Health Organisation (WHO), United Nations Children Fund (UNICEF), United Nations Population Fund (UNFPA), UNITAID and the Global Fund to Fight AIDS, TB and Malaria.

While WHO prequalification certification of Medicines Programme ensures that selected drugs supplied by the aforementioned agencies meet international standards of quality, safety and efficacy, the World Health Organisation and the Global Fund, on their part, spends close to N20 billion each year to purchase medicines for malaria, TB and AIDS intervention programmes in Nigeria from countries like Pakistan, India and Brazil because no pharmaceutical industry in Nigeria is pre-qualified.

Hitherto, the country’s pharmaceutical companies were not in a position to partake in international tenders for drugs against the three pandemics that require WHO prequalification. Health experts identify this as a major challenge on the local supply of medicines, especially anti-malarial, anti-retroviral (ARVs) and anti-tuberculosis agents.

That notwithstanding, the good news is that top Nigerian pharma giants such as May and Baker and others have now joined other global firms in producing medicines that conform with WHO-current Good Manufacturing Practice (WHO-cGMP) standards, a condition for WHO pre-qualification.

Chairman of May & Baker, Lt-Gen. Theophilus Danjuma (rtd) disclosed that following the policy of future based investments projected by the management, the company saw the need for global best practice and competitiveness.

“That was why we embarked on a long term project to seek international accreditation for the manufacturing processes of the company. The first step was to build a factory that would meet the standards of the World Health Organisation (WHO) in Good Manufacturing Practice (GMP) and other ramifications.

“That factory was completed and commissioned in 2011. Now, we are on the verge of obtaining WHO GMP certification for this facility and Prequalification for our products,” he said.

Danjuma strongly believed that above all, May & Baker’s quest for global best practice would further open a floodgate of interests in the Nigerian pharmaceutical manufacturing industry.

The chairman also commended the efforts of government through the Federal Ministry of Health and the National Agency for Food and Drugs Administration and Control, (NAFDAC), which he declared as assisting growth in the pharmaceutical industry.

This hope was fulfilled less than two weeks later.

His optimism was equally shared by the managing director, Pharm. Nnamdi Okafor who said the company has transformed into a global player through the years.

“I can confirm to you that the company has, in the past eight years, been rejuvenated, renewing itself with huge investments in two world class factories, research & development, human capital development and technology / process optimisation,” he said.

He summed it up by reiterating that with the aforementioned initiatives, May & Baker Nigeria is good to go!

In Africa, only South Africa, Morocco, Uganda and Nigeria have WHO GMP certified companies.

It would be recalled that May & Baker Nigeria Plc commemorated her 70th anniversary at Muson Centre, Onikan, Lagos on September 11, 2014 with several pharmacists, government functionaries and relevant stakeholders in the health sector in attendance.

As part of the 70th anniversary celebrations, the pharmaceutical giant donated sickbays to three primary schools in a national project of corporate social responsibility.

According to the company’s managing director, “It is our hope that these facilities will assist the management of the schools and those around them to provide emergency and primary healthcare to the young ones while in school.”

Each sick bay is fully air conditioned and equipped to the standard of a clinic with beds, medical instruments, drugs, recovery motifs and television sets to enable the children feel less of their pains while receiving attention.

The pioneer beneficiary schools were Central Primary School, Ikeja; United African Methodist Primary School, Eleja and St Agnes Primary School, Sabo-Yaba, Lagos.

On September 9, senior officials of May & Baker also made a visit to four charity homes in Lagos and Ogun States with products and other gifts for the inmates.

The company was founded on September 4, 1944 as Nigeria’s first pharmaceutical company and began local manufacturing of pharmaceuticals in 1976. In 2002 the company became 100 per cent owned by Nigerians with the complete buyout of the foreign partners who had decided to divest.

 

May & Baker facility in Ota
The WHO-certified May & Baker Pharma Centre in Ota

 

 

 

ACPN joins Global Handwashing campaign

0

Global Handwashing Day, celebrated every 15 October, is a worldwide campaign to sensitise and mobilise people around the world to wash their hands with soap. This year’s edition, with the theme, “Choose Handwashing, Choose Health,” is essentially meant to raise awareness about handwashing as a key approach to prevention of diseases.

According to a press release by the Association of Community Pharmacists of Nigeria (ACPN), signed by its national chairman, Pharm. (Alh) Olufemi Ismail Adebayo, handwashing is a choice that everyone can make many times a day.

“When people choose to wash their hands with soap, especially after using the restroom and before touching food, they are choosing to create a healthier environment, not only for themselves but for people around them,” it said.

The statement further urged people to imbibe handwashing, not only on Global Handwashing Day but every day.

It noted that handwashing focuses on children because research has shown that children are the segment of the society that are energetic, enthusiastic, and open to new ideas, adding that they are powerful agents of change for behavioural shift like handwashing with soap in their communities.

The ACPN national chairman however disclosed that the association, as a key stakeholder in healthcare delivery, had been marking the event with visits to primary and secondary schools, with practical demonstration of proper handwashing with soap under running water, since 2011.

“We believe that a vast change in hand washing behaviour is critical to meeting the Millennium Developmental Goals (MDGs) of reducing mortality of children under 5 years by two third by year 2015.Handwashing with soap under running water still remains the cheapest and most effective way to prevent Ebola, diarrhea, typhoid and respiratory diseases,” he said.

Enterprising Nigeria: The role of bishops

0

In his book, The Business Angel as a Missionary, Prof. Pat Utomi gave details on his “evangelical” stewardship in the Nigerian business terrain; his efforts at promoting social good through entrepreneurship and management education. In the book, he made it clear that contrary to the pervasive drive for material acquisition which underlies most capitalist pursuits, his big, audacious goals were driven more by an altruistic commitment to social welfare rather than personal enrichment. His commitment and those of many like him have yielded Africa’s premier management learning organisation – the Pan African University.

I have, in previous essays, noted that his life has in many ways engendered my own commitment to the development of men and women in the marketplace, whose primary motivations are driven more from long–term social good, rather than the immediate bottom line.It is a path that I have, in my own little journey so far, found to be very educating with numerous challenges. It is easy to understand why this path is not appealing to many; hence the aim of this article is not to disparage those to whom it would be an anomaly but to embolden those to whom such has earlier occurred.

Recently, in a speech to a group of NYSC members who had just arrived the city of Lagos to undertake the mandatory one year service to motherland, I had cause to share with them my reflections on similar chains of thoughts which I seek to describe and expand below.

 Solving Nigeria’s biggest problem

Our unemployment statistics is no longer news.We know the figures.What I believe we are too quick to miss are the implications of the status quo and our current disposition. For one, more than 70 per cent of our population are young people who naturally constitute the greater bulk of the unemployment data. Of this population, employers believe that a lot of them are not employable.

Our problem is more of a human capital problem than anything else. By human capital I refer to human capital management and development.In spite of our peculiar challenges, a lot of organisations in Nigeria would do a thousand times better if their leaders had a more capable followership.

According to a study by an indigenous consultancy firm, Conceptual Strategy Limited, the following constitute the critical skill-set required by employers in the global marketplace.

 

  1. Business communication skills – Employers know there is a big problem when they have to write every letter and review every corporate communication from their organisations. When the CEO has to draft every concept note himself, the centre is not exactly holding. This skill-set includes achieving structure in thinking and writing; knowledge of Basic Englishand the ability to write concept notes, proposals and project/business plans.

 

  1. Analytical skills – Seeing the big picture is essential here.The ability to put two and two together is not necessarily an inherent trait; it is a product of consistent use of the analytical part of our brains. The “cram and pour” education system in Nigeria has succeeded in dulling the greater majority of her products; students no longer read to understand. Analysis is impossible when understanding is lacking.
  1. Strategic thinking, problem solving and value creation – This is a product of the interplay between technical, conceptual and analytical skills. In Nigeria, the greater majority of employees have just the technical skills – i.e., sufficient skill-set to get the designated job done (as written in the job description). The problem with this is that, in a knowledge economy, the job description is not constant, it is a moving target.
  1. Office tools – This, essentially, is the ability to use MS-Word, MS-Excel, MS-PowerPoint, MS-Access and MS-Outlook.

 

  1. Leadership and organisational skills–Organisations are as big as the number of good leaders they have and not in the size of their captain-leader. An organisation with ten good middle level leaders and an average captain-leader will always outperform one with one very good captain- leader but mediocre middle level leadership.

The international dimension

From the above, it is evident that we do not have sufficient human capacity for our present challenges. The situation looks even grimmer when we consider the effects of global competition. It is not just that we are losing our best brains to Europe and North America; our import-driven economy is helping sustain a culture of consumerism that does not encourage the development of the enumerated skill-set.

A case study of the Nigerian pharmaceutical industry points out the obvious – greater than 90 per cent of our workforces are salesmen.Not that there is anything wrong with sales, but we are made of more.Even the Pharmacy curriculum did not fathom that the demand for our skills would be so skewed in the sales direction. Also, there is always the threat of foreign competition when our manufacturing sector is non-competitive.

 The challenge

The challenge therefore is to expedite human capacity development andcreate a demand for such development in such a way that could be self-sustaining with the government providing the necessary catalysts for favouring the forward direction of such a chemical reaction.It is a challenge that only business leaders – bishops – can make happen.

 The role of bishops

A bishop, by definition, is an overseer, a leader. Bishops play critical roles in religious settings, in academic settings and in political arenas. In this context, however, I wish to limit the definition of bishops to that of business leaders. To me, the role of business leaders in the development of societies is one of the most crucial roles in any society, particularly in capitalist societies like ours.

Business leaders play the following functions:

  • They win and administer the contracts that comprise the majority of the government’s budget.
  • They administer the pooled resources of the society – the insurance, pension funds and savings of the public and the government in banks are all managed by bishops.
  • They manage the resources of the government, e.g. oil wells, firms, etc.
  • They employ the greater majority of the society directly or indirectly.
  • They directly and indirectly influence the quality and quantity of the food on the table of the society in the form of wages and salary.
  • They influence the election of the personnel into government positions.
  • They are lobbied by government to bring in investment and drive economic growth.
  • They lead efforts in the creation of new products and services and determine the level ofindustrialisation of the nation.
  • They are great leaders and are often paid premiums for administering the funds of the nation.

 

The role of bishops in the society is a noble one.They are critical to the advancement of the public good and their focus on profit maximisation or national development would make or mar any civilization. Their commitment to reversing the human capital trends in Nigeria is going to be the critical factor in our quest for national renewal and survival.

Business leaders are more equipped to engage the ruling elite than the mass of the population put together.They are articulate enough to fashion win-win situations for advancing the cause of the Nigerian nation and, much more than labour, they are in the best position to make governments move in a particular direction.

In essence, the problems of the Nigerian polity as it is presently constituted are mainly because business leaders do not know that they are the ones that will change things and partly because of pervasive selfishness.

In the pharmaceutical industry, if we keep waiting for the day the Nigerian government will form the Nigeria Pharmaceutical Export Promotion Council, for example, we might wait forever. A cohesive strategic thrust between business leaders in the pharmaceutical industry will achieve a lot more than any single government intervention, much more when such government interventions are at the impulse of business leaders.

This, however, is not to say that our business leaders are not thinking and acting in this light. I know they are; what is being canvassed is the nobility and urgency of our task.

A particular biblical reference in 1 Timothy 3:1 reads, “He that desires the office of a bishop desires a noble task.” I have found that passage particularly enlightening as it emphasises the power of a noble desire.The rest of the passage outlines the characteristics of a bishop, which, essentially, is that he should be someone able and worthy of influence; the individual should be able to build up the people under his headship so that they can attain to greater heights. This deliberate commitment to capacity development is pretty scarce.

I suggest that firms develop internship positions that are focused on giving management experience to personnel that desire to gain such at the pay they can afford. From my experience, I know that there are many young people who know that such exposure is their only passport to demonstrating their unique contributions to national development.

The bishopric of some of Nigerian business leaders is such that doesn’t bring the level of guts required to take Nigeria out of her current quagmire.It is as if we are all in it for ourselves. As shown above in the roles of bishops, the effects are far-reaching.

Capitalism, as it is presently defined – the maximisation of shareholder’s wealth – is often tilted to the wealth part rather than the shareholder part. We often forget that, as long as we maintain our market share, the growth of the society will reflect in the growth of our private economies.

In Nigeria, the greatest shareholder is the society, whose collective wealth bishops are directly and indirectly supervising.Their actions and inactions would, to a large extent, determine the nature of the nation at the end of the day.We saw such in the banking industry – a few greedy individuals, by their actions, squandered the collective commonwealth of some of us.

 Noble is not necessarily easy

Now, nobility is not necessarily easy, at least in Africa. The path to industrialisation for Nigeria would mean going against global expectations; it would mean renegotiating the terms of our partnerships and suffering the punishments that would come from our “late enlightenment”.Yet it is the only path we can take to escape being the perpetual recipients of global pity parties as is presently witnessed by our siblings in Liberia and Sierra Leone. To do that we must tell ourselves the truth – that our biggest asset is our people and that to be a bishop is much more than a survival engagement or a wealth club – it is a noble calling that reckons with God and man.

Ebola: NANNM mourns slain nurses

0

Members of the National Association of Nigerian Nurses and Midwives (NANNM), Lagos branch, recently took to the streets to mourn their colleagues who lost their lives in the line of duty to the Ebola Virus Disease (EVD).

The nurses, who were clad in black, commenced the candlelight procession from Agidingbi down to the Ministry of Information, Alausa, Ikeja, chanting different dirges, as well as the nursing anthem.

Speaking in an exclusive interview with Pharmanews, NANNM Chairperson, Mrs Olatunde Olushola, explained the essence of the candlelight procession, describing it as the association’s way of mourning its Ebola-slain members, as well as sensitising the government and the public on the need to recognise and compensate the family members of the dead nurses.

“Government and the public have not been mentioning the nurses that died in the line of duty, while caring for Ebola patients. We are all equal before God; so, both the nurses and the doctors that lost their lives due to EVD deserve the same recognition. Moreover, nurses are the first and last contact patients meet in the hospital. And after Nigeria has been declared Ebola-free, nurses will still continue to talk about the disease as well as enlightening patients on it,” she stressed.

Olushola further emphasised the need for government to lead by example, by appreciating nurses, in order to correct the widespread notion that nurses are nobody in the health care team.

“Our government should not wait until nursing will be relegated to the background, as it is often said to us that nurses are nobody in the health sector; it is as if they are ants before the government. If the government believes that there is equality in what we called life, then they should do what is right.”

A sorrowful Olushola, who identified the late nurses as Justina Echelonu and Ukor Evelyn, both staff of First Consultants Hospital, Obalende, said this was the first time in her tenure that the association would lose two nurses to an epidemic in quick succession.

She also faulted the one-sided clamour for the immortalisation of Dr Stella Adadevoh, describing it as an aberration.

“I want to believe that even if it is a health attendant or a security man that died in the course of treating Patrick Sawyer, I think they should be compensated. For government to be mentioning Adadevoh alone, is an aberration. It shows how little the government t appreciates the nursing profession,” she said.

Also speaking on the event, NANNM Secretary, Mr Otaro Daniel, urged the government to console bereaved relatives by shouldering major responsibilities left by the deceased nurses, as well as putting machineries in place to prevent such occurrences in the future.

Comrade Akintunde Ibironke, NANNM’s state auditor II, also expressed her sympathy for the bereaved, urging them to take solace in the Almighty God.

“But at the same time, we still want the government to do one or two things for us. We want to immortalise our nurses; we want the government to recognise the pains that the family members are going through in terms of what they are doing for Dr Adadevoh, and they should do for them too,” she noted.

Ibiroke further added that “as regards our hazard allowance, though we cannot measure money with life, at the same time, we expect the government to revisit our hazard allowance so that we are sure of taking something home that measures up to the type of services we are rendering. We have a lot of nurses working in IDH and they are being exposed to these diseases every blessed day. Again, we need protectives to guard against these infectious diseases which should be supplied at regular interval.”

Addressing the nurses at the government secretariat, Lagos State Commissioner for Health, Dr Jide Idris, said the government was making adequate provision to reward every one that suffered in one way or the other in curtailing the Ebola disease.

He explained that Governor Babatunde Fashola had invited and met with the survivors of all the deceased health workers and not just the doctors, adding that “while some turned up, some did not come. However, we have agreed to support the hospital, by asking them to show us the way in which we can support them.”

He assured that the government would not discriminate in its compensatory efforts.

“I also want to join you in commiserating with the families of the bereaved. I also pray that we don’t see something like this in the future,” the commissioner said.

 

How nutrition, detoxification prevent prostate cancer, by Prof. Ashiru

0

In this exclusive online interview with Temitope Obayendo, Professor Oladapo A. Ashiru, a consultant reproductive endocrinologist at the Mart-Life Detox Clinic, Lagos, disclosed causes of prostatic cancer, and more interestingly, how the rich components of human diets, exercise and reduction of inflammation and oxidation process in the body can prevent the development of prostate cancer. Excerpts:

As a human anatomy expert, could you explain the likely causes of prostate enlargement?

Prostatic enlargement is due to the Androgen deficiency of the adult male. Basically, some hormone imbalance, principally DHEA in men.

What is the population of Nigerian men with prostate enlargement?

According to Dr. Abia Nzelu, coordinator, National Cancer Prevention Programme (NCPP), prostate cancer kills 14 men in Nigeria every day.

What are the symptoms to indicate the onset of benign prostatic hyperplasia (BPH)?

Symptoms may include urinary problems such as frequent urination, inability to urinate, difficulty starting or stopping the urinary stream, dribbling, pain, blood or semen in urine. Other symptoms, like frequent pains in the lower back, hips or thighs, could be noticed, including pain on ejaculation.

 

When does prostate enlargement become cancerous?

If left untreated, the benign prostatic hyperplasia becomes malignant after some years.

What are the available preventive and treatment options for prostate cancer?

Studies have shown that lifestyle, especially nutrition and exercise, has significant influence in prevention and treatment of prostate cancer. Inflammation and oxidation of body cells are natural processes that contribute to the development and progression of prostate cancer. However, environmental toxins and carcinogens also play a major role in developing cancer of the prostate.

Excess weight has been associated with rapidly progressive prostate cancer, which is a severe form. Therefore, incorporating good nutrition, exercise and detoxification (body cleansing) reduces inflammation and oxidation process in the body. At Martlife Detox Clinic, in collaboration with Viva Mayr Centre (Austria), we teach and practise a holistic approach to prevent and manage prostate cancer. Our focus is to maintain optimum health by conducting advanced diagnostic tests, detoxification programmes, health education, nutrition and exercise.

Nutrition can influence cancer prevention and treatment; therefore we encourage eating of foods rich in anti-inflammatory and anti-oxidant substances, such as colourful fruits, ocean-caught fish, flaxseed oil, vegetables, whole grain and spices. Also, you can increase the protective anti-inflammatory components of your diet by cooking properly. Therefore, a diet rich in anti-oxidants, low in pro-inflammatory and carcinogenic substance can make a difference in prostate cancer prevention and treatment.

Orthomolecular supplements help in prevention and treatment of prostate cancer; they include vitamins, carotenoids, and mineral supplements like selenium, folic acid, calcium, magnesium and zinc.  Vitamins are essential in preventing and treating prostate cancer. They include vitamin C, B3, and vitamin E, which is an anti-oxidant that decreases concentration of free radicals that can lead to cancer. Lycopene is a naturally occurring chemical that gives fruits and vegetables a red colour. It is one of the numbers of pigments called carotenoids. Lycopenes is found in tomato, watermelons, pink grapefruits, apricots and pink guavas. Lycopene is a powerful anti-oxidant that may help protect cells from damage. Studies have revealed that lycopene supplements help in preventing prostate cancer.

Magnesium plays an essential role in DNA repair, cell differentiation and proliferation, apoptosis and angiogenesis. Magnesium deficiency is also linked to inflammatory response and oxidative stress; therefore this can alter multiple pathways to cause cancer. Research carried out by the National Cancer Institute found out that higher blood magnesium levels are associated with a lower risk of prostate cancer.  Calcium has been identified to reduce the risk for prostate cancer, especially in black men and lowers the risk for high grade cancer among all men.  Co-enzyme Q10, also called ubiquinone, has been reported to have anticancer properties, as well as folic acid.  Selenium is a mineral supplement, a trace element that is important in prevention of cancer.  Zinc is noted to shrink enlarged prostate glands and is helpful in the prevention and treatment of prostate cancer.

Detoxification is also very helpful. It is the process of cleansing the body from accumulated toxins. These toxins could be derived from the environment or the food we consume daily. Mart-Life Detox Clinic is fully equipped with advanced technology and trained professionals to deliver expert detoxification process which is the core element of any treatment. Emphasis is placed on rest, strict cleansing of the digestive system, and removal of heavy metals by foot hydrolysis detox.

Regular exercise is essential in preventing prostate cancer. This enables one lose excess weight, which is a risk factor for this disease. It helps in reducing the inflammatory and oxidative processes that assist in carcinogenesis.

How best can prostate cancer be managed?

The management of prostate cancer has different treatment options, which depend on the stage of the cancer. These include: watchful waiting, surgery, radiation, hormone therapy or chemotherapy. The choice of treatment depends on the age of the patient and doctor’s recommendation, but most people advocate watchful waiting.

Mart-Life Detox Clinic has successfully managed prostate cancer patients with our Mayr medical practice, which is based on principles of rest; cleansing; re-education of eating habits; nutrition; orthomolecular supplements to hinder the inflammatory and oxidative processes in carcinogenesis; exercise; meditation; and self-discovery.

There is also hormonal treatment, which involves the use of LHRH antagonist like Lupron depot hormones to decrease the size of the prostatic enlargement. The same hormone, Lupron or zoladec, is used in the female to reduce fibroid size.

A recent surgery research has revealed that one in three men treated with surgery or radiation will have cancer return. However, the choice of surgery should be ONLY as a last resort.

 

 

 

Atueyi bags PEFON Fellowship

0

Managing Director of Pharmanews Limited, Sir (Pharm.) Ifeanyi Atueyi, was among 22 distinguished personalities recently made Fellows of the Professional Excellence Foundation of Nigeria (PEFON).

PEFON, which has Prince Julius Adelusi-Adeluyi, managing director of Juli Plc as chairman, board of trustees, aims to identify Nigerian professionals, home and abroad, who have excelled in their chosen fields.

The induction ceremony, graced by several captains of industries and other professionals, took place at Hotel Victoria Palace on 27 September, 2014.

Dignitaries at the occasion include Sir (Dr) Oladipupo Bailey, founder of the foundation; Chief Badru Olaogun, oath administrator; Engr Also Abdullahi, director (steel development), Ministry of Mines & Steel Development; Mr.Dozie Atueyi, executive director of Pharmanews, representing the managing director; Kunle Aderinokun, associate editor in THISDAY newspaper and Olufemi Okeleye, PEFON secretary

In his welcome address, Bailey declared that PEFON was practically the only Foundation that aims to bring distinguished professionals from all walks of life under the same umbrella.

He stressed that, aside giving special recognition to those who have excelled in their chosen careers, the body’s objectives also include raising scholarship funds to assist young ones become professionally qualified, as well as identifying those who, though are not professionals, have established conglomerates that have employed a large number of professionals.

“We strive to celebrate people like Pa Akintola Williams who is about to celebrate his 95thbirthday,” he said.” He is one of those celebrated professionals we like to recognise.”

Explaining more about the purpose of the Foundation, Bailey said, “Today, we have many graduates roaming the streets; some riding okada with good grades. These are some of the people we hope to engage and solve this shortage of manpower in Nigeria. By so doing, we will be building the right leaders for this country.”

Sharing Bailey’s optimism, Adelusi-Adeluyi remarked that there was nothing as grand as an idea whose time had come.

He said, “In Nigeria today, I make bold to say that about 0.05 per cent of the 170 million people are the ones who really run things in this country. Majority are mostly onlookers. Therefore it became imperative to repromote character formation.”

The former minister of health however lamented that good people were not often celebrated in the country.

“It is only when one dies, you hear statements like ‘You are the best president Nigeria never had.’ This is one area PEFON hopes to change. How can we do this? As professionals representing every facet of life, we will continue to grow steadily. By the time we reach about 100 members, we will then gradually start exerting our influence. That is why I congratulate you all, especially our new inductees,” he emphasised.

The induction of Atueyi has increased the number of pharmacy professionals with PEFON Fellowship.

Others include Dr (Mrs) Stella Okoli, chairman, Emzor Pharmaceuticals; Prince Julius Adelusi-Adeluyi, managing director of JuliPlc; Dr Michael Oyebanjo Paul, chairman, Mopson Pharmaceutical Limited; Dr Nelson Uwaga, former PSN president and incumbent president of the Nigerian Institute of Management (NIM); and Pharm. Olumide Akintayo, PSN national president.

Why we organised Sir Atueyi competition – PANS president

20

In recognition of his contributions to pharmacy profession and continued support to pharmacy schools in the country, the recently launched National Essay and Debate Competition has been named after Pharm. (Sir) Ifeanyi Atueyi, managing director of Pharmanews Limited.

The maiden edition of the event, organised under the aegis of the Pharmaceutical Association of Nigerian Students (PANS) in partnership with Faculty of Pharmacy, University of Benin (UNIBEN), was held at the Old Lecture Theatre, Faculty of Pharmacy, UNIBEN, Edo State.

The competition, which witnessed a huge turnout of pharmacy students, was slated for participants from the University of Benin (host); OlabisiOnabanjo University, Ago-Iwoye, Ogun State; and Igbinedion University, Okada, Edo State. However,the representative of Igbinedion University arrived late and, therefore, could not participate in the debate.

Explaining the rationale behind the honour accorded the Pharmanews boss, Samuel Lena, president, PANS UNIBEN, explained that it was the association’s way of appreciating Sir Ifeanyi Atueyi for his contributions to the progress of pharmacy profession in Nigeria and beyond.

Lena further hinted that the competition was already working on modalities to ensure the annual event rotated across pharmacy schools in the country, even though the idea originated from UNIBEN.

“We want it to move across all institutions where Pharmacy is being studied because Sir Ifeanyi Atueyi himself is a man for all,” he remarked.

The actual debate contest, which centred on two topics, “Our Worst Fear, Government or The People?” and “Resolving the Problem of Militancy in Nigeria: Is Amnesty the Way Forward?”, saw Ganiyat Atinuke Alaraba of OlabisiOnabanjo University, Ago-Iwoye emerging the best speaker.

Beaming with smiles, Alaraba disclosed that the competition had boosted her self-confidence, adding that Pharm. Ifeanyi Atueyi had always been a source of inspiration to her.

“I am always proud of him because the first time I heard that the publisher of Pharmanews is a pharmacist, I was surprised. Aside the uniqueness of the journal and its popularity, Pharm. Atueyi continually gives people like me hope that Pharmacy is not all about what you learnt in school but a vision born out of passion,” she said.

Speaking in the same vein, Toyosi Odusanya, a 500-level student of Olabisi Onabanjo University, whose school came second in the debate, described Sir Atueyi as a versatile motivator and mentor.

“Even though I have never had the opportunity to meet him in person, the Pharmanews journal and several of his books have been quite motivational to me. It got me thinking that if someone who graduated as a pharmacist can do well in the world of journalism, the sky is the starting point for people like us who still see him as a mentor,” he noted.

Odusanya further suggested that for future editions of the competition, the judges should be picked from other institutions other than the host school to add more credibility to the event.

Shortly before the debate winners were announced, a list of the top ten winners of the essay writing competition was read out.

According to the organisers, a total of 50 entries were submitted by Pharmacy students from the 15 participating schools. Two of the 10 winners were announced joint winners after clinching first position. They were Onuwabagbe Lisa, University of Benin with 36.5 points and Igodo Uzo also from the University of Benin with 36.5. Others were Agboola Samuel Olakunle from the University of Ibadan, second position, with 35.5 points; Robo, University of Benin, third position, with 35 points.

While presenting the prizes to the winners, Mr Adebayo Folorunso-Francis, who represented Sir Ifeanyi Atueyi at the event, commended the organisers of the competition for a job well done, adding that aside developing the students academically, the competition would also foster unity among pharmacy schools across the nation.

The sums of N60,000 and N40,000, courtesy of Greenlife Pharmaceuticals, were presented to the winner and runner-up of the debate competition respectively, while winners of the essay writing competition were equally rewarded.

Other dignitaries at the event include Dr Patrick Igbinaduwa, senior lecturer, Department of Pharmaceutical Chemistry, University of Benin; and Pharm. Ayo Akinsola, sales manager, Institutions, Shalina Healthcare Nigeria Limited.

Why Pharmacy in Nigeria needs total change, by CPFN president

0

With recent advancements in pharmacy practice globally, the National President of the Christian Pharmacists Fellowship of Nigeria (CPFN), Pharm. (Sir) Ike Onyechi, has called for a comprehensive reform of pharmacy practice in Nigeria, in order for practitioners to compete favourably in the global arena. Speaking to Pharmanews in an exclusive interview, the managing director of Alpha Pharmacy and current winner of the Ikeja Golf Club Eid-el-Kabir Kitty tournament, also discusses the activities of CPFN and the need for a more progressive PSN in the nearest future. Excerpts:

Thinking of PSN at 87, can it be said that Pharmacy has positively affected the nation so far?

Yes, I can say that Pharmacy is evolving, growing and getting better by the day. We wouldn’t forget that we started as dispensers of drugs so many years back, and from a diplomate course, Pharmacy has evolved into a professional course, awarding degrees. We now have West African Post graduate College of Pharmacists (WAPCP), which is now interfacing the public to meet their needs. Also from about three pharmacy schools during our school days in the 1970s, now we have 19 pharmacy schools. So it’s a great improvement compared to the beginning, because it was only OAU that was offering Pharmacy as a course before UNN, ABU, UNIBEN, UNILAG and other universities joined in.

The quality of learning has also improved along the line, and we are hoping to get better. In practice, Pharmacy has also changed from drug-focused to patient-oriented. There is so much enlightenment on pharmaceutical care, and this has resulted in the creation of counselling space in most pharmacies. However, there is still room for improvement.

 The theme of the 87th PSN conference is “Transforming Pharmacy Practice for Better Outcomes”. From your experience and interactions, which areas of the profession need to be changed?

The needed change should be total and holistic. While I admitted in your previous question that we are getting better, it’s on a relative term. During FIP conferences, we normally observe the level of discussions from participants from Australia, UK, France, USA, and others, and we have discovered that the level of their contributions is usually far from where we are. So we need to retool and change the process before we can think of better outcomes.

For better outcomes, the tools will change, and the curriculum needs to change. The way and manner in which lecturers teach students, as well as the quality of facilities used, need massive upgrading for better outcomes. We need to change from the admission policy, to teaching and facilities.

We need also to look into manufacturing areas for change options, remunerations to pharmacists at all levels of their work, need to be improved. Whether you are lecturing, community-based or hospital-based, the entry points into pharmacy have increased, so should the reward be increased. The community pharmacists will have to upgrade from small shops to bigger pharmacies, with available areas for counselling. Also, the aesthetics of pharmacies need to be upgraded in order to compete with global standard. Pharmacies should devote enough space for wellness products, for instance, Alpha Pharmacy in Enugu has specially created a section for wellness equipment like Bicycles, Tennis Boards, Golf Kits, Lawn Tennis rackets and Boards, thread mills, and so on.

CPFN was in Uyo last month for its conference, in preparation for the 87th PSN conference. Were there divine instructions received for the leadership of the profession?

Yes, though not a direct “thus says the Lord”, we had a very good outing and a fulfilled session. We had a lot of interactions on the theme, “Fulfilling Your Purpose”. Pharmacists were reminded of their purpose as co-workers with God to preserve the health integrity of men. Also as labourers in the vineyard of God, we were admonished to take our work more seriously, with more humility, dedication and commitment, with the goal of improving the quality of life of the average man. Pharmacists also need to find ways of serving God within the profession, by demonstrating more compassion towards patients and giving free drugs to the less-privileged.

As the national president of CPFN, what are your plans to check the unethical attitudes of some Christian pharmacists who keep three jobs at a time, as well as defraud companies?

You can only say that many of them are Christians; but in the real sense of it, they are unbelievers. This is happening, not because they are pharmacists, but due to the morally depraved society we find ourselves. And this is why CPFN has been praying for an improved and healthy society – a society that will work with less greed, where there is less grabbing, and so on.

There are also many nominal Christians, who could be as high as 80 per cent, in some congregations. Thus the society needs a holistic change from leadership to followership, from top to bottom. If you get to Europe, many of them are not Christians, but have high moral standard. This calls for intercessory activity on the part of all Christians, and that is part of our obligations at CPFN.

As the Christian umbrella of PSN, what roles has CPFN played in the faceoff between medical doctors and other health workers in the country?

CPFN, in each of our outings, has always prayed for peace. According to the Holy Writs in Hebrew 12:14, “Pursue peace with all men and holiness, without which no one shall see God.” To pursue means to make efforts to be at peace with all men. This is the guiding principle of Christian pharmacists, to be at peace with all men, doctors or non-doctors. We are not regulators. Government representatives are already wading into the issue, but our God can do more.

What is CPFN’s vision for PSN in the next five years?

In the next five years, we would like the PSN to have resolved all its internal acrimonies. We want to see a more mature PSN that will have this guiding principle of finding peace with all and sundry, with a more peaceful coexistence within its ranks and files, with other associations and health workers.